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ABSTRACT
USE OF STATISTICAL ANALYSIS, DATA MINING, DECISION ANALYSIS
AND COST EFFECTIVENESS ANALYSIS TO ANALYZE MEDICAL DATA:
APPLICATION TO COMPARATIVE EFFECTIVENESS OF LUMPECTOMY
AND MASTECTOMY FOR BREAST CANCER
Beatrice Ugiliweneza
November 4t\ 2011
Statistical models have been the first choice for comparative effectiveness in clinical
research. Though effective, these models are limited when the data to be analyzed do not
fit the assumed distributions; which is mostly the case when the study is not a clinical
trial. In this project, data mining, decision analysis and cost effectiveness analysis
methods were used to supplement statistical models in comparing lumpectomy to
mastectomy for surgical treatment of breast cancer. Mastectomy has been the gold
standard for breast cancer treatment for since the 1800s. In the 20th century, an
equivalence of mastectomy and lumpectomy was established in terms of long-term
survival and disease free survival. However, short term comparative effectiveness in
post-operative outcomes has not been fully explored. Studies using administrative data
are lacking and no study has used new technologies of self-expression, particularly the
internet discussion board. In this study, data used were from the Nationwide Inpatient
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Sample (NIS) 2005, the Thomson Reuter's MarketScan 2000 - 2001, the medical
literature on clinical trials and online individuals' posts in discussion boards on
breastcancer.org. The NIS was used to compare lumpectomy to mastectomy in terms of
hospital length of stay, total charges and in-hospital death at the time of surgery.
MarketScan data was used to evaluate the comparative follow-up outcomes in terms of
risk of repeat hospitalization, risk of repeat operation, number of outpatient services,
number of prescribed medications, length of stay, and total charges per post-operative
hospital admission on a period of eight months average. The MarketScan was also used
to construct a simple post-operative hospital admission predictive model and to perform
short-term cost-effectiveness analysis. The medical literature was used to analyze long
term -10 years- mortality and recurrence for both treatments. The web po stings were used
to evaluate the comparative cost to improve quality of life in terms of patient satisfaction.
In NIS and MarketScan data, International Classification of Disease, 9th revision, Clinical
Modification (lCD-9-CM) diagnosis codes were used to extract cases of breast cancer;
and ICD-9-CM procedure codes and Current Procedural Terminology, 4th edition
procedure codes were used to form groups of treatment.
Data were pre-processed and prepared for analysis using data mining techniques such as
clustering, sampling and text mining. To clean the data for statistical models, some
continuous variables were normalized using methods such as logarithmic transformation.
Statistical models such as linear regression, generalized linear models, logistic and
proportional hazard (Cox) regressions were used to compare post-operative outcomes of
lumpectomy versus mastectomy. Neural networks, decision tree and logistic regression
predictive modeling techniques were compared to create a simple predictive model
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predicting 90-day post-operative hospital re-admission. Cost and effectiveness were
compared with the Incremental Cost Effectiveness Ratio (lCER). A simple method to
process and analyze online po stings was created and used for patients' input in the
comparison oflumpectomy to mastectomy. All statistical analyses were performed in
SAS 9.2. Data Mining was performed in SAS Enterprise Miner (EM) 6.1 and SAS Text
Miner. Decision analysis and Cost Effectiveness Analysis were performed in TreeAge
Pro 2011.
A simple comparison of the two procedures using the NIS 2005, a discharge-level data,
showed that in general, a lumpectomy surgery is associated with a significantly longer
stay and more charges on average. From the MarketScan data, a person-level data where
a patient can be followed longitudinally, it was found that for the initial hospitalization,
patients who underwent mastectomy had a non-significant longer hospital stay and
significantly lower charges. The post-operative number of outpatient services, prescribed
medications as well as length of stay and charges for post-operative hospital admissions
were not statistically significant. Using the MarketScan data, it was also found that the
best model to predict 90-day post-operative hospital admission was logistic regression. A
logistic regression revealed that the risk of a hospital re-admission within 90 days after
surgery was 65% for a patient who underwent lumpectomy and 48% for a patient who
underwent mastectomy. A cost effectiveness analysis using Markov models for up to 100
days after surgery showed that having lumpectomy saved hospital related costs every day
with a minimum saving of $33 on day 10. In terms of long-term outcomes, the use of
decision analysis methods on the literature review data revealed that, 10-years after
surgery, 739 recurrences and 84 deaths were prevented among 10,000 women who had
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mastectomy instead oflumpectomy. Factoring patients' preferences in the comparison of
the two procedures, it was found that patients who undergo lumpectomy are nonsignificantly more satisfied than their peers who undergo mastectomy. In terms of cost, it
was found that lumpectomy saves $517 for each satisfied individual in comparison to
mastectomy.
In conclusion, the current project showed how to use data mining, decision analysis and
cost effectiveness methods to supplement statistical analysis when using real world nonclinical trial data for a more complete analysis. The application of this combination of
methods on the comparative effectiveness of lumpectomy and mastectomy showed that in
terms of cost and patients' quality of life measured as satisfaction, lumpectomy was
found to be the better choice.

viii

TABLE OF CONTENTS
PAGE
DEDICATION ...................................................................................... iii
ACKNOWLEDGEMENTS ....................................................................... iv
ABSTRACT .......................................................................................... v
LIST OF TABLES ................................................................................ xiv
LIST OF FIGURES .............................................................................. xvi
CHAPTER 1: INTRODUCTION .................................................................. 1
1.1. Introduction ............................................................................ 1
1.2. Background related to Breast cancer ............................................... 3
1.2.1. Breast cancer overview .................................................. 3
1.2.2. Breast cancer risk factors ................................................ 3
1.2.3. Symptoms of breast cancer ............................................. 4
1.2.4. Diagnosis .................................................................. 5
1.2.5. Breast cancer staging .................................................... 5
1.2.6. Treatment .................................................................. 6
1.2.7. Prognosis .................................................................. 7
1.2.8. Epidemiology ............................................................. 7
1.3. Purpose of the study .................................................................. 7
1.3.1. Target population ......................................................... 7
1.3.2. The problem ............................................................... 8
1.3.3. Objectives ................................................................. 9
1.3.4. Data ....................................................................... 10
1.3.5. Implication from the study ............................................ 11
1.3.6. Innovation ............................................................... 12
1.4. Methods ............................................................................... 12
1.4.1. Study methods overview ............................................... 12
1.4.2. Statistical analysis ...................................................... 13
1.4.3. Data mining methods ................................................... 14
1.4.4. Decision analysis ....................................................... 15
1.4.5. Cost effectiveness analysis ............................................ 15
1.5. Organization ......................................................................... 16
CHAPTER 2: BREAST CANCER .............................................................. 17
2.1. Objective .............................................................................. 17
ix

2.2. Breast cancer overview ............................................................. 17
2.3. Breast cancer classification ......................................................... 19
2.3.1. Breast cancer staging .................................................... 19
2.3.2. Breast cancer histological grading ..................................... 20
2.3.3. Breast cancer hormone receptor status ................................ 22
2.3.4. Breast cancer DNA cytometry .......................................... 22
2.4. Signs and symptoms ................................................................ 23
2.5. Risk factors ........................................................................... 23
2.6. Breast cancer diagnosis and screening ............................................ 25
2.7. Breast cancer treatment ............................................................. 26
2.7.1. Surgery ..................................................................... 26
2.7.2. Medication ................................................................ 26
2.7.3. Radiation .................................................................. 27
2.8. Breast cancer evolution ............................................................. 27
2.9. Summary .............................................................................. 28
CHAPTER 3: LITERTATURE REVIEW AND RELATED WORK ..................... 30
3.1. Introduction .......................................................................... 30
3.2. Methods used to compare lumpectomy to mastectomy in clinical trial
Data ............................................................................... 30
3.3. Methods used to compare lumpectomy to mastectomy in administrative
Data ................................................................................ 35
3.4. Use of advanced data mining techniques to compare lumpectomy
and mastectomy ...................................................................... 35
3.5. Comparison of mastectomy and lumpectomy in terms of patient choice
and psychological outcomes ....................................................... 36
3.6. Economical comparison of mastectomy and lumpectomy ..................... 37
3.7. Summary .............................................................................. 39
CHAPTER 4: STATISTICAL ANALYSIS THEORY ....................................... 41
4.1. Objective .............................................................................. 41
4.2. Statistical analysis overview ....................................................... 41
4.3. Statistical analysis practical notes ................................................. 42
4.3.1. Statistical methods ....................................................... 43
4.3.2. Probability distributions ................................................. 44
4.4. Statistical analysis theoretical notes .............................................. 44
4.4.1. Descriptive statistics ..................................................... 44
4.4.2. Inferential statistics: Confidence interval estimation ............... 45
4.4.3. Inferential statistics: Hypothesis testing .............................. 47
4.4.4. Common inferential statistics techniques for continuous
variables .................................................................. 50
4.4.5. Common inferential statistics techniques for categorical
variables .................................................................. 70
4.4.6. Common inferential statistics techniques for time-to-an event
data ........................................................................ 76
4.5. Summary .............................................................................. 80
x

CHAPTER 5: DATA MINING THEORY ..................................................... 81
5.1. Objective .............................................................................. 81
5.2. Data mining overview ............................................................... 81
5.3. Data mining practical notes ........................................................ 82
5.3.1. Supervised learning ...................................................... 82
5.3.2. Unsupervised learning ................................................... 83
5.3.3. Overview of commonly used data mining techniques .............. 83
5.4. Data mining theoretical notes ...................................................... 92
5.4.1. Predictive modeling ...................................................... 92
5.4.2. Cluster analysis ........................................................... 95
5.5. Summary ............................................................................ 103
CHAPTER 6: DECISION ANALYSIS AND COST EFFECTIVENESS
ANALYSIS THEORY ........................................................................... 104
6.1. Objective ............................................................................ 104
6.2. Decision Analysis .................................................................. l 04
6.2.1. Decision Analysis overview .......................................... 104
6.2.2. Decision Analysis practical notes .................................... 105
6.2.3. Decision Analysis theoretical notes .................................. 107
6.3. Cost-Effectiveness Analysis ...................................................... 108
6.3.1. Cost Effectiveness Analysis overview ............................... 108
6.3.2. Cost Effectiveness Analysis Practical Notes ........................ 108
6.3.3. Cost Effectiveness Analysis Theoretical Notes ..................... 110
6.4. Deterministic model versus Markov model .................................... 112
6.5. Summary ............................................................................ 113
CHAPTER 7: USE OF STATISTICAL METHODS TO COMPARE SHORT TERM
IN-HOSPITAL OUTCOMES FOR LUMPECTOMY AND MASTECTOMy ......... 114
7.1. Objective ............................................................................. 114
7.2. Data - Nationwide Inpatient Sample (NIS) Database ........................ 114
7.3. Data pre-processing ............................................................... 115
7.3.1. Case selection ........................................................... 115
7.3.2. Outcome variables ...................................................... 118
7.3.3. Input variables ........................................................... 119
7.4. Statistical methods ................................................................. 121
7.5. Results ............................................................................... 123
7.5.1. Data description ......................................................... 123
7.5.2. Outcomes variables description ....................................... 124
7.5.3. Inferential statistics: Group Effect comparisons .................... 129
7.6. Summary ............................................................................ 129
CHAPTER 8: USE OF DATA MINING, STATISTICAL METHODS AND
COST EFFECTIVENESS TECHNIQUES TO COMPARE SHORT-TERM
POST-OPERATIVE FOLLOW -UP OUTCOMES FOR LUMPECTOMY
AND MASTECTOMY ........................................................................... 130
xi

8.1. Objective ............................................................................ 130
8.2. Data - Marketscan database ...................................................... 130
8.3. Data pre-processing ............................................................... 131
8.3.1. Patient selection ......................................................... 131
8.3.2. Selection of post-operative data ...................................... 132
8.3.3. Outcome variables .. , ................................................... 136
8.3.4. Input variables ........................................................... 137
8.4. Use of statistical methods and cluster analysis to analyze clinical
outcomes ................................................................ 138
8.4.1. Summary of statistical methods ....................................... 140
8.4.2. Results .................................................................... 140
8.5. Use of predictive modeling to analyze hospital re-admission ............... 156
8.5.1. Objective ................................................................. 156
8.5.2. Summary of methods ................................................... 157
8.5.3. Results .................................................................... 158
8.6. Post-operative short-term Cost Effectiveness Analysis ....................... 161
8.6.1. Objective ................................................................. 161
8.6.2. Summary of methods ................................................... 161
8.6.3. Results .................................................................... 163
8.7. Summary ............................................................................ 164
CHAPTER 9: USE OF DATA MINING AND COST EFFECTIVNESS ANALYSIS
TO COMPARE LUMPECTOMY TO MASTECTOMY USING ONLINE
COMMENTS OF SATISFACTION AS A MEASURE OF QUALITY
OF LIFE ............................................................................................ 166
9.1.
9.2.
9.3.
9.4.

Objective ............................................................................. 166
Decision tree ........................................................................ 166
Data - Online comments ........................................................... 168
Pre-processing ....................................................................... 168
9.4.1. Transformation of comments into a table ............................ 168
9.4.2. Use ofSAS to format the table in appropriate analysis format... 169
9.4.3. Exploring the resulting data to obtain analysis variable values ... .171
9.5. Data - NIS ........................................................................... 173
9.6. Using probability values to fill out the decision tree .......................... 174
9.7. Measures of effectiveness ......................................................... 175
9.7.1. Effectiveness in the Mastectomy group .............................. 176
9.7.2. Effectiveness in the Lumpectomy group ............................. 176
9.8. Measure of cost ..................................................................... 177
9.9. Incremental Cost Effectiveness Ratio (ICER) .................................. 177
9.10. Summary ........................................................................... 178

CHAPTER 10: USE OF TEXT MINING TO ANAL YZE PATIENT OPINION
WITH LUMPECTOMY OR MASTECTOMY IN FORM OF ONLINE
COMMENT POSTING ......................................................................... 179
10.1. Objective ........................................................................... 179
10.2. SAS Text Miner in Enterprise Miner .......................................... 180
xii

10.3. Data - Online comments ......................................................... 180
10.4. Analysis with SAS Enterprise Miner .......................................... 180
10.5. Results - Clusters and concept links ........................................... 181
10.6. Summary ........................................................................... 184
CHAPTER 11: USE OF DECISION ANALYSIS METHODS TO EVALUATE
THE LONG-TERM -10 YEARS- COMPARATIVE EFFECTIVENESS
FOR LUMPECTOMY AND MASTECTOMY .............................................. 186
11.1. Objective ........................................................................... 186
11.2. Decision tree ...................................................................... 188
11.3. Literature search strategy, selection and data extraction ................... 188
11.3.1. Literature search strategy and selection ............................ 188
11.3.2. Data extraction ......................................................... 188
11.3.3. Computation of probability estimates ............................... 190
11.4. Results .............................................................................. 191
11.4.1. Effectiveness in terms of 10-year local/regional recurrence .... 191
11.4.2. Effectiveness in terms of 10-year mortality ....................... 191
11.5. Summary ........................................................................... 192
CHAPTER 12: DISCUSSION AND CONCLUSION ...................................... 193
12.1. Overview .......................................................................... 193
12.2. Description of findings .......................................................... 194
12.3. Implications ....................................................................... 196
12.3.1. Implications in data analysis ......................................... 196
12.3.2. Implications in breast cancer surgical treatment .................. 196
12.4. Limitation .......................................................................... 197
12.4.1. Limitation related to the method and the analysis ................ 197
12.4.2. Limitation related to the data and the variables ................... 197
12.5. Contribution of the current study to research ................................. 198
12.5.1. Contribution to comparative effectiveness analysis .............. 198
12.5.2. Contribution in the area of breast cancer treatment .............. 198
12.6. Areas of future research ......................................................... 199
12.6.1. Future research in methodologies ................................... 199
12.6.2. Future research in health outcomes ................................. 199
12.7. Summary of the current study and conclusion ................................ 200
12.7.1. Summary of methods ................................................. 200
12.7.2. Summary of results ................................................... 201
12.8. Conclusion ........................................................................ 202
REFERENCES ................................................................................... 203
CURRICULUM VITAE .............................................................................................. 207

xiii

LIST OF TABLES
TABLE

PAGE

Table 1.1: Cancer staging ......................................................................... 6
Table 2.1: Breast cancer histological grading techniques .................................... 21
Table 2.2: Description of cancer grades ........................................................ 21
Table 4.1: Common descriptive statistics for central tendency and dispersion ........... 41
Table 4.2: Data display for group comparisons ............................................... 50
Table 4.3: Layout of Randomized Block Design ............................................. 55
Table 4.4: ANOV A Summary Table for the Two-way ANOV A ........................... 55
Table 4.5: Layout for a Repeated Measures Design .......................................... 57
Table 4.6: ANOV A Summary for Repeated Measures Design .............................. 58
Table 4.7: Layout for the Chi-Square test ...................................................... 66
Table 4.8: Layout for logistic regression ....................................................... 70
Table 4.9: Layout for log-rank test for two groups ............................................ 73
Table 7.1: ICD-9-CM codes for breast cancer ................................................ 111
Table 7.2: Translation of Charlson comorbidity index component into ICD-9-CM
codes from Deyo et al. ' s paper ............................................... 115
Table 7.3: NIS 2005 Data description for the short-term analysis ........................ 119
Table 7.4: Short-term two group comparison ................................................ 124
Table 8.1: CPT-4 codes for mastectomy and lumpectomy ................................. 127
Table 8.2: Summary of the database of analysis ............................................. 136
Table 8.3: Description of the diagnosis clusters ............................................. 137
Table 8.4: Description of the analysis data ................................................... 139
Table 8.5: Comparison of healthcare resources use and charges .......................... 150
Table 8.6: Predictive model comparison ...................................................... 154
xiv

Table 8.7: Association with post-operative re-hospitalization ............................. 154
Table 8.8: Odds Ratio ........................................................................... 155
Table 8.9: Risk of90-day hospital re-admission as a function ofthe procedure type ... 155
Table 8.10: Incremental Cost Effectiveness Ratio values for different days after the
initial surgery ................................................................... 159
Table 9.1: Random Sample of the pre-processed data ...................................... 165
Table 9.2: Satisfaction probability estimates by procedure ................................ 168
Table 9.3: Probability estimates for the event 'discharge status' ......................... 169
Table 10.1: Clusters of the comments ......................................................... 177
Table 11.1: Studies used in the comparative effectiveness analysis ...................... 184
Table 11.2: Adjusted data for studies [6], [2] and [3] ....................................... 185
Table 11.3: Estimated group sizes of the pooled data for comparative effectiveness ... 185
Table 11.4: Summary of probability estimates from the literature ......................... 185

xv

LIST OF FIGURES
FIGURE

PAGE

Figure 2.1: Illustration of the female breast ................................................... 18
Figure 6.1: A hypothetical simple decision tree ............................................. 102
Figure 7.1: In-hospital death distribution ..................................................... 120
Figure 7.2: Kernel Density Estimation for the in-hospital length of stay
for all observations .............................................................. 121
Figure 7.3: Kernel Density Estimation for hospital total charges for all observations ... 122
Figure 7.4: Comparative in-hospital length of stay distributions in the two groups ... 123
Figure 7.5: Comparative hospital total charges distributions in the two groups ........ 124
Figure 8.1: Diagram flow of the Text Miner node in SAS Enterprise Miner ............ 136
Figure 8.2: Number of post-operative hospital admissions ................................. 140
Figure 8.3: Number of post-operative outpatient services .................................. 141
Figure 8.4: Number of post-operative prescribed medications ............................ , 142
Figure 8.5: Length of stay per post-operative hospitalization .............................. 143
Figure 8.6: Charges per post-operative hospital stay ........................................ 144
Figure 8.7: Charges per post-operative outpatient service .................................. 145
Figure 8.8: Charges per post-operative prescribed medication ........................... 146
Figure 8.9: Flow chart of predictive model comparison ................................... 153
Figure 9.1: Decision tree for the Cost Effectiveness model ............................... 162
Figure 9.2: Flow diagram for comment sampling ........................................... 166
Figure 9.3: The decision tree filled with obtained probability estimates ................ 170
Figure 10.1: Process flow for Text Mining Analysis ........................................ 175
Figure 10.2: Enterprise Miner node settings for the analysis .............................. 176
Figure 10.3: Concept links ofthe term 'bilateral mastectomy' ........................... 177
xvi

Figure 10.4: Concept links of the term 'single mastectomy' ............................... 178
Figure 10.5: Concept links of the term 'good advice' ....................................... 178
Figure 10.6: Concept links of the term 'good decision' .................................... 179
Figure 10.7: Concept links of the term 'form regret' ........................................ 179
Figure 11.1: Decision tree to evaluate lumpectomy in comparison to mastectomy
in terms of tumor recurrence averted ........................................ 182
Figure 11.2: Decision tree to evaluate lumpectomy in comparison to mastectomy
in terms of deaths averted ..................................................... 182

xvii

CHAPTERl
INTRODUCTION
1.1. Introduction

Statistical models have been the primary choice when comparing lumpectomy to
mastectomy for the treatment of breast cancer. This is mainly due to the fact that many
studies in this field were clinical trials. Clinical trials can be defined as research on
human subjects (medical, biomedical or behavioral) that are designed to answer very
specific questions. The inclusion! exclusion criteria for subject selection for the study
ensure that the data to be collected will fit the statistical methods proposed to be used.
Clinical trials are the best types of study for medical research. However, they are
expensive and not always feasible. Alternatives to clinical trials are observational studies
including the use of administrative data. Healthcare administrative data are medical data
collected for administrative purposes such as processing health insurance claims. These
data represent the real world effects since the subjects are not pre-screened for inclusion.
Statistical methods can be used to analyze these data. However, the data have to be
cautiously pre-processed to fit the needed statistical assumptions. Sometimes, the
assumptions cannot be verified. Other times, the assumptions are verified, but the sample
size is too large that all results will be significant. In the current study, methods to
supplement statistical models are presented when comparing health outcomes for two
groups; in this case, lumpectomy and mastectomy.
1

Mastectomy was the "gold" standard for breast cancer surgical treatment until the mid20th century[l]. It was then that clinical trials established the equivalent effectiveness of
lumpectomy. Since then, women diagnosed with early stage breast cancer are given the
choice between lumpectomy as a minimally invasive surgery or mastectomy, the
traditional approach.
Various studies, mainly clinical trials [2-7], in different settings have compared
lumpectomy to mastectomy generally in terms of disease-free and overall survival. They
all come to the conclusion that lumpectomy is comparable to mastectomy.
Although the long-term benefits of lumpectomy in comparison to mastectomy were
assessed, the short-term outcomes following the surgery have not yet been clearly
discussed. Moreover, the comparisons of these surgeries using non-clinical trial data are
lacking. Clinical outcomes such as in-hospital length of stay, post-operative healthcare
resource use (such as the number of hospitalizations, the number of outpatient services,
and the number of prescribed medications) and the risk of post-operative hospital
admission have yet to be compared.
The purpose of this study was to present methods that can be used to analyze
administrative data consisting of hospital data and insurance claims data in comparing
lumpectomy to mastectomy in health, clinical outcomes and healthcare utilization. The
main goal was to use statistical methods supplemented with data mining techniques to
assess the effectiveness of lumpectomy in comparison to mastectomy in short-term,
immediate follow-up and long-term outcomes after the surgery. Secondary objectives
included comparing these surgical procedures using data extracted from the literature
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with decision analysis methods and comments extracted from online discussion board
with text mining and cost effectiveness analysis.

1.2. Background Related to Breast Cancer
1.2.1. Breast cancer overview
Breast cancer is a development of malignant cells in the breast. Most commonly, cancer
originates from the milk-producing organs (10 buies) or the tubules (ducts) that conduct
the milk to the nipple [8]. Breast cancers that originate from the ducts are called ductal
carcinomas; those originating from the lobules are known as lobular carcinomas. In rare
cases, breast cancer can start in other areas of the breast [8].
1.2.2. Breast cancer risk factors
The risk factors for breast cancer can be divided into two categories: factors that can be
changes and those that cannot be changed. For breast cancer, risks factors that cannot be
changed include [8]:
•

Age: breast cancer risk has been found to be increasing with age

•

Gender: women are 100 times more at risk of breast cancer than men

•

Family history of breast cancer: having a close relative with breast cancer
has been found to be associated with a higher risk of breast cancer

•

Genes: having genes more prone to developing breast cancer such as
BRAC1 and BRAC2

•

Early onset of menstruation: having the first period before the age of 12
3

•

Late menopause: having menopause at or after the age of 55

Risk factors that can be changed for breast cancer comprise but are not limited to [8, 9]:
•

Child birth: never having a child or having a first child after the age of 30
is a risk of developing breast cancer

•

Hormone Replacement Therapy (HRT): Receiving hormone replacement
therapy for years for menopausal symptom relief has been associated with
a high risk of breast cancer

•

Radiation: Being exposed to radiation as a child or as a young adult
increased the risk of developing breast cancer

•

Obesity, high-fat intake and alcohol use have been linked to a high risk of
breast cancer

1.2.3. Symptoms of breast cancer

Very early onset breast cancer may stay unnoticed for a while. Growing breast cancer
symptoms comprise [9]:
•

A breast lump or a lump in the armpit

•

Change in the size, shape or feel of the breast

•

Nipple discharge, including blood

Metastatic breast cancer can be noticed by [10]:
•

Pain or discomfort in the breast

•

Swelling of the arm

•

Pain in the bones
4

•

Skin ulcers

1.2.4. Diagnosis

The diagnosis of breast cancer is accomplished with tests looking for any sign or
symptom. The usual tests consist of a biopsy of any suspicious lump or a mammogram to
identify an observed anomaly [11]. Even when a woman has no signs or symptoms, it is
recommended to get regular breast examinations either using a Breast Self-Examination
or an exam by a healthcare professional (Clinical Breast Examination). The American
Cancer Society recommends an annual mammogram for all women starting at age 40
[10]. All these screening techniques are recommended in an effort to diagnose any
malignancies early. Diagnosis of breast cancer at an early stage has been associated with
longer survival [11].
For women who present breast cancer symptoms, additional exams (in addition to biopsy
and/or mammograms) may be judged necessary. These tests include ultrasounds,
computer tomography (CT) and magnetic resonance imaging (MRI). If a diagnosis is
confirmed to be breast cancer, then the physicians will perform additional tests to
determine if the cancer has spread beyond the breast [8]. This is called breast cancer
staging.
1.2.5. Breast cancer staging

The stages of breast cancer describe the extent of the metastasis. The stage depends on
whether the cancer is invasive or in-situ, the size of the tumor, how many lymph nodes
are involved, and ifit has spread beyond the breast [10]. Breast cancer stages range from
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zero to four and the higher the stage, the more advanced the cancer [8]. The following
table summarizes stage I to IV [11].
Table 1.1: Cancer staging [11]
Stage Description
The tumor size is no more than two centimeters and no cancer cells are found in
1
the lymph nodes
The tumor size is more than two centimeters and no more than five centimeters
2
and the cancer has spread to the lymph nodes
The tumor size is more than five centimeters or less than five centimeters but the
3A
cancer has spread to the lymph nodes, which have grown into each other
The cancer has spread to tissues near the breast (local invasion), or to lymph
3B
nodes inside the chest wall, along the breast bone
The cancer has spread to the skin and lymph nodes beyond the axilla or to other
4
organs of the body

1.2.6. Treatment

Treatment depends on many factors, including type and stage of breast cancer, hormonal
reception status and whether the cancer overproduces Human Epidermal growth factor
Receptor 2 (HER2) [9].
In general, the main treatment is surgery in order to remove all the cancer. In a surgical
treatment for breast cancer, the whole infected breast can be removed (mastectomy) or
only the tumor along with surrounding healthy tissues (Breast Conserving Surgery) can
be taken out [11]. Radiation therapy is offered after surgery to kill locally any
microscopic tumors that might have escaped surgery [9]. Drug therapy or chemotherapy
can be offered before and/or after surgery. Before therapy (neo-adjuvant), it is intended to
shrink the tumor. After surgery (adjuvant therapy), it is intended to kill any remaining
cancers. Some women also receive hormonal therapy to block certain hormones.
6

1.2.7. Prognosis
A prognosis is a prediction of an outcome and the probability of progression-free survival
or disease-free survival [9]. The prognosis for breast cancer depends on the type, stage
and classification of the cancer [11]. Survival decreases with the stage of the disease.
About 80% of patients at stage I are cured and only 70% of patients at stage II survive
breast cancer. The five-year survival for patients at stage III is estimated to be 40% and
only 20% for stage l'V patients. Younger women tend to have a poorer prognosis than
post-menopausal women [9].

1.2.8. Epidemiology
The incidence of breast cancer is variable around the world: the highest rates are in moredeveloped countries while the lowest rates are observed in less-developed countries [8].
In the USA, the annual incidence rates of breast cancer are 128.6 per 100,000 in white
women and 112.6 per 100,000 in African American women [11]. These statistics place
the USA among the countries with the highest rates in the world [8, 11]. About 45,000
women die of breast cancer each year [11]. Breast cancer is the second-most common
cancer (after skin cancer) and the second-most common cancer death (after lung cancer)
[11 ].

1.3. Purpose of the study
1.3.1. Target population
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It is well established that breast cancer is much more likely to affect women than it is to

affect men [8]. Every woman is at risk of breast cancer and the risk increases with age. At
25 years of age, a woman has a 1 in 19,608 risk of developing breast cancer, but this
number increases to 1 in 93 by the age of 45. A woman who lives to age 85 has a 1 in 8
risk of developing breast cancer in her lifetime [11]. This condition disproportionally
affects older women, especially in the post-menopausal stage. The majority of all breast
cancer cases are found in women over 50 while less than 55 percent of breast cancer
cases are discovered in women under the age of 35 [11].
1.3.2. The problem

Breast cancer is a terrible condition that affects a considerable proportion of the US
female population. The medical area of breast cancer treatment has gone through
considerable improvements, which have resulted in both patient satisfaction and
prolonged survival. Breast radical removal (mastectomy), once a gold standard for first
step breast cancer treatment is no longer the only choice. Breast Conserving Surgery such
as lumpectomy has been proven to be just as effective in terms of overall- survival and
disease-free survival. This equivalence is well established and many studies have been
undertaken with different population settings and designs and reports have been reported
in the medical literature [2-7]. Also, recent studies have suggested that breast conserving
treatment improves quality of life.
However, in 2003, research showed that young women who choose breast conserving
surgery are at a higher risk of local recurrence [11]. Thus, the controversy in the choice of
surgical treatment for breast cancer remains. Moreover, the comparative effectiveness in
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terms of health outcomes in the period following the surgery has not yet been fully
explored. Patients need to be aware of what to expect after surgical treatment, not only in
terms of long term survival but also in terms of short term immediate and follow-up
health and clinical outcomes. That is, there is a need to address breast cancer postoperative treatment management by providing statistical comparison of health and
clinical outcomes and developing simple predictive models or scores for short term
healthcare resources use.
1.3.3. Objectives

The main goal for this study was to use data mining to supplement statistical analysis in
comparing breast cancer surgical treatments in terms of health and clinical outcomes
healthcare utilization and charges. The comparison of the surgical procedures was
performed in two stages: a short-term analysis that compared the outcomes of the
hospitalization during the surgery and follow-up analysis that compared the longitudinal
data of patients after they undergo the operation. Two groups were compared: patients
treated by mastectomy and patients treated by lumpectomy (breast conserving surgery).
Patients who underwent both procedures at the same time were excluded from the study.
Health outcomes were in-hospital death during the hospitalization for the surgery.
Healthcare utilization was expressed as in-hospital length of stay, number of rehospitalizations, number of outpatient services and the number of prescribed medications.
Healthcare resources charges considered were hospitalization charges, outpatient service
charges and medication charges.
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Secondary goals included (1) the use of decision analysis to perform a long-term
comparative effectiveness of the mastectomy and the breast conservation surgery in terms
of deaths averted; (2) the use of cost effectiveness analysis to analyze the incremental
cost oflumpectomy in comparison to mastectomy; and (3) the use of text mining to
explore patient opinion through online comments on discussion boards.
1.3.4. Data

Data used for the current analysis are the Nationwide Inpatient Sample records of2005,
the MarketScan database records of 2000 and 2001, the medical literature and online
posting in discussion board forums. The NIS data was used for the short-term in-hospital
comparisons; the MarketScan data were used for the follow-up data analysis as well as in
the predictive modeling. The literature was used in the long-term comparative
effectiveness and the online comments were used in the exploratory analysis of patient
OpInIOn.
The NIS is part ofthe Healthcare Cost and Utilization Project (HCUP). NIS is a large
national database containing hospital discharges from all-payer. It is a 20% sample of all
US non-federal hospitals and contains data from approximately 1000 hospitals in 37
states. Hospitals are selected to represent 5 strata of hospital characteristics: ownershipcontrol, bed-size, teaching status, rural-urban location, and geographical region. For a
given year, NIS provides information on approximately five million to eight million
hospital stays from about 1000 hospitals. Inpatient stay records in NIS include hospital
and resource use. Hospital data are provided by the American Hospital Association's
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annual survey of hospitals. The large sample size of the NIS provides numerous
advantages, including analyses ofrare conditions [12].
The Thomson Reuter's MarketScan Database contains person-level information on
hospitalization usage, charges and enrollment. The annual datasets include data from
about 100 payers and comprises inpatient, outpatient and prescription drugs, from about
45 large employers, health plans, government and public organizations. The collective
MarketScan Databases refers to five individual databases: Commercial Claims and
Encounters Database, Medicare Supplemental and COB Database, Health and
Productivity Management Database, Benefit Design Database and Medicaid Database
[13]. For this analysis, the Commercial Claims and Encounters Database were used. Sets
were linked using an encrypted enrollee unique identifier named ENROLID [13].
Relevant medical literature was obtained from searching MEDLINE through PUBMED.
MEDLINE (Medical Literature Analysis and Retrieval System Online) is a database
containing more than 18 million records covering biomedicine and health from 1950 to
the present [14]. MEDLINE is freely accessible on the internet via PUBMED.
Topics related to lumpectomy versus mastectomy from discussion board forums in
breastcancer.org were obtained and analyzed.
1.3.5. Implication from the study

The current study will provide methods to pre-process and analyze longitudinal
administrative data. It will also give insights in how to explore online po stings and
process them to factor them in our analyses. Finally, it will give an analysis algorithm
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that can be used to have a complete study with results from different aspects of the
problem, not only from the statistics.
From the healthcare perspective, the current analysis will provide more information to the
patients and their physicians which will help them in their choice of surgical procedures
for breast cancer, in particular those for whom lumpectomy is an option. The results
obtained in the comparison of the clinical outcomes in the index procedure
hospitalization and in the follow-up data will help the patients and their families get
prepared. The results of the predictive models will provide the patients and their families
with an insight into the risk of a subsequent hospital admission. This will guide them in
choosing an optimal surgical choice.
1.3.6. Innovation

The ultimate goal of this study was use statistical, data mining, decision analysis and cost
effectiveness analysis methods on real-world data in order to provide health outcomes
results of the main surgical procedure treatments for breast cancer. The 'real world' data
include administrative claims data and online comments. First, the approach used in this
study to compare lumpectomy to mastectomy differs from previously published reports in
the fact that real data are used in a retrospective fashion as opposed to prospective
clinical trials. Second, another innovation is the use of data mining techniques such as
cluster analysis and predictive modeling to breast cancer data in addition to classical
statistical methods. Third, exploration of online comments in discussion boards provides
an algorithm to factor patient opinion into classical analysis such as cost effectiveness
analysis.
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1.4. Methods
1.4.1. Study methods overview

The current study investigated the health outcomes and healthcare resources utilization
for breast cancer patients who undergo a mastectomy or a lumpectomy. First, to analyze
the current study data, a descriptive statistical analysis was performed to look at the
population involved. Then, an inferential analysis was performed to test for differences in
outcomes studies between the two groups. Second, data mining techniques were applied
to classify and predict future re-hospitalization in case of surgical treatment for breast
cancer. Third, decision analysis was used to analyze data from published reports to assess
the effectiveness of a breast conserving surgery in comparison to the traditional
mastectomy. Finally, text mining and cost effectiveness methods were used to study
patients' postings online in lumpectomy versus mastectomy.
1.4.2. Statistical analysis

Statisticians are faced with more than just advocating a choice that represents the highest
probability of a wanted outcome. They aim to discover new relationships in order to
make new statements and/or validate old ones.
Statistical analysis mainly aims to describe the data and to make inferences. Most
statistical methods assume that data follow pre-defined distributions. A number of other
assumptions are also made, including the nature of the sample. These methods are called
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"parametric methods". If the assumptions are not satisfied, statisticians rely on the
counterpart of "non-parametric methods" when available.
The commonly used parametric models include the Generalized Linear Models (GLM)
and the regression analysis models (linear, logistic, Poisson). The most used nonparametric models comprise the Wilcoxon tests and the Kaplan Meier curves. Some
models are semi-parametric such as the Proportional Hazard Regression (Cox
Regression).
Statistical models have been the benchmark for data analysis for a long time. Even
though their usefulness is still effective, their efficiency is limited when it comes to data
that do not fit the assumed distributions and also when the size of the data is very large,
in which case all tests tend to be statistically significant.
1.4.3. Data mining methods

Nowadays, immense amounts of data are available. New and evolving technologies have
given the companies, organization and institutions, including healthcare institutions, the
capacity to collect and store very large data sets. These data contain important
information, mostly useful for decision making. One way of digging into this information
is to use data mining. Data mining can be defined as "the non-trivial extraction of
implicit, previously unknown and potentially useful information from data" [15]. Data
mining comprises the classical statistical analysis, artificial intelligence, machine learning
and the development of large databases [16].
Data mining has the capabilities of the traditional data analysis methods blended with
more sophisticated algorithms to process large volumes of data. With these algorithms,
14

data mining is able to find new patterns and associations that would have otherwise been
unidentified [16]. The most used data mining techniques are cluster analysis and
predictive modeling, or classification.

1.4.4. Decision analysis
Decision analysis is a systematic quantitative approach for assessing the value of
different alternative choices [17, 18]. The uncertainly associated with each choice is
represented through probabilities and probability distributions [18]. If there is a risk
involved in the decision making, the attitude to risk is represented through utility
functions. Otherwise, the utility functions are replaced by probabilities of achieving the
uncertain aspiration levels [18]. As a result, the option that maximizes the probability of
achieving the uncertain aspiration level is chosen. In other words, the decision whose
consequences yield the maximum expected utility is recommended [18]. The
probabilities are estimated using collected data or data from previously published reports.
Decision analysis uses decision trees as graphical tools. Initially, decision analysis was
developed as a method to help clinicians make decisions on an individual patient's
management. It is increasingly used as a policy making tool in the management of groups
of patients [17].

1.4.5. Cost effectiveness analysis
Cost Effectiveness Analysis is an economic analysis which compares alternative actions
in relative costs and outcomes [19]. It is mostly used in health economics and
pharmacoeconomics for evaluation of health programs or interventions. In this context,
the cost-effectiveness is the ratio of the cost of the program or intervention to a defined
15

measure of its effect. It is primarily used for funds allocation but it can also be used for
individual decision making [20].

1.5. Organization
In the following chapters, the research agenda will be discussed. Chapter 2 provides an
overview of the breast cancer disease, steps from diagnosis to prognosis, including
treatment and all the features taken into consideration to make a particular treatment
choice. Chapter 3 discusses the literature review and work related to the current research.
Chapters 4, 5 and 6 provide the mathematical theory behind the current analysis.
Chapters 7 to 11 provide methods used and results obtained comparing lumpectomy to
mastectomy. The following methods are used from chapter 7 to chapter 11 respectively:
statistical methods, statistical methods and data mining, decision analysis, text mining,
data mining and cost effectiveness analysis. Chapter 12 discusses the findings as well as
the possible implications. Chapter 12 also presents the limitations and future research and
summarizes the study, while providing an overall conclusion to the study.
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CHAPTER 2
BREAST CANCER
2.1. Objective

The purpose of this chapter is to provide some basic information about breast cancer.
First, its definition and characteristics are presented. Second, the signs and symptoms are
evaluated. Third, breast cancer risk and protective factors are reviewed. Fourth, the
current methods of diagnosis, screening and treatment are summarized. Finally, the
treatment evolution since the early 1900 to the present is presented.

2.2. Breast cancer overview

Breast cancer is a malignant (cancerous) growth that begins in the tissues of the breast.
Cancer is a disease in which abnormal cells grow in an uncontrolled way [21]. Figure 2.1
illustrates the mammary gland of the human female breast.

17

Chest wall

----r-fJ.~;,;{

Lobules

Fatty tissue

Figure 2.1: Illustration of the mammary gland of the human female breast [22]
Types of breast cancer [23]

The types of breast cancer depend on whether it begi~s in the lobules (organs that
produce the milk) or in the ducts (the tubes that carry the milk from the lobes to the
nipple). The cancer that originates from the lobules is called lobular or medullar
carcinoma and the one that starts in the ducts are called ductal carcinoma.
The type of breast cancer also refers to the cancer' s attitude towards surrounding tissues.
If it is contained within its initial tissue, then it is called carcinoma in-situ. If on the other
hand, the cancer cells can infiltrate and spread to other tissues, it is called invasive breast
cancer.
The combinations of these characteristics define the four main types of breast cancer:
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•

Ductal Carcinoma In-Situ (DCIS).· the breast cancer is confined inside the ductal
system.

•

Invasive Ductal Carcinoma (IDC): the breast cancer started in the ductal system
and it is infiltrating to surrounding tissues

•

Medullary carcinoma: the breast cancer started in the lobes and it is in-situ

•

Infiltrating medullary carcinoma: the breast cancer started in the lobes and is
InVaSIVe

2.3. Breast cancer classification
The classification of breast cancer is done in an effort to offer a tailored treatment to each
patient. It also helps predict treatment response as well as prognosis.
Breast cancer is classified according to its stage, histological appearance, differentiation
grade, hormone receptor status and DNA changes.
2.3.1. Breast cancer staging [24, 25]
For breast cancer, most registries use the summary staging, which groups cancer cases
into five main categories: in-situ, localized, regional, distant and unknown. Cancer
staging is the description of how cancer has spread. The most commonly used cancer
staging is the TNM system (T=Tumor, N=the spread to the lymph nodes, M=Metastasis).
The different TNM combinations correspond to five main stages which are denoted by
the roman numerals I, II, III, IV and the digit 0 (i.e. stage 0, stage I, stage II, stage III and
stage IV).
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•

T-levels: T represents different types of tumor evaluation:

TX: non evaluable tumor
TO: no sign of tumor
Tis: early tumor that has not spread
Tl, T2, T3, T4:size and lor extension of the primary tumor
•

N-levels: N represents different types of tumors spread to the regional lymph

nodes:
NX: non evaluable lymph node
NO: no cancer in lymph nodes
Nl, N2, N3: number and/or extent of regional spread
•

M-levels: M represents different types of distant metastasis:

MX: non evaluable metastasis
MO: No cancer spread in other parts of the body
Ml :Cancer has spread to the other parts of the body
•

The five main cancer stages:
Stage 0: Carcinoma in situ (early cancer, only present in primary
cells)
Stage I: Cancers are localized into one part of the body
Stage II: Cancers are locally advanced
Stage III: Cancers are also locally advanced
Stage IV: Cancers have spread to other organs

2.3.2. Breast cancer histological grading [26]
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A cancer's grade is determined in terms of three factors: the frequency of cell mitosis or
division, the tubules formation and the nuclear pleomorphism (change in cell size and
uniformity). Pathologists assign a score between one and three to each ofthese features
and add them up. Table 2.1 describes the scoring technique [26].
Table 2.1: Breast Cancer histological grading techniques [26]

Feature

Levels

Score

Tubule formation
(percentage of carcinoma
composed of tubular
structures)

>75%

1

10-75%

2

Less than 10%

3

Nuclear Pleomorphism
(change in cell)

Small, uniform cells

1

Moderate increase in size and variation 2

2

Marked variation

3

Up to 7

1

8 to 14

2

15 or more

3

Mitosis count (cell division)

The final score ranges from 3 to 9. If this sum is 3, 4 or 5, the tumor is considered grade
1. If it is 6 or 7, the assigned grade is 2. A sum of 8 or 9 is a grade 3. Table 2 details the
descriptions of each grade.
Table 2.2: Description of cancer grades [26]

Grade

Scores Description

1

3,4,5

(lowest)

Well-differentiated breast cells; cells are not growing rapidly;
cancer cells are arranged in small tubules
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Grade

Scores

Description

2

6, 7

Moderately-differentiated breast cells; have characteristics
between grade 1 and grade 3 tumors

3

8,9

Poorly-differentiated breast cells; cells do not appear normal and
tend to grow and spread aggressively

(highest)

2.3.3. Breast Cancer Hormone receptor status
In a breast cancer examination, physicians evaluate whether a hormone receptor is
present. When the receptor is present, it is noted by the plus sign (+) after the hormone
and when it is not present, it is noted by the negative sign (-) after the hormone. Breast
cancer mayor may not have three important receptors: an estrogen receptor (ER), a
progesterone receptor (PR) or the human epidermal growth factor receptor 2 (HER2) [27,
28].
ER+ cancers depend on estrogen for their growth. Thus, blocking this estrogen slows the
growth and reproduction of cancerous cells [27]. Not much is known about PR receptors
yet. However, it has been noticed that most ER+ breast cancers are also PR+ and that if
an ER+ breast cancer is PR-, the patient has a bad prognosis [27]. HER2+ represents an
over-expression of HER2, a protein responsible for regulating cell growth. HER2+
responds to drugs [28].

2.3.4. Breast cancer DNA cytometry
Breast Cancer DNA cytometry consists of counting and measuring a breast tumor's DNA
in order to determine its ploidy (amount of DNA). Ploidy can be defined as a marker that
can help predict how quickly a cancer is likely to spread. If a breast cancer cell has the
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same amount of DNA as the normal cells, then the cancer is called diploid. If the amount
is different, the cancer is called aneuploidy [9, 29].

2.4. Signs and Symptoms [30]
There are signs that may be indicative of presence of breast cancer. These are:

•

A new lump in the breast or armpit

•

Thickening or swelling of part of the breast

•

Irritation or dimpling of the breast skin

•

Redness or flaky skin in the nipple area or breast

•

Pulling in of the nipple or pain in the nipple area

•

Nipple discharge other than breast milk, including blood

•

Any change in the size or shape of the breast

•

Pain in any area of the breast

It is important to note that most of these symptoms may not represent an underlying

breast cancer. Nevertheless, it is recommended to take each and everyone of them
seriously.

2.5. Risk factors [31]
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A risk factor is anything that increases the chance of developing cancer. The most
significantly higher risk is a personal history of breast cancer. There are several
moderately higher risks:
•

Getting older: breast cancer risk increases with age

•

Direct family history: having a mother, sister or daughter with breast cancer
increases the risk of breast cancer

•

Genetics: being a carrier of either of two familial breast cancer genes BRAC1 or
BRAC2 puts a woman at higher risk of breast cancer

•

Breast lesions: a previous breast biopsy result of atypical hyperplasia increases
breast cancer risk

Other risks include but are not limited to:

•

Distant family history: having a distant relative with breast cancer increases breast
cancer risk

•

Age at childbirth: having a first child after the age of35 or never having children
is a risk for breast cancer

•

Early menstruation: having periods before the age of 12

•

Late menopause: beginning menopause after the age of 55

•

Weight: being overweight with excess caloric and fat in-take

•

Excessive radiation: being exposed to a large amount of radiation before the age
of30

•

Family history of other cancer: family history of cancers of the ovaries, cervix,
uterus or colon has been associated with higher risk of breast cancer
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•

Hormone replacement therapy (HRT): long-term use of combined estrogen and
progesterone

2.6. Breast cancer diagnosis and screening
In the presence of a breast cancer sign, a physician performs additional exams to
determine whether the underlying condition leads to a diagnosis of breast cancer. Since
breast cancer is a serious disease, healthy individuals with no signs or symptoms are
tested or screened in an effort to achieve an earlier diagnosis.
There are several screening techniques available [10]. Starting at age 20, it is
recommended that every woman performs a breast self-examination (BSE) and reports
any changes as soon as possible. For those who do not know how to perform a DBS or
choose not to, there is an option to have it done by a health care professional, in which
case, it is called a clinical breast examination (eBE) [10].
Even though these exams are very important, it has been found that they playa small role
compared to other diagnostic screening tests. More sophisticated techniques are
recommended for women with a high risk of breast cancer, and for every woman after the
age of 40. These methods include mammogram and magnetic resonance imaging (MRI).
A mammogram is an x-ray of the breast. The doctor looks for calcifications (tiny mineral
deposits) and a mass within a breast. An MRI is usually offered in addition to the
mammogram for certain high risk women. The MRI scans use magnet and radio waves as
opposed to x-ray and produce high quality images [10].
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2.7. Breast cancer treatment
Usually, the main treatment for breast cancer is surgery. Then, there is an association
with either medication (such as chemotherapy) or radiation, or both.

2.7.1. Surgery [32]
Surgery is performed in an effort to remove all the breast cancer cells. It constitutes the
main line attack in the episode of treatment. There are two types of surgeries:
Mastectomy and Breast Conservation Surgery. Mastectomy is the removal of all of the
breast tissue. Breast Conservation surgery, mostly referred to as Lumpectomy, is the
removal of only the tumor along with an amount of surrounding healthy tissues.

2.7.2. Medication [9]
Medications are usually offered after surgery (adjuvant therapy), but they can also be
offered prior to surgery (neo-adjuvant therapy) in order to shrink the tumor. In neoadjuvant therapy, the medications offered are chemotherapy. In adjuvant therapy, there
are three main groups of medications used:

•

Hormone Blocking Therapy

•

Chemotherapy

•

Monoclonal Antibodies
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Hormone Blocking Therapy medications are used in women with ER+ and PR+.
Chemotherapy consists of a combination of medications for a period of 3 to 6 months.
Monodermal Antibodies are used to block the over-expression ofHER2+.
2.7.3. Radiation [9]
Radiation therapy (or radiotherapy) is offered to women to target and destroy very small
tumors that may have not been seen. It is usually administered after surgery (external
beam radiotherapy) for several weeks, but it can also be administered at the time of
operation (branchy-therapy or internal radiotherapy).

2.S. Breast cancer evolution [33]
The area of breast cancer has seen tremendous evolution from the early 1900 to the
present. In the 1970s, the breast cancer incidence in the USA was about 105 per 100,000
women. At that time in history, mastectomy was the only surgical treatment adopted and
the relative survival rate was about 76%. In medical research, there was only one
completed clinical trial, the randomized trial of mammography. The clinical investigation
of combination chemotherapy and of the drug, tamoxifen, as well as adjuvant therapy had
just started.
In 2007, the incidence rate of female breast cancer was estimated to be 125 per 100,000
with a mortality rate of 23 per 100,000. The five-year relative rate was then 91 % among
white women and 78% among African American women. Mastectomy was no longer the
first option as a surgical treatment; it had been replaced by Breast Conservation Surgery
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supplemented by radiation. In addition, women had an option of neo-adjuvant (preoperation) therapy to help shrink the tumors. The use of tamox ifen and other selective
estrogen receptor modulators had become a regular treatment for women with type
estrogen receptor positive (ER+). The knowledge in genomics had advanced and breast
cancer could be classified in terms of gene susceptibility (BRAC1, BRAC2, TP53 and

PTENINMACl).
Nowadays, the knowledge in genomics has increased considerably and is in rapid and
extraordinary evolution. Studies on more advanced and less toxic treatments are being
done. With the exploration of gene expression knowledge, treatments tailored to the
tumor characteristics will be developed [33].
The future holds promising advances in breast cancer. Development in breast cancer
prevention will be made possible through the increasing knowledge of the immune
system. Vaccines of breast cancer are under clinical evaluation. Screening techniques
providing detection of breast cancer at the earliest stages will be developed with the
constant increase in technology. The development in biology, medicine, and
pharmaceutical science will provide treatments that will reduce breast cancer mortality
rates and improve survival.

2.9. Summary
Breast cancer is an uncontrolled growth of the breast tissues that can start either in the
lobules or in the ducts. There are various classifications that are used, the tumor size, the
spread, the cell division and the DNA composition. Breast cancer has many signs and
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symptoms that alert the patient. Screening techniques are available and the can help
diagnose breast cancer early. When breast cancer is confirmed, many treatment
sequences options are available. However, surgery remains the core action. Breast cancer
treatment has gone through remarkable improvement through the years thanks to the
evolution of technology and scientific knowledge. Because of this, the future in breast
cancer treatment research holds promising discoveries.
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CHAPTER 3
LITERATURE REVIEW AND RELATED WORK
3.1. Introduction

In this chapter, the literature is reviewed to analyze the types of studies that were done in
the comparison oflumpectomy to mastectomy. The methods used for analysis are
evaluated along with the types of data. Also, the objectives of the study as well as the
results are presented.
Several studies have been conducted to evaluate the long-term effect of breast
conservation surgery in comparison to mastectomy. These studies used different designs
and analyzed different types of data covering different populations. Most of them
achieved the same conclusion that breast conservation surgery has the same disease free
survival and overall survival as mastectomy.

3.2. Methods used to compare lumpectomy to mastectomy in clinical trial data

In 1995, Jacobson et al [5] in an effort to confirm the clinical equivalence of the
conservative therapy and mastectomy reported the results of a clinical trial. The main
objective was to compare lumpectomy plus radiation with modified radical mastectomy.
The recruitment time was from July 1979 to December 1987 and the patients were
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followed until November 1993 for a median follow up time of 121 months. A total of 237
eligible participants with clinical stage I and II breast cancer were randomly assigned to
either mastectomy (116) or lumpectomy and radiation (121). The investigators were
interested in the 10-year overall survival, 10-year disease free survival and the 10-year
local-regional recurrence. As results, it was found that the overall survival was 75% in
the mastectomy arm and 77% in the lumpectomy arm (p-value=0.89). The 10-year
disease free survival rate was 69% in the mastectomy in comparison to 72% in the
lumpectomy plus radiation arm (p-value=0.93). Finally, 10% of women treated with
mastectomy had a local-regional recurrence compared to only 5% in the lumpectomy arm
(p-value=0.17). Jacobson and colleagues concluded that in the management of stage I and
II breast cancers, breast conservation with lumpectomy and radiation offer results at 10years that are equivalent to those with mastectomy. In this research, data were analyzed
with Kaplan-Meier estimates to calculate the probability of survival and disease free
survival and the Mantel-Haenszel test to determine the significance of the difference
between pairs of actuarial curves.
Van Dongen et al [4] published a report in 2000 about a randomized multicenter clinical
trial with two arms, mastectomy and breast conservation therapy. They realized that there
were no trials with women with large tumors and decided to compare breast conservation
surgery with mastectomy in women with stage II breast cancers with tumors up to five
centimeters. The study population consisted of 868 patients with a diagnosis of stage I or
II invasive carcinoma of the breast, among which, 420 were randomized to undergo a
mastectomy and 448 breast conservation therapy. Patients were recruited from May 1980
to May 1986. Follow up time was from the randomization date until May, 1990. The
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overall survival rate was 66% in the mastectomy group versus 65% in the breast
conservation therapy group (p-value=O.lI). The distant metastasis-free rate was 66% in
the mastectomy group versus 61 % in the breast conservation therapy group (pvalue=0.24) and the locoregional recurrence rate was 12% in the mastectomy arm versus
20% in the breast conservation surgery group (p-value=O.OI). The investigators
concluded that breast conservation therapy and mastectomy demonstrated similar
survival rates in a trial in which the majority of participants had stage II breast cancer.
Statistical methods used to analyze the data were the Kaplan-Meier curves to estimate
duration of survival, time to distant metastasis and time to locoregional recurrence, and
the log rank test to compare the results of mastectomy and breast conservation therapy.
The Cox proportional hazard models were also used.
In 1969, Veronesi and colleagues [3] conducted a randomized trial for which reports were
published in 1977 [34] and 1981 [35]. In 2002, an update of the 20-year follow up was
published [3]. It had as an objective to compare the efficacy of radical (Halsted)
mastectomy with that of breast conservation surgery. The trial had two arms: the radical
mastectomy and breast conservation surgery. About 701 women were enrolled, 349 in the
mastectomy arm and 352 in the breast conservation group during the recruitment time
(from 1973 to May 1980). The investigators compared the two groups in terms of
recurrence of the tumor in the same breast and mortality. Other events included
contralateral breast carcinomas, distant metastases and secondary primary cancers. After
20 years of follow up, 30 individuals in the breast conservation arm had had recurrent
tumors versus only eight in the mastectomy arm (p-value<O.OOI). No statistically
significant difference in the occurrence of other events or in mortality was observed. The
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investigators concluded that the long-term survival of women with breast cancer who
were treated with breast conservation surgery was virtually identical to the rate among
women who had radical mastectomy. The overall survival and breast cancer-specific
survival rates were also similar in the two groups. Data analysis was performed using the
Gray test to compare the crude cumulative incidence of recurrent tumor and the local
recurrence of tumors and the Kaplan-Meier curves to estimate the survival curves.
Fisher et al [2, 36, 37] initiated a study in 1973 and published reports of the eight year
results [37], the 12 year results [36] and the 20 year results [2]. The latter was published
in 2002 and aimed to determine whether lumpectomy with or without radiation was as
effective as total mastectomy for the treatment of invasive breast cancer. The design was
a prospective randomized clinical trial with three arms: total mastectomy, lumpectomy,
and lumpectomy with additional breast irradiation. Women were recruited between
August 8th 1976 to January 2ih 1984 and they were followed up for a mean of 20.8 years
(total mastectomy group), 20.6 years (lumpectomy group) and 20.7 years (lumpectomy
with irradiation group). The 20-year follow up data were available for 1851 participants,
589 in the total mastectomy arm, 634 in the lumpectomy arm and 628 in the lumpectomy
plus radiation arm. The investigators looked at the disease-free survival, distance-disease
free survival, and overall survival. It was found that the Hazard Ratio for death was 1.05
(95% confidence interval: 0.90-1.25) for the lumpectomy group and 0.97 (95%
confidence interval: 0.83-1.14) for the lumpectomy plus radiation group in comparison to
the mastectomy group. As a conclusion, no significant differences were observed among
the three groups of women with respect to disease-free survival, distance disease free
survival or overall survival. Data were analyzed using the Kaplan-Meier method to
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estimate disease-free survival, distant disease-free survival and overall survival rates and
the log-rank statistics to determine differences among the treatment groups with respect
to death from causes other than breast cancer.
In 2003, Poggi [6] and colleagues conducted a randomized prospective clinical trial in
which 237 women with breast cancer stage I and stage II were assigned to either the
mastectomy therapy (116 patients) arm or the breast conservation therapy (121 patients).
The median age was 50 years old. The participants were followed from 1979 for a
median time of 18.5 years. The investigators were interested in the overall survival as
well as disease free survival. They were motivated by the fact that there was no long-term
randomized data in the literature and they aimed to confirm the fact that there were no
detectable differences between the mastectomy therapy and the breast conservation
surgery in overall survival and disease-free survival. Their study found that the estimated
overall 20-year overall survival rate was 58% for the mastectomy therapy group and 54%
for the breast conservation therapy group (p-value=0.67). The overall disease-free
survival rate was 67% for the mastectomy group and 63% for the breast conservation
surgery group (p-value=0.64). The occurrence of secondary events (isolated chest wall
events, regional events, distant events and non-breast cancer events) were also evaluated.
It was found that their occurrence was not significantly different between the two groups.

Peggi et al concluded that there were no statistically significant differences in overall
survival and disease-free survival. In this study, the investigators used the Kaplan-Meier
methods to compare the probabilities of overall survival and disease-free survival and
Mantel-Haenszel tests to evaluate the differences between pairs of actuarial curves.
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3.3. Methods used to compare lumpectomy to mastectomy in administrative data
In the year of2003, Kroman et al [7], realizing that the published studies comparing
breast conservation therapy to radical mastectomy had used data of middle-aged or older
women, decided to analyze the effect of age on breast carcinoma survival according to
the type of surgical treatment used. They performed a registered data-based research
study using the Danish Breast Cancer Cooperative Group database. The study analyzed
data from 9285 premenopausal women of 50 years old and under with primary breast
carcinoma who had undergone radical mastectomy (7165 women, 77.2%) or breast
conservation surgery (2120 women, 22.8%). Women considered for analysis were those
diagnosed between January 1st 1982 and December 31 st 1998. The variable of interest
was the 10-year overall death rates. The study found that in comparison to women who
had received the radical mastectomy, women of age less than 45 did not have a different
risk of death. The report concluded that for younger women, long-term survival was
similar for those who were treated by breast conservation therapy and those who were
treated by radical mastectomy. The statistical methods used were the Poisson Regression
performed as likelihood ratio tests to analyze the relative risk of death due to breast
carcinoma and the Chi-Square tests to analyze the associations between baseline
characteristics.

3.4. Use of advanced data mining techniques to compare Mastectomy to
Lumpectomy
Martin et al. [38] published a study in 2006 in which a comparison of Mastectomy and
Breast Conserving Surgery was made using a classification tree approach. They used data
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from the Western Australian data on a population of women diagnosed between 1990 and
2000. The main objective was to identify the most important factors to determine the type
of surgery. The total number of women was 2713 among which 39% underwent
Mastectomy and 61 % underwent Breast Conserving Surgery. The outcome of analysis
was type of surgery and the factors of interest included tumor size, age, area of residence,
tumor histology, lymph node (nodal) status, country of birth, payment class and marital
status. Two models were compared, the decision tree and the logistic regression. They
found that tumor size was the primary determinant of patient choice. Patients with
smaller tumors (less than 20 mm in diameters) preferred Breast Conserving Surgery. For
patients with larger tumors (greater than 20 mm), important factors for choice were age,
nodal status and tumor histology. Methods used for analysis were the decision tree and
the logistic regression. In terms of model, they found that classification trees performed
as well as logistic regression for predicting type of surgery.
3.5. Comparison of Mastectomy and Lumpectomy in terms of patient choice and
psychological outcomes

Kirby et al. [39] analyzed the effect of patient choice on the rates of Mastectomy. This
was a cross-sectional study in which 203 breast cancer patients who had mastectomy
were invited to fill out a questionnaire to assess whether an option of Breast Conserving
Surgery was provided and the reason of the choice made. This study found that patients
chose Mastectomy because they felt safer (n = 119), wanted to decrease the risk of further
surgery (n = 87) and/or wished to avoid radiotherapy (n = 34). It was found that despite
being advised that there is no difference between survival rates of Mastectomy and Breast
Conserving Surgery, many patients still felt safer with Mastectomy.
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Fallowfield et al. [40] evaluated the psychological outcome of different treatment policies
in women with early breast cancer who underwent either mastectomy or breast
conservation surgery depending on the surgeon's opinion or the patient's choice outside a
clinical trial. This was a prospective, multicenter study. The study population comprised
269 women under 75 with a probable early stage cancer who were referred to 22 different
surgeons. The main outcomes of interest were anxiety and depression as assessed by
standard methods two weeks, three weeks, and 12 months after surgery. It was found that
the incidences of anxiety, depression, and sexual dysfunction were high in all treatment
groups. There were no significant differences in the incidences of anxiety and depression
between women who underwent Mastectomy and those who underwent Lumpectomy.
This study was inconclusive as to the question whether women with early breast cancer
who undergo breast conservation surgery have less psychiatric morbidity after treatment
than those who undergo mastectomy.

3.6. Economic comparison of Mastectomy and Lumpectomy
Barlow et al. [41] compared the cost of Mastectomy and Breast Conserving Therapy for
Early Stage Breast Cancer in a total of 1675 women 35 years old or older. Their objective
was to evaluate the cost of medical care up to five years after diagnosis in early breast
cancer where both treatment had been shown to be equally officious. This study was a
retrospective observational longitudinal study using a regional nonprofit health
maintenance organization in the period 1990 through 1997. Comparative treatment
groups were Mastectomy only (n = 183), Mastectomy with adjuvant hormonal therapy or
chemotherapy (n = 417), Breast Conserving Therapy with radiation therapy (n = 405) and
Breast Conserving Therapy with radiation therapy and adjuvant hormonal therapy or
37

chemotherapy (n = 670). In this study, it was found that six months after diagnosis, the
differences among the mean total medical care costs for the four treatment groups were
statistically significantly (p-value < 0.001), with Breast Conserving Therapy being more
expensive than Mastectomy. The adjusted mean costs were $12987, $14309, $14963 and
$15779 respectively for Mastectomy alone, Mastectomy with adjuvant therapy, and
Breast Conserving Therapy plus radiation therapy, Breast Conserving Therapy plus
radiation therapy with adjuvant therapy. One year after diagnosis, the difference in cost
was still statistically significant (p-value < 0.001), but costs were influenced more by the
use of adjuvant therapy than by the type of surgery. The one-year adjusted mean costs
were $16704, $18856, $17344, $19081, respectively for Mastectomy alone, Mastectomy
with adjuvant therapy, Breast Conserving Therapy plus radiation therapy, Breast
Conserving Therapy plus radiation therapy with adjuvant therapy. By five years, Breast
Conserving Surgery was less expensive than Mastectomy (p-value < 0.001). The fiveyear adjusted mean costs of $41930, $45670, $35787 and $39926 respectively for
Mastectomy alone, Mastectomy with adjuvant therapy, Breast Conserving Therapy plus
radiation therapy, Breast Conserving Therapy plus radiation therapy with adjuvant
therapy. They concluded that had higher short-term costs but lower long-term costs in
comparison Mastectomy.
Polsky et al. [42] conducted an economic evaluation comparing Breast Conservation and
radiation with Mastectomy. The purpose of their study was to compare the incremental
cost effectiveness of Breast Conservation and radiation versus Mastectomy with the
restriction of choice to a single therapy versus providing a choice of either therapy. This
was a random retrospective cohort study which included a total of 2517 Medicare
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beneficiaries with early breast cancer treated in the years 1992 to 1994. The outcome
variables of interest were quality-adjusted life-years and 5-year medical costs. In terms of
cost, they found that Breast Conservation and radiation had significantly higher costs
than Mastectomy in the first year after surgery. Five years after surgery, the adjusted
costs were $14,054 (95% confidence interval, $9791 to $18312) higher for Breast
Conservation and radiation than for Mastectomy. The incremental cost effectiveness ratio
comparing Breast Conservation and radiation to Mastectomy was $219594 per quality
adjusted life year for comparison of both treatment strategies. They also found that if
possibility of patient choice from maintaining the availability of multiple treatments
versus restricting choice to mastectomy alone provides a quality-of-life gain of 0.031
quality adjusted life years, then the cost-effectiveness ratio of this choice option was
$80440 per quality adjusted life years. They concluded that the system of providing a
choice between Mastectomy and Breast Conservation surgery was economically
attractive when the economic analysis includes the benefit of patient choice of treatment.

3.7. Summary
Many breast cancer studies published, comparing breast conservation surgery to
mastectomy, were clinical trials and record-based observational analyses. The main
variables of interest across many of them were health outcomes expressed in terms of
mortality and survival. Data analysis of such variables has been performed with the use
of statistical models such as Kaplan-Meier estimates, Log-Rank tests, ANOV A, Logistic
Regression, Poisson Regression, etc.
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In contrast to these generated data analysis models, the focus has also been into
developing mathematical models to assess the risk of breast cancer [43, 44]. These
models include 'the risk for familial breast cancer model' [45,46], 'the individualized
probability of developing breast cancer model [47], the log-incidence mathematical
model of breast cancer incidence' [48], and the breast cancer prediction model which
incorporates familial and personal risk factors [49].
To this investigator's knowledge, there are no studies in which lumpectomy was
compared to mastectomy in terms of breast cancer health outcomes and hospitalization
usage variables using data mining techniques such as cluster analysis and predictive
modeling. Nor is there any study that reported a prediction model for a risk of rehospitalization in the case of surgical treatment for breast cancer. The current study will
provide a new approach of large longitudinal record-data analysis.
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CHAPTER 4
STATISTICAL ANALYSIS THEORY
4.1. Objective
The objective of the current chapter is to discuss the theory of statistical analysis behind
this examination of breast cancer. Statistical analysis was used to evaluate the contrast of
lumpectomy to mastectomy in terms of short-term in-hospital resources use and shortterm post-operative follow-up healthcare resources use (hospital, outpatient service and
prescribed medication use). First, an overview of the statistical analysis is presented.
Then, statistical analysis practical notes are reviewed before summarizing the statistical
theory. Since the current study is a comparative, the emphasis is put on the statistical
methods and models used in comparing outcomes among groups.

4.2. Statistical analysis overview
Statistics is the branch of the scientific method where limited sample data are used to
make inferences about random phenomena [50, 51]. It can simply be defined as the
science of the organization of data collection and data interpretation [52]. Statistical
methods include every process from the planning of data collection to producing reports
of data analysis. The field of statistics has two main areas: mathematical statistics and
applied statistics. Mathematical statistics is about the development of new methods
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requiring in-depth knowledge of abstract mathematics. Applied statistics is about
applying the methods of mathematical statistics to specific subject fields, such as
business, human sciences, public health and medicine [51].
In general, the aim of the field statistics is to characterize a population based on the
information observed in a sample taken from the same population. The sample
information is expressed by functions of the observed data, which are called statistics.
The field of statistics seeks to determine which functions are the most relevant in the
characterization of various populations [53].

4.3. Statistical Analysis Practical Notes
Applied statistics can be viewed as a set of methodologies used to help carry out
scientific experiments. In keeping with the scientific method, applied statistics consists of
developing a hypothesis, determining the best experiment to test the hypothesis,
conducting the experiment, observing the results, and making conclusions. The
statistician's responsibilities include: study design, data collection, statistical analysis,
and making appropriate inferences from data. In doing so, the statistician attempts to
limit bias, maximize objectivity and obtain scientifically valid results [52].
Often, the common goal for a statistical research project is to examine causality: the
effect of independent variables (or predictor variables) on dependent variables (or
responses). However, no statistical study can make a conclusion as causality; they can
only investigate whether or not parameters are related. There are two types of statistical
research studies: experimental studies and observational studies. The difference between
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the two resides in the conduct of the study and the randomness of the data. In an
experimental study, the investigator takes measurements of the system under study,
manipulates the system, evaluating how the manipulation modifies the measurement. In
contrast, in an observational study, the investigator has no control over the
measurements. In this case, data are gathered and the investigator examines the
relationship/association between predictor and response. There is no randomness and the
attempt of the investigator in an observational study is to approximate the concept of
randomness as much as possible.
4.3.1. Statistical methods

Statistical methods used to analyze the sample data in an objective to characterize
populations can be classified as descriptive, inferential or exploratory analyses.
Descriptive statistics are methods used to describe the distribution of the measurements.

They consist of estimates ofthe central tendency, measures of variability, counts,
percentages and graphical tools [51, 53]. Inferential statistics are methods that use
probability to express the level of certainty about estimates and to test specific
hypotheses. There are two main inferential statistics methods: confidence interval
estimation and hypothesis testing [51, 53]. Exploratory analyses methods use both
descriptive and inferential techniques to explore potential relationships in data. Given a
large data set, it is very likely that at least one statistically significant result can be found
by using exploratory analysis. The results found are not used to draw conclusions but
they are considered 'hypothesis-generating' because they are not pre-planned. Usually,
these results inspire the design of new prospective studies to test these new hypotheses
[53].
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4.3.2. Probability distributions
Probability distributions playa major role in statistics. In inferential statistics, probability
distributions are used to test hypotheses. There are two types of probability distributions:
discrete and continuous.
Discrete distributions describe variables that can only take discrete values (discrete

random variables). Commonly, the discrete distributions include the binomial, the
negative binomial, the poisson and the hypergeometric distributions [53].
Continuous distributions describe variables that can take any value within an interval

(continuous random variables). The common continuous distributions used are the
normal distribution, the exponential distribution, the chi-square distribution, the Fdistribution and the Student's t-distribution [53].

4.4. Statistical Analysis theoretical notes
Mathematical statistics is the study of statistics using mathematical theories, such as
probability theory, statistical theory and also linear algebra and analysis [52]. Methods
used in applied statistics are developed in mathematical statistics. There are mainly two
types of statistical analysis: descriptive and inferential.

4.4.1. Descriptive statistics
Descriptive statistics describe the probability distribution of the population. This is
achieved by computing measures of central tendency and dispersion, counts and
frequencies and by viewing the shape of the distributions using density estimations and
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histograms. Descriptive statistics is the first step in a statistical study; it gives the overall
picture of what the data look like [53].
Table 4.1: The common descriptive statistics for central tendency and dispersion [53]
Type of
measure
Measures of
central tendency

Measure

Formula

Arithmetic mean

- LXX=_L=

+X2+···+Xn
n

-

Median

The middle value if n, the
sample size, is odd
- The average of the two
middle values if n is even
The most frequently occurring value
Xi)11n = (xJ* X2 * X3 * ... * xntn
n
~ = n{(l!xl) + (l!X2) + ... +
(Xi)
(l/Xn)} -I

Mode
Geometric mean
Harmonic mean

(n

Weighted mean

xw = LW-Xu:

Trimmed mean

Arithmetic mean omitting the largest
and the smallest observations
Arithmetic mean after replacing
outliers with the closest non-outliers
values
X)2
s2 = L(X-L

L ,

Winsorized mean

Measures of
dispersion

Xl

11

Variance

where W = L

Wi

n-1

Standard deviation
Standard Error (of the
mean)
Range
Mean absolute deviation

s =..JSl
(S2 / n)1/2 = standard deviation of x

Inter-Quatile range
Coefficient of Variation

75 m percentile - 25 tn percentile

Largest value - smallest value
Llxi - xl

n
s

-

x

4.4.2. Inferential statistics: Confidence interval estimation
The two primary statistical methods for making inferences are confidence interval
estimation and hypothesis testing. Population parameters can be estimated by point
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estimates such as the mean and median using descriptive statistics. This estimate
represents the 'best guess' at the value of the true parameter. However, a point estimate
does not give any idea about how much information it is based on or how likely it is close
to the true parameter. A way to remedy this incompleteness of a point estimate is to
obtain an estimate of an interval that is likely to contain the true value of the parameter,
also known as a confidence interval. A confidence interval is constructed around the
point estimate and it contains the parameter with a specific high probability or confidence
level. In general, the confidence interval is finite ofthe form [8 l , 8u l, where 8l represents
the lower limit and 8u is the upper limit ofthe interval [53, 54]. The probability that a
confidence interval will contain e is called the confidence coefficient.
Suppose that

e and eu are the (random) lower and upper confidence limits, respectively
l

for the parameter e. Then if

the probability (1 - a) is the confidence coefficient. The resulting random interval
defined by [8z,

O'u] is called a two-sided confidence interval. One widely used method for

finding confidence intervals is called the pivotal method. This method depends upon
finding a pivotal quantity that possesses two main characteristics: (1) It is a function of
the sample measurements and the unknown parameter e, where e is the only unknown
quantity and (2) its probability distribution does not depend upon the parameter e [46].
The logic behind this method is that for a random variable X, the probability P (a :5 X :5
b) is unaffected by a change of scale or translation on X. Therefore, if the probability
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distribution of a pivotal quantity is known, the operations such as scaling and translation
may be used to create a confidence interval [55].
Suppose that a pivotal point quantity Q (X, 9) has been determined for a random sample
XI, X2, .... , Xn

from a population X with probability density function f (x; 8), where 8 is

the unknown. For a specific value of a, two numbers a and b that do not depend on 8, can
be found to satisfy
P(a:58:5b)~

I-a

With algebraic manipulation of the inequality, 9 can be isolated in the middle yielding

4.4.3. Inferential statistics: Hypothesis testing
Hypothesis testing is a means of formalizing the inferential process for the purpose of
decision-making. It is a way to use logical arguments to test hypothesized statements
about population parameters in a statistical approach [53]. In many ways the formal
procedure for hypothesis testing is similar to the scientific method [50].
The scientist observes nature, formulates a theory, and then tests this theory against
observation. In the statistical context, the scientist poses a hypothesis concerning one or
more population parameters. Then, he/she samples the population and compares her
observations with the hypothesis. If the observations disagree with the hypothesis, the
scientist rejects it. If not, the scientist concludes either that the hypothesis is true or that
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the sample did not detect the difference between the real and hypothesized values of the
population parameters.
Any statistical test of hypotheses works in exactly the same way and is composed of five
essential elements: (1) the null hypothesis (Ho), (2) the alternative hypothesis (Ha), (3) the
test statistics and (4) the rejection region or decision rule and (5) the conclusion [46, 49].
In mathematical terms, the hypothesis test is an ordered sequence (XI, X2, ... , Xn; Ho, Ha;
C) where XI, X2, ... , Xn is a random sample from a population X with the probability
density function f(x; 9), Ho and Ha are hypotheses concerning the parameter 9 in f(x; 9),
and C is a Borel set in ~n [56].

Borel sets are defined using the notion of a-algebra. A collection of subsets A of a set S
is called a a-algebra if (i) SEA, (ii) ACE A, whenever A E A, and (iii) Uk=l Ak E A,
whenever AI, A2, ... , An, ... EA. The Borel sets are the members ofthe smallest a-algebra
containing all open sets of ~n. Two examples of Borel sets in ~n are the sets that arise by
a countable union of closed intervals in ~n, and a countable intersection of open sets in
~n

[56].

The set C is called the critical region in the hypothesis test. The critical region is obtained
using a test statistic W(X I, X2, ... , Xn). If the outcome of (XI, X2, ... , Xn) turns out to be
an element ofC, then we decide to accept Ha; otherwise we accept Ho [56].

4.4.3.1. The null hypothesis and the alternative hypothesis
A statistical hypothesis H is a conjecture about the distribution, f(x; 9), of a population X.
This conjecture is usually the parameter [56].
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A hypothesis H can be a simple hypothesis if it completely specifies the density f(x; e) of
the population; otherwise, it is called a composite hypothesis.
The hypothesis to be tested is called the null hypothesis (denoted by Ho) and the negation
of the null hypothesis is called the alternative hypothesis (denoted by Ha).
If e denotes a population parameter, then the general format of the null hypothesis and
alternative hypothesis is
Ho:

e E no

and

Ha:

e E na

[56]

where no and na are subsets of the parameter space n with
no

n na = 0 and no u na !;;;; n

[56].

Most often, no u na = n; thus, the expressions of the null and the alternative hypotheses
become
Ho:

e E no

Ha : e f£ no

and

[56]

If no is a singleton set, then Ho reduces to a simple hypothesis.
4.4.3.2. The test statistic
Broadly speaking, a hypothesis test is a rule that tells us for which sample values we
should decide to accept Ho as true and for which sample values we should decide to reject
Ho and accept Ha as true.
Typically, a hypothesis test is specified in terms of a test statistic, W. There are several
methods to find test procedures including: (1) Likelihood Ratio Tests, (2) Invariant Tests,
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(3) Bayesian Tests, and (4) Union-Intersection and Intersection-Union Tests. The most
commonly used method is the likelihood ratio test. The likelihood ratio test statistic for
testing the simple null hypothesis Ho: 8 E no against the composite alternative hypothesis
Ha: S f£ no based on a set of random sample data Xv X2,

where n denotes the parameter space, and L(8,xV

... ,xn

X2' ... ,xn )

is defined as

denotes the likelihood

function of the random sample, that is

A likelihood ratio test (LRT) is any test that has a critical region C (rejection region) of
the form

where k is a number in the unit interval [0, 1].
If Ho : S = 80 and Ha : 8 = Sa are both simple hypotheses, then the likelihood ratio test
statistic is defined as

4.4.4. Common inferential statistical techniques for continuous variables
4.4.4.1. One sample t-test [51, 53]
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The one-sample t-test is used to infer whether an unknown population mean is different
from a constant value. The t-test assumes that the data are normally distributed with a
constant variance.
Suppose that a set ofn data points, YI, Y2, ... , Yn, represents a random sample selected
from a normally distributed population with unknown mean, Il. The test statistic t is a
function of the deviation between y (the sample mean) and Ilo. It is standardized by the
standard error of the sample mean,

/..Jii . When Ho is true, t has the Student's t

probability distribution with (n-l) degrees of freedom.
The one-sample two-sided t-test is summarized below [53]:
Null hypothesis:

Ho: Il= Ilo

Alternative hypothesis:

Test statistic:

Decision rule:

reject Ho if It I > tal2, n-I

The value tal2, n-I represents the 'critical t-value' of the Student's t-distribution at a twotailed significance level, a, and (n - 1) degrees of freedom.
4.4.4.2. Two sample t-test [51, 53]

The two-sample t-test is used to compare the means, III and 1l2, of two independent
populations, denoted III and 1l2. The two populations are assumed to be normally
distributed with the same variance (i.
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Let (YII, Y12, ... , Y1n) and (Y21, Y22, ... , Y1n2) be two random samples selected,
respectively, from Population 1 and Population 2. Let III and 112 the unknown means of
the two populations. Then III and 112 are estimated by 5'1 and 5'2, respectively.
The test statistic, t, is a function of the difference between 5'1 and 5'2 standardized by its
standard error, s(1/nl + I/n2)1I2. When Ho is true, t has the Student's t distribution with N
-2 degrees of freedom, where N = nl + n2. The unknown common variance (52 is estimated

by the 'pooled' variance (Sp 2):

The two-sample t-test is summarized below [53].
Null hypothesis:
Alternative hypothesis:

Test statistic:

Decision rule:

reject Ho if It I > tal2, N-l

4.4.4.3. Wilcoxon rank-sum (Mann Whitney U) test [51, 53]
The Wilcoxon rank-sum test is a non-parametric alternative to the two-sample t-test. It
does not assume that the data is normally distributed and can be used to make inferences
about the mean as well as the median. It does assume a symmetric population
distribution.
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Let Yil, Yi2, ... , Yini (for i = 1,2) be two random samples of sizes nl and n2, selected from
two independent populations. The test is based on the ranking ofthe nl + n2 combined
sample and Wilcoxon rank sum is the sum of the ranks of one of the samples. Without
loss of generality, assume that it is the sum of the ranks of the first group.
Let rlj = rank ofYlj (j = 1,2, ... ,nl) and r2j = rank ofY2j (j = 1,2, ... ,n2), and compute

- ,\,nl
d R - ,\,nz
R 1L..j=l Tlj an
2 - L..j=l T2j
The closer the average ranks RI/nl and R2/n2 are, the more likely the hypothesis of equal
means will be supported. For large samples, the rank sum test is performed through a
normal approximation. With N = nl + n2, the sum of the ranks (1 + 2 + ... + N) can be
expressed as N (N + 1) / 2. When Ho is true, it is expected that the proportion of the sum
of ranks from sample 1 is about nl/N and the proportion from sample 2 is about n2/N.
Thus, the expected value ofRI under Ho is

~,uRl

= (nl) (N (N+l)) = nl *(N+l)
N

2

2

The variance ofR I can be expressed as

The test statistic based on an approximate normal distribution, using a 0.5 continuity
correction, is summarized below [53]:

Null hypothesis:

Alternative hypothesis:

53

Z = IR l -IlR 1 1-0.5

Test statistic:

(JRl

reject Ho if IZI > ZaJ2

Decision rule:

where 81 and 82 represent the location parameter (mean, median, ... ) for the two
populations on which the inference is being made.
4.4.4.4. One-way ANOVA [51, 53, 54]
One-way ANOVA (analysis of variance) is used to infer the equality of two or more
means of independent groups based on selected random samples. One-way ANOV A
assumes that the populations (groups) are normally distributed arid have all the same
•

vanance,
Let

2

0' .

Yil, ... , Yini

be the random sample selected from group (population) i(i=l, 2, ... ,k).

The data are displayed in Table 4.2.
Table 4.2: Data display for the group comparisons [53]
GROUP
Group 1

Group2

...

Group k

Yll

Y21

...

Ykl

Yl2

Y22

...

Yk2

...

...

...

...

Yln1Ylnl

YZn2

...

Yknk
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The null hypothesis (Ho) stipulates that there is no difference in mean responses of the
different groups or, in other words, that there is "no Group effect" (i.e., no difference in
mean responses among groups). The alternative hypothesis is that at least two group
means are different or that "the Group effect is important". When Ho is true, the variation
among groups and the variation within groups are independent estimates of the same
measurement, (i, and their ratio should be close to 1. The test statistic F uses this ratio,
variation among groups (MSG)/variation within groups (MSE). Let N = nl + n2 + ... + nk.
Then the test statistic F has the F-distribution with k-l upper and N-k lower degrees of
freedom.
The test summary is given as [53]
Null hypothesis:
Alternative hypothesis:

Ha: not Ho

Test statistic:

F=MSG
MSE

Decision rule:

reject Ho ifF > F~=~(a)

MSG is an estimate of the variability among groups, and MSE is an estimate of the
variability within groups.

4.4.4.4.1. Mean Square Error (MSE)
One ofthe assumptions ofthe ANOV A is that the within-group variance is constant
across groups. This assumption is also called the 'variance homogeneity'. For the k
groups, this can be expressed as
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a12 = a 22 =

where

...

= a k2 = a 2

al denotes the unknown variance of the ith population. The common variance a2

is estimated by

S2,

computed as the weighted average of the k sample variances:
.... k

.... ni (

L.i=l L. j=l

- )2

Yij- Yi

N-k

where:

is the estimate of the variance within group i and N = nl + n2 + ... + nk.
s2is called the mean square error (MSE), and its numerator is the sum of squares for error
(SSE). The term 'error' is for the deviation of each observation from its group mean.
4.4.4.4.2. Mean Square for the Group factor (MSG)
The 'among groups' variability is a function of the deviations of the group means (Yi)
from the overall average y. The overall variance is expressed as:
.... k (-)2
MSG = L.i=l
Yi- Y =

k-l

SSG

k-l

where

SSG:=

Lf=l(Yi -

y)2 is the sum of squares for groups.

4.4.4.5. Kruskal-Wallis Test [51,53]
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The Kruskal-Wallis test is a non-parametric substitute of the one-way ANOVA when the
response variable is not normally distributed. Like in the one-way ANOV A case, samples
used to perform the test are assumed to be random and independent as well as symmetric.
The Kruskal-Wallis test is an extension of the Wilcoxon rank-sum for more than two
groups, just as a one-way ANOVA is an extension of the two-sample t-test.
Let Yil, ... , Yin-! be the random sample selected from group (population) i (i=l, 2, ... ,k)
following the display in Table 4.2. The null hypothesis (Ho) is that of equal mean
responses among groups. Suppose that the data are ranked, from lowest to highest, over
the combined samples; the test statistic is a function of the ranks and sample sizes.
For i = 1,2, ... , k andj = 1,2, ... , ni, let rij = rank ofYij over the k combined samples. For
each group (i=l, 2, ... , k), compute

The average rank of all N = nl + n2 + ... + nk observations is R = (N +1)/ 2. When the
null hypothesis is true, the average rank for each group, Ri = (RJ ni), should be close to
this value and the sum-of-squared deviations
k

I

ni(Ri - R)2

i=l

should be small.
The Kruskal-Wallis test statistic is a function of this sum of squares, which simplifies
algebraically to the quantity
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h* =

12
N (N+1)

(Lt
Rf)_3 (N + 1)
1-1 ni

When Ho is true, h* has an approximate chi-square distribution with k - 1 degrees of
freedom.
Let 9 represent the population location parameter; the test is summarized as shown
below.
Null hypothesis:
Alternative hypothesis:

Ha: 9i

'* 9j for at least one pair (i, j)

Test statistic:

reject Ho ifh > X~-l(U)

Decision rule:

X~-l(U) represents the critical value from a chi-square distribution based on k -1 degrees

of freedom and a significance level of u.
4.4.4.6. Two-way ANOVA [51, 53, 54]
The two-way ANOVA is used when analyzing two factors that affect a response
simultaneously. As in the one-way ANOVA, a two-way ANOVA factors in the analysis,
a group effect. In addition, the two-way ANOV A includes another identifiable source of
variation called a blocking factor. Because of this blocking factor, the two-way ANOVA
layout is sometimes referred to as a 'randomized block design'.
In general, the randomized block design (two-way ANOV A) has g (g
'group' factor and b (b

~

~

2) levels of a

2) levels of a 'block' factor. Independent samples are
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measurements taken from each of the g

X

b cells formed by the group-block

combinations. Let nij represent the number of measurements taken in Group i and Block j
(cell i - j), and let N represent the total number of all measurements over all g x b cells.
Let Yijk denote the kth response in Cell i - j (k = 1, 2, ... , nij). The general layout of the
randomized block design is shown in Table 4.3.
Table 4.3: Layout of the Randomized Block Design [53]
Group 1
Block 1 YIll, Y1l2, ... ,

Group 2
Y211, Y212, ... , Y21nll

...

Group g
Ygll, Yg12, ... ,
Yglnll
Yg21, Yg22, ... ,
yg2nll

Yllnl1

Block 2 Y121, Y122, ... , YI2nll

Y221, Y222, ... , Y22nll

...

...

...

Block b Ylbl, Ylb2, ... , Ylbnll

...

...

Ygbl, Ygb2, ... ,
ygbnll

Y2bl, Y2b2, ... , Y2bnll

The general entries in a two-way ANOVA summary table are represented as shown in the
following table.
Table 4.4: ANOVA Summary Table for the Two-Way ANOVA [53]
Source

Group (G)
Block (B)
GxB
(Interaction)
Error
Total

df
g-1
b-l
(g-l )(b-l)

SS

MS

SSG
SSB
SSGB

MSG
MSB
MSGB

N - gb
N-1

SSE
TOT(SS)

MSE

F
Fo=MSG/MSE
FB=MSB/MSE
FOB = MSGBIMSE

The SS represents the sum of squared deviations associated with the factor listed under
Source. Sum of squares are computed similarly as in one-way ANOV A.
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The mean square (MS) is ratio of the SS by the corresponding degrees of freedom. The
MS represents a measure of variability associated with the factor listed under source.
When there is no effect due to the specified factor (under source), this variability is the
measurement of error variability,

ci, which is estimated by MSE.

The F-values are ratios of the effect mean squares (MS ~ to the mean square error (MSE).
When the null hypothesis is true, i.e. there is no effect, the F-ratio should be close to 1.
These F -values are test statistics used for testing the null hypothesis of no mean
differences among the levels of the factor.
The F-test for group (FG) tests the primary hypothesis of no group effect. Denoting the
mean for the ith group by Ili, the test is summarized below [53].

Null hypothesis:
Alternative hypothesis:

Ha: not Ho

Test statistic:

F=

Decision rule:

reject Ho ifF > F:~;(a)

MSG
MSE

4.4.4.7. Repeated Measure ANOVA [51, 53, 54]
Repeated measure ANDV A is used to evaluate a group effect in the case where multiple
measurements are taken on the same subject. These type of data (repeated measure
measurements) also called 'longitudinal data' have the particularity to be nonindependent. Most of the times, the repeated response are measurements taken over time.
Comparisons are made through a single F -test form a repeated measure analysis.
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In general, there are g independent groups of experimental units who are subjected to
repeated measurements of the same response variable, y, at t time periods. Let nj be the
number of subjects in Group i (i=l, 2, ... , g), table 4.5 shows the layout for the Repeated
Measure ANOV A design.
Table 4.5: Layout for a Repeated Measures Design [53]

Time
Group
1

2

Subject
1
2

1

2

Ylll

Y112

...

Y12l

...

Y122

nl

Y ln 1 l

Yln 1 2

1
2

Y211

Y2l2

Y22l

Y222

n2

Y 2n 2 l

Y 2n 2 l

1
2

Ygll

Yg12

...

Yg2l

Yg22

...

...

Ygn g l

Ygn,q2

...

g

ng

...

...

...

...
...

...
...
...
...
...
...
...

...
...
...
...

T
Yllt
Y12t

...

Yl~t

Y2lt
Y2Zt

...

Y1Zt

Yglt
YgZt

...
Ygn,qt

Repeated measure ANOVA measures can be handled using several analytic approaches.
The 'univariate' approach using ANOVA concepts is presented here.
In the 'univariate' method, the Group, Patient, and Time effects shown in the Table 4.5
(above) are considered three factors in an ANOV A. Thus, one can examine the variability
within and among these factors, keeping in mind that the Time effect constitutes
correlated measurements. The response might vary among groups, among subjects within
groups, and among the different measurement times. Therefore, the model includes a
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Group effect, a Subject (within-Group) effect, a Time effect as sources of variation in the
ANOV A and in addition, a Group-by-Time interaction. Table 4.6 contains the repeated
measure ANOV A summary with N = n) + n2 +... + ng•
Table 4.6: ANOV A Summary for Repeated-Measures Design [53]
SOURCE
GROUP
SUBJECT (within
GROUP)
TIME
GROUP-by-TIME
Error
Total

For the balanced layout (n)

=

df
g-1
N-g

SS
SSG
SSS(G)

MS
MSG
MSS(G)

t- 1
(g-1 )(t-l)
(N-g)(t-l )
Nt - 1

SST
SSGT
SSE
TOT(SS)

MST
MSGT
MSE

n2 = ...

=

Fa =

F
MSGIMSS(G)
....

Fr = MST/MSE
For = MSGTIMSE

...

ng), the sums of squares can be computed in a way

similar to that used for the two-way ANOV A. Then, the mean squares (MS) are
calculated, by dividing the sums of squares (SS) by the corresponding degrees of
freedom.
Variation from subject-to-subject is one type of random error, as estimated by the mean
square for Subject (within Group). If there is no difference among groups, the betweengroup variation merely reflects subject-to-subject variation. Therefore, when the null
hypothesis (of no Group effect) is true, MSG and MSS (G) are independent estimates of
the among-group variability. Thus, Fa has the F-distribution with g - 1 upper and N - g
lower degrees of freedom.
4.4.4.8. Linear Regression [51, 53, 54]
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Regression analysis is used in analyzing the relationship response variables, and
quantitative factors. When there is only one response and one explanatory variable, the
model is a simple linear regression. When there are one or more response variables
and/or more than one explanatory variables, the model is a multiple linear regression.
4.4.4.8.1. Simple linear regression
Simple linear regression is used to find the best line that fits through a set of data points,
(xv Yl), (XZ, YZ)' ... , (Xn , Yn) drawn as a scatter plot. The objective of the analysis is to

determine the significance and the strength of the linear relationship, to estimate mean
responses for given predictor values, and to predict future responses. The slope of the line
is representative of the relationship between the response and the predictor variable.
Thus, inferences are made regarding this slope.
A linear relationship between a response, y, and an independent explanatory variable, x,
can be expressed as
y=a+~x+E

where a is the intercept and

~

is the slope. The response y is subject to a random

measurement error, the random error E accounts for this random nature of the response y.
This random error E is assumed to be normally distributed with mean 0 and variance (52.
This assumption implies that the response y is also normally distributed with mean
a + ~ x and variance (52. The parameters a, ~ and (52 are unknown and simple linear
regression methodologies attempt to estimate them from the observed data points
(xv Yl), (xz, Yz), ... , (x n , Yn)·
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4.4.4.8.1.1. Parameter estimation

Let ((Xi,Yi), for i = 1,2, ... , n) be a set ofn pairs where the Yi'S are assumed to be
independent, normally distributed with the same variance ci, for all x values. From these
data, the model parameters a and ~ are estimated by

a and p, respectively, in such a way

that the resulting 'prediction equation'

y=a+p

x

is the 'best-fitling' line through the measured pairs. When this is achieved, the prediction
equation represents the best estimate of the unknown linear regression model. The search
for the estimates

a and P is done in a way that minimizes the error (y - y), which is the

difference between the actual observed response and the predicted response. The most
common method used to satisfy this requirement is the Least Square method.

The Least Squares methods seeks

a and Pby minimizing the sum of squared differences

between y and y,

The derivation of the parameter estimates based on the Least Squares criterion is
presented below:
One of the assumption of the linear regression modeling is that the error has mean

o
~ Lf:l{Yi -

ya =

~ Lf:l{Yi - (a +

pxa} = 0

By solving the equation above, the estimate for a is obtained
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Substituting this value in the sum of square error expression, the SSE is
~n
SSE -_ L..i=1(Yi
-

~ 2 _ ~n {
ya
- L..i=1 Yi -

(~

a

A )}2 -_ L..i=1
~n {
A_+ {lXi
A )}2
+ {lXi
Yi - ( {lx

= Lb1{ (Yi - y)2 + Z P(Yi - Y)(Xi - i) + p2(Xi - i)2}
=_1_~~_ (y. _y-)2 _

n-1 L..z-1

z

znP

_1_~~_ (y. -y-)(x. -i)

n-1 L..z-1

z

z

+

n2_1_~~ (x.-

P

n-1 L..z-1 z

Define the quantities Syy, Sxx and Sxy as follows:

The expression for the SSE becomes:

_ 2

A 2 + {lA2 Syy
2

SSE - Syy - Z{lSxy

Differentiate this equation with respect to Pand equate the result to 0
d(SSE) _

----=-A- d{l

2

A

-ZSxy

2

+ Z{lSxx

_

- 0

By solving this last equation, the estimate of ~ is obtained:

The 'best-fitting' line based on the Least Squares criterion is given by
'"
'"
{}
y=a+px

where

A

Sxy

{l=Sxx

and
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a=Y-

Pi.

2

The best estimate for the variance, cr , is
2
SSE
S =-

n-2

4.4.4.8.1.2. Inference on the slope p

The main question in simple linear regression analysis concerns the significance of the
slope parameter. Given a number of observed values of normally distributed response
variable, (Yv Y2, ... , Yn), the mean, y, represents the best estimate of a future response. If
the slope

~

= 0, then the value of x will not improve the prediction of y over the ordinary

predicted, y. A significant slope

~

indicates that a linear relationship exists between y and

x and that the knowledge of the x-values will significantly improve the prediction ability.

Under the assumption that E

~ N(O, cr), the estimate P~ N(~' J

(J

L~l(Xi- X)2

)

=

N(~, "sxx
:-).

The statistical test is based on a function ofthe slope estimate which has the t-distribution
with n-2 degrees of freedom, when the null hypothesis of'slope=O' is true. The test
summary

IS:

Null hypothesis:

Ho:

~

=0

Alternative hypothesis:

Test statistic:

t=~

Decision rule:

reject Ho if It I > taJ2, n-J

s/fS;;

4.4.4.8.2. Multiple linear regression
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Multiple linear regression is used when there are one or more response variables and/or
more than one predictor variables.
Suppose that there are n response variables Yv Y2, ... ,Yn and p explanatory variables
Xv X2, ... , xp.

If the relationship between the response variables and the predictor

variables is assumed to be linear then the model can be expressed as:
Y=XP+E

whereY=

Yl): ,X=(!IX11 ... lxp)= (1 :
(Yn
1

X11

P
XI: )

X nl

x np

:

with I =

(1): ,
1

A number of assumptions are made in the multiple linear regression: (1) the entries of the
error vector E are independent from each other and normally distributed with mean 0 and
variance (/. Also the covariance of any two distinct entries is O. (2) Consequently, the
response vector contains elements that are mutually independent and each with variance

The parameters a, P and (J2 are known and they are estimated from the observed data. Just
like in the simple linear regression case, inferences are made on the entries of the

p vector

which symbolize the effect of the corresponding predictor variables on the responses. Let

11 be the estimate of p; the regression equation is given by
Y=x~.
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4.4.4.8.2.1. Parameter estimation
To estimate

~,

the Least Squares approach, analogous to the simple linear regression

case, is used. Here, the function to minimize is:

Algebraic methodology can be applied to find

~:

From the regression equation,

v = XP+E

In matrix form, the sum of squares can be expressed as
SSE= IIV-XPII2 = (V-XP)'(V-XP)
where the matrix M' represents the transpose of the matrix M
Perform matrix operations to obtain
SSE = Y'Y - p'X'Y =

Y'X~

+ P'X'X~

Y'Y - 2 p'X'Y + ~'(X'X)~

Differentiate this expression with respect to
a(SSE) = _ 2

aJ3

Equate the last expression to 02 =

~

to obtain

X'Y + 2 X'X~

(~ ~) and solve the resulting equation to

obtain ~
- 2 X' Y + 2 X'Xp = 02

X'Xp =X'Y
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This estimate obtained minimizes the sum of squared errors.
The estimate of ci is given by:

s=

SSE

n - (p

+ 1)

4.4.4.8.2.2. Inference on the slope vector Pentries

Just like in the case of simple linear regression, under the assumption that every error in
the error matrix e is normally distributed with mean 0 and variance ci,

where Sx'x'
=
! !

L)' Xl?)'

- nil? and Rx2'IX
X· x.
xkis the coefficient of determination for
!
1, .. ' !-1 !+1'"

the multiple regression of Xi on all other explanatory variables.

The standard error for

Pi is given by
1

s(pa = s

With all this information, the test summary for each factor is summarized below [49]
Null hypothesis:

Ho:

~i

=0

Alternative hypothesis:
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= Pi

Test statistic:

t

Decision rule:

reject Ho if It I > tal2, n-(p+I)

s(

pa

4.4.5. Common inferential statistical techniques for categorical variables
4.4.5.1. Chi-square test [51, 53, 57]
The chi-square test is used to test the equality of two independent binomial proportions,
PI and P2. The chi-square test is an approximate test, which assumes that the normal
approximation to the binomial distribution is applicable. If this assumption is violated,
the alternative is the Fisher's Exact test, which is a test based on exact probabilities.
Assume that there are two independent groups (Group 1 and Group 2) of, respectively, ni
and n2 subjects. Suppose that there are Xl responders in Group 1 and X 2 responders in
Group 2 (Table 4.7).
Table 4.7: Layout for the Chi-Square Test [53]

Group 1
Group 2
Combined

N umber of N onResponders
nl-X I
n2- X2
N -(Xl + X2)

Number of
Responders
Xl
X2
Xl +X2

Total
nl
n2
N=nI +n2

The goal of the Chi-square test is to compare population 'response' rates (PI vs. P2) based
on these sample data. Compute
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Assuming that the normal approximation to the binomial distribution is applicable, the
chi-square test summary is:
Null hypothesis:

Ho: PI= P2

Alternative hypothesis:
2 _

NUMERATOR 2

Test statistic:

X -

Decision rule:

reject Ho if X 2 > xf(u)

DENOMINATOR

The rejection region is found by obtaining the critical chi-square value based on 1 degree
of freedom, denoted as Xf(u), from chi-square tables.
4.4.5.2. Fisher's exact test [51,53,57]
Fisher's exact test is an analogue to the chi-square test for comparing two independent
binomial proportions, PI and P2 when the normal approximation to the binomial
distribution is not applicable. This usually is the case when the cases sizes are small or in
case of extreme proportions.
When the null hypothesis is true, Fisher's exact test method is based on computing exact
probabilities of observing a given result or a more extreme result. The same notation as in
the Chi-square test and same layout as in Table 4.7 are used here. Given equal
proportions, PI = P2, the probability of observing the configuration shown in Table 4.7,
when the marginal totals are fixed, is found by the 'hypergeometric probability
distribution' as
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b 'l'ty -- G~)*G~)
pro ball
( N )
x 1 +XZ

where

(~) = b!*(:~b)! is the combinatorial symbol that represents "the number of ways 'b'

items can be simultaneously selected from a set of 'a' items" without replacement.
The p-value for the test, Fisher's exact probability, is the probability of the observed
configuration (Table 4.7) plus the sum of the probabilities of all other configurations with
a more extreme result for fixed row and column totals.

4.4.5.3. Logistic Regression [51, 53, 57]
The logistic regression method is used to analyze the effect of one or more factors
(predictor variables) on a dichotomous response.

4.4.5.3.1. The Logit Model: One covariate
Consider a response variable, Y, taking two possible values, which can be coded as 0 and
1. Let a response ofY=1 indicate that the event of interest occurs (event), and a response
of Y=O indicate that the event does not occur (non-event). Suppose that a variable x is
included in the model.
Logistic regression models apply a transformation of the response variable using the
'logit function' as follows:
P

y* = Ln(-)
l-P

where P is the expected value ofY for a specified set of X-values and 'Ln' represents the
natural-logarithm function.
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Since Y takes only two values 0 and 1, the mean ofY is the Probability that Y=1. Denote
this probability by Px• As a probability Px, 0 :5 P x :5 1. In logistic regression, it is assumed
that the relationship ofP x with X is sigmoidal:
P =
x

1
1+ e-(a+ PX)

With algebraic computation, this can be re-expressed as
P

Ln (_X ) = a + ~X
1-Px

the left of which is the logistic transformation or 'logit' function (Y*). The expression
Px /(1 - P x) represents the 'odds' that Y=I, i.e., the odds that the event of interest occurs.
The logit is sometimes referred to as the 'log-odds'. In logistic regression methodologies,
the log-odds becomes a linear function of the covariate, X, assuming a sigmoidal
relationship between X and Px•
4.4.5.3.2. The Odds Ratio
Applying the log function on both sides of the logistic regression model, the odds for a
specific covariate value of X = x is

Replacing x by x+ 1, the odds for a covariate value of X = x + 1 is

Hence, the ratio of the odds based on a I-unit increment in X is

OddsX + 1
Oddsx
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= ef3.

This value is called the 'odds ratio' (OR) for the covariate X. 100(1- OR) represent the
percent change in the odds of event occurrence when the covariate (X) increases by 1
unit. When X is a dichotomous variable with values 0 and 1, the OR represents the factor
by which the odds of event increases level X=l relative to x=o.
4.4.5.3.3. Model Estimation

For a fixed value of the covariate, X=x, Px can be estimated by fix =

Yx, where nx is the

nx

number of observations at X = x and Yx is the number of events out of the nx
observations. Since Yx is a binomial random variable, fix is a better estimate when nx is
large.
Most often, an estimate ofPx is obtained by using the 'Maximum likelihood' method.
This method uses the data to estimate the model parameters, in a way that maximizes the
likelihood of observing the data collected. Estimates obtained are called 'maximum
likelihood estimates' (MLE). A model obtained with the maximum likelihood estimation
can be used for prediction purposes.
The mathematical derivations are based on the maximum likelihood method and they
yield a set of simultaneous equation that can be solved for the estimates of a and

p. These

equations, which do not have a closed solution, are of the form

There are numerical techniques, such as iteratively weighted least-squares and NewtonRaphson algorithms, which are used by computer software to solve these equations.
4.4.5.3.4. The Logit Model: Multiple Co variates
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In general, the logistic regression layout has N responses and k covariates, Xl, X2 ,

••. ,

and a typical data set can have the following layout:
Table 4.8: Layout for Logistic Regression [53]
Response

y

Yl
Y2

Covariates

...
...
...
...
...

X2

Xl
X 11

X21

X12

X22

'"

...

...

YN

X1N

X2N

Xk
Xkl
Xk2

. ..
XkN

The Xi's can be continuous, ordinal categorical or nominal categorical.
The model for the probability of 'event', P, becomes

Thus, the logit becomes the linear function

Exponentiating both sides, the odds are obtained and can be expressed as
(~)
l-P

= e(a+ PlXl + PzXz+···+ PkXk)

For a particular factor Xi , the odds ratio is

with the interpretation that 100 (e Pi - 1) represents the percent increase in the odds of
'event' occurrence when Xi increases by 1 unit and all other X's are held constant.
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Xk,

4.4.5.3.5 Inference on the Pi coejicients
The parameter coefficient Pi measures the effect of the covariate (Xi) on the event
probability. Estimates (b i ) of these coefficients can be obtained as discussed above by the
maximum likelihood methods. If the sample size is large, the estimates have
approximately a normal distribution with mean Pi' If Sb represents the standard error of
the estimate bi> then b/Sb has an approximate standard normal distribution when the null
hypothesis Pi=O is true. Its square has the chi-square distribution with 1 degree of
freedom. The test summary for each model parameter, Pi> is based on this Wald chisquare, and is summarized as follows [53]:
Null hypothesis:
Alternative hypothesis:

Test statistic:

Decision rule:

reject Ho if Xa. > xi(u)

4.4.6. Common inferential statistical techniques for time-to-an event data
4.4.6.1. Log Rank test [51, 53, 58]
The log-rank test is used to compare distributions of 'time until the occurrence of an
event of interest' among different independent populations (or groups). In medical
research, the event is often death, but it can be any outcome, such as cure, response,
relapse, failure, etc. The elapsed time from initial observation time until the occurrence of
the event is called 'survival time' even when the event of interest is not 'death'.
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The log-rank test does not make any assumption about the distributions of the event
times. Thus, it is non-parametric method. One important factor in the log-rank test is that
it adjusts for censoring. An individual is said to be censored when the event of interest
does not occur during the observation period. If all the individuals experienced the event
during the observation time, then data could be modeled and analyzed with the
Wilcoxon-Rank Sum test. However, some subjects may drop out or experience the event
before or after the study time. Event times for these individuals are estimates of the
unknown event times.
The null hypothesis tested by the log-rank test is that of equal event time distributions
among groups. Equality ofthe distributions of event times implies similar risk-adjusted
event rates among groups. Rejection of the null hypothesis indicates that the event rates
differ among groups at one or more time points during the study.
Without loss of generality, two independent groups are examined here. The method can
easily be extended to more than two groups. Let Y be the time from initial observation to
the event occurrence and let 'c' indicate a censored value. Table 4.9 represents the layout
for a log-rank test with two groups
Table 4.9: Layout for a log-rank test for two groups [53]
GROUP2
Event Time
Sub.iect Number
102
Y2J 'c'
105
Y22
Y23
106

GROUPl
Event Time
Subject Number
101
YII
Y12 'c'
103
104
YI3

NJ

N2

YJNJ 'c'
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Y2N2

'c'

'c' indicates censored time
Suppose that the study is divided into k distinct time periods, tl, t2, ... , tk, where tj (j = 1,
2, ... , k) represents the /h time point when one or more patients in the combined samples
experiences the event. Let djj represent the number of subjects in Group i (i = 1, 2) who
first experience the event at time period tj, and let njj represent the number of subjects in
Group i who are at risk at the beginning of time period tj. At risk represents the subjects
who have not yet experienced the event and are still in the study. Let dj = d lj + d2j and let
nj = nlj + n2j. For j = 1,2, ... , k, compute

and

and compute,

Denote by Yj a random variable that represents the event time for Group i (i = 1, 2), and
let Sj (t) = Prob (Yj ;::: t). The test summary for the log-rank test is as follows:
Null hypothesis:

Ho: SI (t) = S2 (t) (for all times, t)

Alternative hypothesis:

Ha: SI (t)

'* S2 (t) (for at least one time, t)

Test statistic:

Decision rule:

reject Ho if X 2 > xi(a)

4.4.6.2. Cox Proportional Hazard [51,53,58]
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The Cox proportional hazards model, like the log-rank test is another method used to
analyze event or 'survival' times with no assumption on their distribution. The inverse of
the time to event occurrence is called the 'hazard'. The hazard of some events, such as
death, might be likely to increase with the passage of time. Thus, the Cox proportional
hazards model adopts the a reasonable assumption that the event hazard rate changes over
time, but an assumption that the ratio of event hazards between two individuals is
constant, is made. This is known as the 'proportional hazards' assumption, and it
stipulates that the ratio of hazards between any two values of a covariate does not vary
with time.
Let Xl,
The

X2, ... , Xk

Xi'S

be k covariates in a Cox proportional hazard model on the event times.

can be continuous covariates, numerically coded ordinal responses or dummy

variables. The model for the hazard function of the Cox proportional hazards method has
the form

where h(t) is the hazard function, the

~i' S

represent the parameter coefficients of the Xi'S,

and A(t) represents an unspecified initial hazard function.
Just like in the regression analysis, the magnitudes ofthe

~i'S

show the importance of the

covariate's effect on survival times. Thus, inferences are made about these parameters.
~i'S

can be estimated by b i based on a 'maximum partial likelihood' , a modification of the

maximum likelihood method. For large samples, these estimates (bi ) have an approximate
normal distribution.
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Suppose that Sb is the standard error of the estimate bi , then b/sb has an approximate
standard normal distribution under the null hypothesis that

~i

= 0, and its square has the

chi-square distribution with I degree of freedom. The test summary for each model
parameter,

~i,

can be summarized as follows [53]:

Null hypothesis:
Alternative hypothesis:

Test statistic:

Decision rule:

reject Ho if Xa. > xf(a)

The magnitude of the effect of a covariate is often expressed as a hazard ratio similar to
the odds ratio. The ratio of hazards for a I-unit increase in Xi (all other covariates held
constant) is e Pi .

4.5. Summary

Statistical methods and models are widely used for inference. Their efficacy and
effectiveness has been proven by their extensive use in research projects. When the data
to be analyzed does not follow the assumed distribution, statistical methods are limited
because not all models have equivalent non-parametric options. Data mining offers data
exploration methods that do not rely on data distributions.
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CHAPTERS
DATA MINING THEORY
5.1. Objective
The aim of this chapter is to provide an overview of data mining theory. Data mining was
used for data grouping into clusters and for predictive modeling purposes in an objective
to contrast lumpectomy to mastectomy in terms of short-term post-operative follow-up
health outcomes. First, data mining is reviewed in general. Then, the data mining
practical notes are presented. Finally, data mining is summarized from a theoretical
standpoint, focusing on predictive modeling and cluster analysis.

5.2. Data mining overview
Data mining is 'the non-trivial extraction of implicit, previously unknown, and
potentially useful information from data' [15]. Data mining can also be defined as the
process by which patterns are extracted and/or discovered from large amount of data [16].
Data mining is a composite science that uses principles of algorithms used in statistics,
artificial intelligence, pattern recognition, and machine learning. Processes such as
sampling, estimation and hypothesis testing derive from statistics while processes such as
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search algorithms, modeling methods and learning theories derive from artificial
intelligence, pattern recognition and machine learning [16].
Data mining tasks are mostly either predictive or descriptive in nature. Predictive tasks
seek to predict the value of a particular attribute based (called target, dependent or
response variable) on the values of other attributes (called predictors, independent or
explanatory variables). Descriptive tasks, usually exploratory in nature, are used to derive
patterns (i.e. correlations, clusters, trends) summarizing the unknown underlying
relationships in the data.

5.3. Data mining practical notes
There are two types of data mining procedures: supervised learning and unsupervised
learning. In supervised learning, there are variables measured that are assumed to have an
influence on one or more other variables [59]. In the unsupervised learning, there is no
specific output variable [59].

5.3.1. Supervised learning

In supervised learning, there is an outcome measure-target variable (quantitative or
qualitative) and the goal is to predict it based on feature measurements-predictor
variables. There is training set of data (xv Yl), (X2' Y2), ... , (XN' YN) where both the
outcome (Xi) and feature (Yi) measurements are observed and this set is used to build a
prediction model that enables to predict new outcome.
Supervised learning presents an analogy with 'learning with a teacher'. Under this
metaphor, the 'student' presents an answer Yi for each Xi in the training sample, and the
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supervisor or 'teacher' provides either the correct answer and/or an error associated with
the student's answer. This is usually associated with some loss function L (y,

y) [59].

Supervised methods include regression, nearest neighbor methods, discriminant analysis,
logistic regression, kernel methods, decision trees, neural networks, etc. [60]
5.3.2. Unsupervised learning
As opposed to supervised learning, in unsupervised learning, there is no outcome
measure. This is analogous to 'learning without a teacher'. In this case, there is a set of
observations (xv X2J

... J XN)

and the goal is to infer the properties of the underlying

distribution without the help of a supervisor or a 'teacher' providing correct answers or
degrees of error for each observation.
The absence of 'supervision' is not without consequences. With supervised learning there
is a clear measure of success that can be used to judge the performance of a model and to
compare the effectiveness of different methods. In the case of unsupervised learning,
there is no such direct measure of success. It is difficult to determine the validity of
conclusions drawn from the output of most unsupervised learning methods [59].
The most common unsupervised learning techniques include association rules, cluster
analysis, principal components, etc. [59]
5.3.3. Overview of commonly used data mining techniques
5.3.3.1. Predictive Modeling
Predictive modeling is one of the most commonly used techniques in data mining. It is
the process of using the patterns found in the training data set to predict future outcomes.
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Predictive modeling algorithms build a model for the dependent variable as a function of
the independent variables. There are two types of predictive modeling tasks:
classification and regression. Classification tasks are used when the target or dependent
variable is qualitative. Regression tasks are used when the target variable is quantitative.
Predictive modeling problems are comprised of four things: a dependent variable,
independent variables, a learning/training set, and a test data set. The learning/training
data set contains values for both the dependent and independent variables, and is used to
build the model. This model is then applied to the test set for evaluation. The
performance of the model is based on the counts of the test records that are correctly or
incorrectly predicted or classified.
There are several predictive modeling techniques. The most commonly used methods are
decision trees, regression and neural networks.

Decision trees [16]: A decision tree is a predictive model in which the results are
structured as a tree. A decision tree consists of a collection of decision nodes, which are
connected by branches, descending from the root node until coming to an end at the leaf
nodes. Each branch of the tree is a classification question and the leaves are the partitions
or segments of the datasets with the classification. These decision trees are different from
the decision trees used in Decision Analysis. While growing the tree, a question is asked
at each branch or split point in the tree. The tree stops growing when there is either only
one record in the segment, each of the records in the segment are the same, or there is not
any significant gain in making a split. In order to apply a decision tree algorithm, the
target variable must be discrete. There are several algorithms that are used to produce
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decision trees. These include: ID3, C4.5. Classification and Regression Trees (CART),
and Chi-Square Automatic Interaction Detector (CHAID).
Neural Networks [16]: Neural networks try to mimic the capabilities of the human brain.

The brain can recognize patterns, make predictions, and learn. Neural networks are data
mining methods with pattern recognition and machine learning algorithms to build
predictive models. There are two main structures in a neural network: nodes and links.
Nodes are artificial neurons and links are the connections between them. To make a
prediction, the neural network accepts values for the independent variables or predictors
at the input nodes. The values of these nodes are then multiplied by values stored in the
links. These values are added together at the output node, after which some threshold
function is used and the resulting number is the prediction. Most neural network usually
have a hidden layer of nodes between the input and output nodes. They are deemed
'hidden' because their contents are not made known to the end user. It is also possible to
have more than one hidden layer, thus making the network very complex.
Regression [61]: Regression analysis is a popular method used in many data mining

projects for building predictive models. Linear regression models are used to predict a
continuous response and logistic regression models are used to predict binary responses.
Linear regression models define the linear relationship between a series of independent

variables and a single response variable. If there is one independent variable, the linear
regression is referred to as a simple linear regression. In this case, the model can be
visualized as a straight line overlaid on a scatterplot. Multiple linear regression analysis
involves understanding the relationship between more than one independent variable and
a single response variable. Logistic regression models are built from one or more
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independent variables that can be continuous, discrete, or a mixture of both. In addition to
classifying observations into these categories, logistic regression models also calculate a
probability that reflects the likelihood of a positive outcome.

5.3.3.2. Cluster analysis
Clustering [16, 59, 61] can be defined as a division of data into groups of similar objects.
Instances within these groups or clusters are more similar to each other than instances
belonging to other clusters. Clustering differs from predictive modeling in the fact that
there is no target or dependent variable in clustering. Clustering algorithms try to segment
the whole data set into homogenous clusters. The more similarity within a cluster and the
bigger the difference between clusters the better the clustering. There are two main types
of clustering algorithms: hierarchical and partitional.
Hierarchical Clustering: Hierarchical clustering creates a tree of clusters known as a

dendrogram. In the dendrogram, the smallest clusters in the tree join together to create the
next level of clusters. The top or root of this tree (dendrogram) is the cluster that contains
all the records. There are two types of hierarchical clustering: agglomerative and divisive.
Agglomerative clustering algorithms begin with each record consisting of a cluster. At

this level, there are as many clusters as there are records. Then, based on some distance
criteria, the clusters that are closest to one another are joined together to create the next
largest cluster. This process in continued until the hierarchy is built with a single cluster,
which contains all records. Divisive clustering algorithms work in an opposite way. These
algorithms start with all of the records in one cluster and then, based on some suitable
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distance choice, split it into two clusters. This process continues until some stopping
criteria are met.
Depending on how similar or dissimilar items are in each cluster, the merging or splitting
of the clusters occurs. The distance used to measure similarity between individual records
is generalized to a robust between-cluster measure which is then used to evaluate the
need for merging or splitting. This between-cluster measure is called a linkage metric.
The major linkage metrics include: Single Linkage, Complete Linkage, and Average
Linkage. Single linkage (nearest neighbor) is based on the minimum distance between
any record in one cluster and any record in another cluster. Cluster similarity is based on
the similarity of the most similar members from each cluster. Complete linkage (farthest
neighbor) is based on the maximum distance of any record in one cluster and any record
in another cluster. Cluster similarity is based on the similarity of the most dissimilar
members from each cluster. Average linkage was designed to decrease the dependence of
the cluster linkage criteria on extreme values. The criteria here is the average distance of
all the records in one cluster from all the records in another cluster.
Partitional Clustering: Partitional clustering is dividing the data set into clusters that are

exhaustive and mutually exclusive. In contrast to the hierarchical clustering, a single
partition of the data is produced. Partitional clustering algorithms begin with a randomly
picked or user defined number of clusters. The algorithms then optimize each cluster
based on some validity measure. There are several partioning clustering approaches. The
most common are K-Means and Expectation Maximization (EM).
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K-Means is one ofthe oldest and most widely used clustering techniques. The name KMeans stands for the fact that each of the K clusters is represented by the mean point of
that cluster (the centroid). Basically, the K-mean algorithm is as follows:
1. Select K points as the initial centroids

2. Repeat
a. Form K clusters by assigning all points to the closest centroid
b. Recompute the centroid of each cluster
3. Until the centroids do not change
First step: K initial centroids are randomly selected. Second step: each point is assigned
to the closest centroid. The resulting groupings constitute clusters. Third step: for each
cluster, the centroids are recomputed. Fourth step: data points are re-assigned based on
the new centroids. The second, third and fourth steps are repeated until the centroids do
not change. The assignments of points to centroids are made based on a proximity
measure that quantifies the closeness of points. There are several types of proximity
measures such as Euclidian distance and Cosine similarity.

Expectation Maximization (EM): The EM technique also starts with a random guess of
the k clusters. In this case, the k clusters are represented by a set of probability
distributions. The EM algorithm is a repetitive two-step process: Expectation and
Maximization. The Expectation part consists of calculating cluster expected class values.
The Maximization part consists of finding distribution parameter estimates that
maximizes the expectation given the data. These steps are repeated until the loglikelihood converges.
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5.3.3.3. Text mining
Text mining [62, 63] is a variation on the field of data mining that tries to find interesting
patterns from large databases in character format. The patterns in effect provide
information that can be extracted to derive summaries ofthe words contained in the
documents, or to compute summaries for the documents based on the words contained in
them. One of the main themes supporting text mining is the transformation of text into
numerical data.
Usually, data sets used in data mining consists of attributes or columns and records
(rows) chosen before data are collected. In the case of text mining, records (rows) are
text documents and features (columns) are elements extracted from these documents.
These elements can be single words or combination of words. Most commonly, these
elements consists of simple words. The method used to transform text into instances
counting the frequency of simple words is called the bag of words representation [62].
Without loss of generality, the bag of words representation will be discussed. With this
representation, each document is a set of words, some occurring more than once [62].
The values stored in each feature (or column) are the number of times the element occurs
in the corresponding document.
Transformation of documents into a data set [62]: In the presence of many documents,

usually, a word dictionary is constructed. This dictionary contains all the words that
occur at least once in every document. One way to construct the data set is to consider a
column for each word. The problem with this method is that for example a dictionary
may have 10,000 words and a particular document only 200 words. The representation
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(or row) of this document will have 9,800 columns with D's for the unused words. Ways
to resolve this issue include the 'stop words' and the 'stemming' techniques. These
methods help reduce the size of the word dictionary which is representative of the feature
(column) space size.
Stop words: The stop words methods is an approach that removes words more likely to

be useless from the word dictionary. There is no universal list of stop words; they vary by
language. In English, stop words choices includes words such as: 'a', 'an', 'the', 'is', '1',
'you', 'of, etc ...
Stemming: Stemming is another method used to reduce the number of words in the word

dictionary by putting together all the words that have the same linguistic root. For
example, the words 'computing', 'computer', 'computation', 'computes',
'computational', 'computable 'and 'computability' can be reduced to the root (stem)
'comput'.
5.3.3.4. Association rules

Association rules analysis or discovery is a useful technique of finding important
relationships in large data sets. Association rules are based on frequencies of the
occurrence of items (or attributes) alone or in combination with other items (or attributes)
[16, 64]. The relationships are expressed in the form: (X

~

Y: support (X, Y),

confidence (X, Y)) where X and Y are disjoint item sets. X (the left hand side) is called
the antecedent and Y (the right hand side) is called the consequent. The confidence and
support are elements that measure the strength of the association or the performance of
the rule discovery [16,64]. The association (X
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~

Y: support (X, Y), confidence (X, Y))

means 'If item X is part of an event, then item Y is also part of an event x percent of the
times'.
The support measures how often the items X and Y occur together. The confidence
assesses how many times Y appear in instances that contain X. There are two more
measures of the goodness of the association rules: the expected confidence and the lift.
The expected confidence of an association rule (X => Y: support (X, V), confidence (X,
V)) quantifies the number of records that contain Y. The lift is the ratio of the association

rule's confidence to the association rule's expected confidence. A good rule has a large
confidence, a large support and a lift greater than 1.
Mathematical expressions

SuppO rt -

records that contain both X and Y
all records

1 ence =
Contid

records that contain both X and Y
.
records that contam X

1 ence =
Expect ed contid

Lift =

records that contain Y
all records

confidence
expected confidence

Association rules analysis is useful for finding interesting relationships that are hidden in
large data sets. The goal of this type of analysis is to uncover rules (or associations) for
quantifying the relationship between two or more attributes.

These relationships are

displayed in the form of an association rule. An association rule is an implication

91

expression of the form: X ==> Y: support (X, Y), confidence (X, Y) where X and Yare
disjoint item sets.
5.4. Data mining theoretical notes
Predictive modeling and cluster analysis are discussed in mathematical terms below.
5.4.1. Predictive modeling
The definitions, objectives and main use of data mining predictive modeling have been
presented in section 5.3.3.1. Below, the mathematical background of predictive modeling
is presented. In general, predictive modeling tasks can all be viewed as a function
approximation task [59]. First, the difference between predictive modeling and linear
models is discussed.
5.4.1.1. Difference between predictive modeling and linear models
As discussed in the sections above, one of the core theories of data mining is statistical
analysis. Predictive modeling methods used in data mining are very identifiable to the
ones used in statistical inference [63]. The main difference of predictive modeling and
statistical inference techniques resides in the fact that it is possible, in data mining to fit
many different models and compare their performance on a testing set; in statistical
inference, usually, a single model is fit and its performance is judged through p-values
[63].
5.4.1.2. Quantitative outputs
Let X E

IR{P

denote a real valued random input vector, and Y E

IR{

a real valued random

output variable. Let P (X, Y) be their joint distribution. A predictive modeling task is to
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search a function f(X) which best predicts Y given values of the input X. The errors in
prediction are measured through the loss function L(Y, f(X)). The most common loss
function used is the squared error loss:
L(Y, f(X))

=

(Y - f(X)) 2 [60]

For a given funder this squared error loss, the expected prediction error is:
EPE (f) = E [L(Y, f(X))2]

=

f (y -

[(x))2P(dx, dy)

=

EPE (f) = ExEy1x([Y - f(X)] 2)

[60]
Predictive modeling attempts to minimize this function. It is minimized by
f(x)

=

argminc EYlx([Y - c]21X = x) = E(YIX = x) [60]

which is a conditional expectation, also called the regression function. This solution
shows that the best prediction of Y at any point X = x is the conditional mean.
The best solution is measured by average squared error:
I(x) = Average (YilXi

= x) [56].

Using the Nearest Neighbor for classification, the solution is given by
I(x) = Average (YilXi E Nk(x)) [60].

where Nk (x) is the neighborhood containing the k points closest to x.
Using linear regression, the regression function f(x) is approximately linear to its
arguments
f(x) ~ xT ~ [60]
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where

~

is estimated using least square methods.

5.4.1.3. Qualitative outputs
Typically, qualitative variables are transformed into numerical codes using coding such
as dummy variables [59]. In general, when the output is qualitative, a different type of
loss function is used to measure the errors in prediction. Let G denote a qualitative output
and 0, the set of all possible classes. Let

C be the predicted value of G. The loss function

L (G, C(X)) can be represented by a K x K matrix L, where K = card (0). L contains
zeros on the diagonal and nonnegative values elsewhere. A matrix input L (k, 1) is the
error for classifying an observation belonging to class Ok as 01. Most often, the zero-one
loss function is used, where all misclassifications are charged a single unit. For a given G,
the expected prediction error is
EPE = E [L (G, C(X))] [59].
where the expectation is taken with respect to the joint distribution P (G, X). If it is
conditioned, the EPE can be written as

Pointwise, the EPE is minimized by

U sing the 0 -1 loss function, this solution simplifies to

C(x) = argmingEo[1 - P(gIX = x)] [59]
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or simply
e(x) = Ok ifP(OklX = x) = maxg P (glX

= x) [59].

This solution is called the Bayes classifier. In this case also, different approaches attempt
to provide an optimal solution.

5.4.2. Cluster analysis
As in the case of predictive modeling in the section above, definitions, objectives and
main uses of cluster analysis have been discussed in section 5.3.3.2. The center common
notion of the clustering objectives is the degree of closeness (or similarity) or difference
(or dissimilarity) between individual objects being clustered [59]. Thus, the mathematical
theory behind the measure of similarity and dissimilarity is presented below. Also, the
mathematical backgrounds of combinatorial algorithms, agglomerative and divisive
algorithms are presented.

5.4.2.1. Dissimilarity of individual measurements in the same attribute
Consider measurements

Xij

for i = 1, 2, ... , N, on variables Xj, j = 1, 2, ... , p (also called

attributes). In most common case, dissimilarity is defined as

d j (Xij,Xi1j)

between values

of the /h attribute. Define

as the dissimilarity between objects i and i'. There are several choices for
but the most common choices is the squared distance
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dj(Xij, Xi1j)

However, the choice depends on attribute type:
•

Quantitative variables. Quantitative variables have measurements which are
continuous real-valued numbers. In this case, the dissimilarity is measured as a
distance between measurements as a monotone-increasing function of their
absolute difference

Beside the squared distance
•

(Xi - Xi,)2,

a common choice is the identity.

Ordinal variables. Ordinal variables are qualitative variables which constitute an
ordered set. Distance measures for ordinal variables are generally defined by
replacing their M original values with

i-l/2

.

t:1 ' l = 1,2, ... , M [59]
in the prescribed order of their original values. They are then treated as
quantitative variables on this scale.

•

Categorical variables. With unordered categorical variables, the degree-ofdifference between pairs of values must be delineated explicitly. If the variable
assumes M distinct values, these can be arranged in a symmetric MxM matrix
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with elements Lrn

= Lnn Lrr = 0, Lrn

~

O. The most common choice is

Lrr, = 1.
5.4.2.2. Dissimilarity of different attributes in an object
Most often, a single overall measure of dissimilarity D (Xi. XiI) is done by computing
a weighted average of the p-individual attribute dissimilarities dj (Xij.Xilj),j= 1,2,

... ,p:

Here Wj is a weight assigned to the /h attribute.

5.4.2.3. Clustering algorithms
5.4.2.3.1. Combinatorial algorithms
Combinatorial algorithms work directly on the observed data with no direct reference
to an underlying probability model. Each observation is uniquely labeled by an
integer i E {I, ... , N}. A prespecified number of clusters K < N is postulated, and
each one is labeled by an integer k

E

{I, ... , K}. Each observation is assigned to one

and only one cluster. These assignments can be characterized by a many-to-one
mapping, or encoder k = C* (i), that assigns the ith observation to the kth cluster. One
seeks the particular encoder C* (i) that achieves the required goal, based on the
dissimilarities d (Xi. XiI) between every pair of observations. These are specified by
the user. Generally, the encoder C (i) is explicitly delineated by giving its value
(cluster assignment) for each observation i. The "parameters" of the procedure are the
individual cluster assignments for each of the N observations. These are adjusted so
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as to minimize a "loss" function that characterizes the degree to which the clustering
goal is not met.
One approach is to directly specify a mathematical loss function and attempt to
minimize it through some combinatorial optimization algorithm. Since the goal is to
assign close point to the same cluster, a natural loss function would be

This criterion characterizes the extent to which observations assigned to the same
cluster tend to be close to one another. It is sometimes referred to as the "within
cluster" point scatter since

or
T = Wee) + B(e) [59],

where d ii , = d(Xi,Xi'). Here T is the total point scatter, which is constant given the
data, independent of cluster assignment. The quantity

is the between cluster point scatter. This will tend to be large when observations
assigned to different clusters are far apart. Thus one has
wee) = T - B(e) [59]

and minimizing wee) is equivalent to maximizing B(e).
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Cluster analysis by combinatorial optimization is simple and straightforward. One
simply minimizes W (which is equivalent to maximizing B) over all possible
assignments of the N data points to K clusters. Since most clustering problems
involve very large data sets, such optimization by complete enumeration is practically
difficult. More practical combinatorial clustering algorithm are able to examine only a
very small fraction of all possible encoders k = C (i). The goal is to identify a small
subset that is likely to contain the optimal one, or at least a good suboptimal partition.
Such feasible strategies are based on iterative greedy descent. An initial partition is
specified. At each iterative step, the cluster assignments are changed in such a way
that the value of the criterion is improved from its previous value. Clustering
algorithms of this type differ in their prescriptions for modifying the cluster
assignments at each iteration. When the prescription is unable to provide an
improvement, the algorithm terminates with the current assignment as its solution.
Since the assignment of observations to clusters at any iteration is a perturbation of
that of the previous iteration, only a very small fraction of all possible assignments
are examined.

K-means: The K-means algorithm is one ofthe most popular iterative descent cluster
method. It is used in cases where all variables are quantitative, and the dissimilarity
measure is the squared Euclidian distance

The within-point scatter can be written as
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where Xk = (Xlk' ... , Xpk) is the mean vector associated with the kth cluster, and

Nk

= L~=l [(C(O = k). Thus, the criterion is minimized by assigning the N

observations to the K clusters in such a way that within each cluster the average
dissimilarity of the observations from the cluster mean, as defined by the points in
that cluster, is minimized.
An iterative descent algorithm for solving

can be obtained by noting that for any set of observations S

Hence we obtain C* by solving the enlarged optimization problem

This can be minimized by an alternating optimization procedure below.
Step!: For a given cluster assignment C, the total cluster variance is minimized with
respect to {mv ... , mK} yielding the means of the current assigned clusters.
Step 2: Given a current set ofmeans{mv ... , mKJ, the enlarged optimization problem
above is minimized by assigning each observation to the closest (current) cluster
mean. That is
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Step 3: Steps 1 and 2 are iterated until the assignments do not change.
5.4.2.3.2. Hierarchical algorithms

Hierarchical clustering [55] produce hierarchical representations in which clusters at
each level of the hierarchy are created by merging clusters at the next lower level. At
the lowest level, each cluster contains a single observation. At the highest level there
is only one cluster containing all the data points.
Agglomerative clustering (bottom-up) [55]: Agglomerative clustering algorithms

begin with every observation representing a cluster with one element. At each of the
N-l steps the closest two clusters are merged into a single cluster, producing one less
cluster at the next higher level. Let G and H represent two such groups. The
dissimilarity d (G, H) between G and H is computed form the set of pairwise
observation dissimilarities d iif where one member of the pair i is in G and other i' is
in H. Single linkage (SL) agglomerative clustering (also called the nearest neighbor
technique) takes the intergroup dissimilarity to be that of the closest (least dissimilar
pair)

dSL(G, H)

= !EG,tfEH
. mjn d iif

Complete linkage (eL) agglomerative clustering (furthest-neighbor technique) takes

the intergroup dissimilarity to be that of the furthest (most dissimilar) pair

dCL(G,H)

= !EG,!fEH
. mjn d iif

Group average (GA) clustering uses the average dissimilarity between the groups
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dGA(G,H) = N

~

G

II

d Uf

H iEG ifEH

Where NG and NH are the respective number of observations in each group.
Divisive clustering (top-down) [55]: Divisive clustering algorithms begin with the
entire data set as a single cluster, and recursively divide one of the existing clusters
into two daughter clusters at each iteration in a top-down fashion.
The divisive paradigm can be employed by recursively applying any of the
combinatorial methods to perform the splits at each iteration. One divisive algorithm
was proposed by Macnaughton Smith et al. in 1965. It begins by placing all
observations in a single cluster G. it then chooses that observation whose average
dissimilarity from all the other observations is largest. This observation forms the first
member of a second cluster H. At each successive step that observation in G whose
average distance from those in H, minus that for the remaining observations in G is
largest, is transferred to H. This continues until there are no longer any observations
in G that are, on average, closer to those in H. the result is a split of the original
cluster into two daughter clusters. The observations transferred to H, and those
remaining in G. these two clusters represent the second level of the hierarchy. Each
successive level is produced by applying this split procedure to one ofthe clusters at
the previous level. Kaufman and Rousseeuw (1990) suggest choosing the cluster at
each level with the largest diameter
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for splitting. An alternative would be to choose the one with the largest average
dissimilarity among its members

This recursive splitting continues until all clusters either become singletons or all
members of each one have zero dissimilarity from one another.

5.5. Summary

One of the bases of data mining is statistics. However, data mining methods for data
analysis go further than statistical methods because they mostly do not assume any
underlying distribution. Also, although some techniques are exploratory, they have
the power to generate and validate hypotheses simultaneously. This quality makes
them very promising. Data mining methods have been used and validated in business.
Their use in healthcare research is still evolving and is yet to be validated in the
literature.

103

CHAPTER 6
DECISION ANAL YIS AND COST EFFECTIVENESS ANALYSIS THEORY
6.1. Objective
The aim of this chapter is to present the theory of decision analysis and cost-effectiveness
analysis. Decision analysis was used to compare lumpectomy to mastectomy in terms of
long-term (lO-years) comparative effectiveness. Cost-effectiveness analysis was used to
analyze the incremental cost per satisfied patient after lumpectomy versus mastectomy.
First, the decision analysis theory is reviewed. Then the cost-effectiveness theory is
presented.

6.2. Decision analysis
6.2.1. Decision analysis overview
Decision analysis can be defined as an organized quantitative method for measuring the
relative value of different decision options. Decision analysis results are aimed to provide
information on which strategy has the best 'outcome' of interest. Historically, it was used
as an approach to help physicians make decisions on how to treat individual patients.
Nowadays, it is increasingly used to help policy makers in decisions about the
management of groups [17].
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6.2.2. Decision analysis practical notes
Decision Analysis (DA) is performed in five steps: (DA 1) Identifying and bounding the
problem, (DA 2) Structuring of the problem and construction ofthe decision tree, (DA 3)
Gathering the information to fill out the decision tree, (DA 4) Analysis of the decision
tree using probability and estimation methods and (DA 5) Sensitivity analysis [17].
6.2.2.1. Identifying and bounding the Problem
In this step, the first component is to state the alternative strategies to be compared. Then,
the events that follow the different alternative methods are identified. The last component
is to define the outcome [17].
6.2.2.2. Structuring the Problem
Structuring the problem mainly involves the construction of the decision tree. The
decision tree is a graphical representation of the different alternatives, their subsequent
consequences and the resulting outcomes [17]. In general, decision trees are made of
nodes (decision nodes and chance nodes), branches and outcomes. Decision nodes
identify points where there are alternative actions that are under the control of the
decision maker. In the simplest problem, the decision node describes the problem.
Chance nodes identify points where events that are not in the control of the decision
maker may occur [17]. There are conventions that guide the construction of the decision
tree. First, decision trees are built from left to right. Second, when time is involved,
earlier events or choices are represented first (put on the left) left and later ones are
presented next (on the right) [17]. Third, decision nodes are drawn as squares, chance
nodes as circles and outcomes as large triangles. Fourth, branches are drawn at right
105

angles to nodes; they connect nodes with nodes and nodes with outcome [17]. Fifth,
chance nodes for the same events should line up horizontally. Probabilities are associated
with the events that are mutually exclusive and jointly exhaustive [17]. Figure 6.1
illustrates a hypothetical decision tree.

Event 1
outcome
Decision option

probability 1
Event 2
outcome

Decision

1 - probability 1
Event 1
outcome

alternative action

probability2

~------------~~

Event 2
outcome

1 - probability2

Figure 6.1: A hypothetical simple decision tree [17]
In the decision tree, outcomes are the consequences of the final events depicted in the
tree. An outcome can be life or death; disability or health; or any variety of other risks or
benefits of the strategy [17]. An outcome may also be the extension in life or the quality
of life. In most current decision analysis studies, the outcome measures are life
expectancy or quality adjusted life expectancy. Estimation of quality adjusted life
expectancy involves the measurement of utilities. A utility is a measure of preference for
the outcome (condition) to society or to an individual [17].
6.2.2.3. Gathering information to Fill in the Decision Tree.
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Information to fill the decision tree can be gathered from a literature review (including a
meta-analysis), primary data collection, consultation with experts or all of the above [17].

6.2.2.4. Analyzing the Decision Tree
The decision tree is analyzed by a process called folding back and averaging. This
method results in an estimate of the probability of the expected outcome of each
alternative. There are a number of computer software available to perform decision
analysis (such as TreeAge, etc.). However, the computations necessary to analyze simple
decision trees are simple arithmetic operations [17].

6.2.2.5. Sensitivity analysis
A sensitivity analysis is conducted in order to measure the stability of the conclusion with
respect to the assumptions made. In a sensitivity analysis, probabilities on which
assumptions were made are varied. [17]

6.2.3. Decision Analysis Theoretical Notes
The task of the analyst is to present the systems along with their estimated effectiveness
to the decision-maker [65]. From a mathematical point of view, effectiveness can be
viewed as either a random variable or not.

6.2.3.1. Decision analysis when effectiveness in a non-random variable
If effectiveness is a non-random variable, its values for the different alternatives can be
known with certainty in advance of acquiring the strategy. In this case, the comparison is
straightforward.
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6.2.3.2. Decision analysis when effectiveness is a random variable
If effectiveness is a random variable, its values for each strategy are not known but the
probability distribution of different levels of effectiveness can be estimated.
Assume two methods A and B are compared. Let a (e) and b (e) be the probability that A
and B respectively, if acquired would have a level of effectiveness e. Let the probability
that the methods' level of effectiveness is ultimately e* or greater be A (e*) and B (e*).
Then,

A (e*) = P (e ?:..e*) =

Ie: a (e) de and B (e*) = P (e ?:..e*) = Ie: b (e) de for every

possible e* [65].
Thus, the decision-maker can select B in preference over A ifB (e*) > A (e*) or if:

6.3. Cost Effectiveness Analysis
6.3.1. Cost Effectiveness Analysis overview
Cost Effectiveness Analysis is a full economic evaluation that compares decision options
in term of their monetary cost per unit of effectiveness [17, 66]. In this type of analysis,
both the cost and the consequences of the alternatives are examined [66]. In health
economics, cost effectiveness analysis is mostly used for allocating limited funds but it
can also be used in decision making by groups or individuals [20].

6.3.2. Cost Effectiveness Analysis Practical notes
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A Cost Effectiveness Analysis (CEA) study consists of seven steps [18]: (CEA 1) stating
the problem, (CEA 2) describing the conceptual model, (CEA 3) defining the perspective,
(CEA 4) identifying contributors to cost and gathering data to value costs, (CEA 5)
identifying outcomes and gathering data to value outcomes, (CEA 6) estimating cost
effectiveness, and finally (CEA 7) performing a sensitivity analysis.
Cost effectiveness analysis is closely related to decision analysis. Decision analysis is
concerned with comparing outcomes in terms of their effectiveness. Cost effectiveness
analysis goes beyond just effectiveness to include the cost. Decision analysis is somewhat
factored into cost effectiveness analysis and some steps of analysis are similar. In fact,
(CEA 1) is identical to (DAI), (CEA 2) to (DA 2), (CEA 5) to (DA 3), and (CEA 7) to
(DA 5). Thus, only steps (CEA 3), (CEA4) and (CEA 6) are presented below.

6.3.2.1. Defining the perspective
Costs and outcomes included in a cost effectiveness analysis may differ considering
which angle or point of view is taken for analysis. For example, the cost of a
hospitalization is different for a insurance provider and for a hospital. For the insurance,
it is the amount of money that the insurance pays. For a hospital, it is the sum of money
paid to the caregivers, money to run the hospital and other direct and indirect charges
[17]. These points of views are called perspectives. In a cost effectiveness analysis, the
perspective must be stated explicitly. Popular perspectives used are the societal and the
program. The societal perspective includes all costs, and the program's perspective
includes only the cost to implement the program.

6.3.2.2. Identifying contributors to cost and gathering data to value costs
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The next step is to identify contributors to the cost. These contributors depend on the
perspective. Contributors to costs include direct and indirect costs [17]. Direct costs are
costs disbursed such as cost of treatment, cost paid to administer the treatment, etc.
Indirect costs comprise cost of travel for patients, costs of lost wages for patients, etc.
After the contributors to cost have been identified, data on these costs are gathered. Cost
data can be obtained from primary data collection (micro-cost) or from the medical
literature or in an electronic data set (gross cost) [17, 67].
6.3.2.3. Estimating cost effectiveness
The cost effectiveness of an action relative to its alternative is the ratio of the net cost to
the net effectiveness [17]. The net cost is the difference between costs of different
alternatives. The net benefit is the difference between effectiveness of different
alternatives. Consider two alternatives 1 and 2, the incremental cost effectiveness ratio
(lCER) is of the form
ICER =

cost (alternative 2)-cost (alternative 1)
effectiveness (alternative 2)-effectiveness (alternative 1)

6.3.3. Cost Effectiveness Analysis Theoretical notes
The need of a cost effectiveness analysis usually arises when there is no fixed cost
constraint and no fixed effectiveness requirement. In fact, if the cost is fixed, then all the
alternatives are eliminated but the one that yields the greatest effectiveness [65]. Ifthe
effectiveness is fixed, the question would be a cost-minimization one. Most often, there is
an acceptable range of cost and an acceptable range of effectiveness [65]. In
mathematical terms, cost and effectiveness can be random or non-random variables.
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6.3.3.1. Cost effectiveness analysis in the case where cost and effectiveness are both
non-random variables
. If cost and effectiveness are non-random variables, then their values are known with
certainty for the different alternatives. Suppose that an alternative B is compared to an
alternative A; three cases are possible: (1) B costs more and is less effective than A. In
this case B is said to be dominated and it is rejected. (2) B costs less and is more
effective. In this case A is dominated and B is adopted. (3) B costs more and is more
effective. In this case, the leER is computed and, based on the value obtained, the
decision maker has to determine whether the additional effectiveness is worth the
additional cost.

6.3.3.2. Cost effectiveness analysis in the case where cost is a non-random variable
and effectiveness is a random variable
Assume that the cost is known with certainty and that effectiveness is a random variable.
This case is similar to the case of decision analysis when effectiveness is a random
variable.

6.3.3.3. Cost effectiveness analysis in the case where cost is a random variable and
effectiveness is a non-random variable
Assume that effectiveness is known with certainty and cost is a random variable for
which the probability distribution can be estimated. The solution here is analogous to the
case where effectiveness is a random variable and cost is known with certainty. Let a (c)
and b (c) be the probability density function of cost for the alternatives A and B
respectively. B is chosen if, for every c*,
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f~* b (e) de < f~* a (e) de. [65]
6.3.3.4. Cost effectiveness analysis in the case where both cost and effectiveness are
random variables
In the case where both cost and effectiveness are random variables, a joint probability
distribution associated with both cost and effectiveness can be derived for each
alternative. Let a (e, c), b (e, c) represent the joint distribution of effectiveness and cost
for alternatives A and B, respectively. Then B is chosen if, for every e* and c*,

6.4. Deterministic model versus Markov model
The model presented so far is called a deterministic model. This model is represented by
simple decision trees such as the one in Figure 6.1. In this type of model, time is not a
component of the alternatives.
When time is a factor in the alternative, then it is more appropriate to use a Markov
model. In a Markov model, there is a recursive component that repeats over time. In this
case, individuals can shift from one state of the recursive component to the other with a
certain probability. A Markov model is also called a state transition model [67]. In this
type of model, the system can be represented by two types of matrices: the state matrix
and the transition probability matrix. The transition probability matrix, noted M, is a
square matrix of order n where n is the number of different states [68, 69]. An entry mij of
this matrix represents the probability of moving from state i to state j in one step. The
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state matrix, noted A is a 1Xn matrix containing probabilities of being in each of the n
states.

6.S. Summary

Decision analysis is used in presenting the relative effectiveness of one alternative in
comparison to another. Cost effectiveness presents the comparison in terms of monetary
value. Although decision analysis can be performed alone, it is usually a first step to costeffectiveness analysis.
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CHAPTER 7
USE OF STATISTICAL METHODS TO COMPARE SHORT TERM INHOSPIT AL OUTCOMES FOR LUMPECTOMY AND MASTECTOMY
7.1. Objective
The objective of this chapter was to use the classical statistical methods to compare
lumpectomy to mastectomy. Data used are administrative; thus, the first task is to use a
good algorithm of patient selection and the second task is to clean and manipulate the
data to fit the assumptions of the statistical models. The difference of the real world data,
such as the one used in this section, and clinical trial data, is that the clinical trial data are
already nicely selected and cleaned from the inclusion-exclusion criteria. Here, SAS is
used to select cases of mastectomy and lumpectomy then data are prepared and finally
statistical methods are applied to the data. Lumpectomy is compared to Mastectomy in
terms of clinical outcomes such as length of stay and hospital charges and health
outcomes in terms of in-hospital death.

7.2. Data -Nationwide Inpatient Sample (NIS) Database
This study used the Nationwide Inpatient Sample (NIS) for the year 2005 [12]. The NIS
was described in section 1.3.4.
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7.3. Data pre-processing
7.3.1. Case selection
The NIS database contains up to 15 diagnoses (DXl - DXI5) and 15 procedures (PRI PRI5) for each discharge record. The coding uses the International Classification of
Disease, 9th edition, Clinical Modification (lCD-9-CM) diagnosis and procedure codes.
ICD-9-CM translation is publically available at www.icd9cm.chrisendres.com.
A cohort of hospital stays with any malignant neoplasm of the breast was generated with
the extraction of observation with any of the following ICD-9-CM codes: 174.0, 174.1,
174.2, 174.3, 174.3, 174.4, 174.5, 175.6 and 174.8 (Table 7.1). Among patients with a
diagnosis of breast cancer, only those with a surgical treatment procedure were retained
for the analysis. Mastectomy was recognized by the presence of codes 85.41, 85.42,
85.43,85.44, 85.45, 85.46, 85.47, and 85.48 in at least one of the procedures and, for
Lumpectomy, procedure code 85.21 was used. Cases with missing age or race were
excluded.
Table 7.1: ICD-9-CM codes for breast cancer

Code type
Diagnosis

ICD-9CM codes
174
174.0
174.1
174.2
174.3
174.4
174.5
174.6
174.8
174.9

Description
Malignant neoplasm of the female breast
Malignant neoplasm of the female breast nipple and
areola
Malignant neoplasm of the female breast central portion
Malignant neoplasm of the female breast upper-inner
quadrant
Malignant neoplasm of the female breast lower-inner
quadrant
Malignant neoplasm of the female breast upper-outer
quadrant
Malignant neoplasm of the female breast lower-outer
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Code type

ICD-9CM codes

Description

quadrant
Malignant neoplasm of the female breast lower-outer
quadrant
Malignant neoplasm of the female breast axillary tail
Malignant neoplasm of the female breast, other specified
sites
Procedure
Mastectomy

85.4
85.41
85.42
85.43
85.44
85.45
85.46
85.47
85.48

Lumpectomy 85.21

Mastectomy
Unilateral simple mastectomy
Bilateral simple mastectomy
Unilateral extended simple mastectomy
Bilateral extended simple mastectomy
Unilateral radical mastectomy
Bilateral radical mastectomy
Unilateral extended mastectomy
Bilateral extended mastectomy
Local excision of lesion of breast

Cases of mastectomy and lumpectomy were selected using the following SAS code:
Code 7.1: selection of mastectomy and lumpectomy cases
/*extract breast cancer patients*/
DATA INPATBC;
SET NIS2005.NIS - 2005 - CORE;
DX1=TRIM(DX1); DX2=TRIM(DX2); DX3=TRIM(DX3);
DX4=TRIM(DX4); DX5=TRIM(DX5); DX6=TRIM(DX6);
DX7=TRIM(DX7); DX8=TRIM(DX8); DX9=TRIM(DX9);
DXIO=TRIM(DXIO); DXll=TRIM(DXll); DX12=TRIM(DX12);
DX13=TRIM(DX13); DX14=TRIM(DX14); DX15=TRIM(DX15);
ARRAY DXX {15} $ DXI-DX15;
DO 1=1 TO 15;
IF DXX[I]='1740' OR DXX[I]='1741' OR DXX[I]='1742' OR
DXX[I]='1743' OR DXX[I]='1744'
OR DXX[I]='1745' OR DXX[I]='1746' OR
DXX[I]='1748' THEN BC=l;
END;
OUTPUT;
RUN;
DATA INPATBC;
SET INPATBC;
DXCLUSTER=CATX(' , OF DXI-DX15);
IF BC=l;
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RUN;
/*get the groups*/
DATA INPATBC20LD;
SET INPATBC;
PR1=TRIM(PR1); PR2=TRIM(PR2); PR3=TRIM(PR3); PR4=TRIM(PR4);
'PR5=TRIM(PR5); PR6=TRIM(PR6); PR7=TRIM(PR7);
PRB=TRIM(PRB);
PR9=TRIM(PR9); PR10=TRIM(PR10); PR11=TRIM(PR11);
PR12=TRIM(PR12);
PR13=TRIM(PR13); PR14=TRIM(PR14); PR15=TRIM(PR15);
ARRAY PRR {15} $ PR1-PR15;
MAST=O; LUMP=O;
DO 1=1 TO 15;
IF (PRR[I]='B541' OR PRR[I]='8542' OR PRR[I]='8543'
OR PRR[I]='8544' OR PRR[I]='8545' OR
PRR [I] = ' 8546' )
THEN MAST=l;
'8521') THEN LUMP=l;
IF (PRR [I]
END;
OUTPUT;
RUN;
DATA INPATBC20LD;
SET INPATBC20LD;
IF MAST=l AND LUMP=O THEN GROUP=l;
IF MAST=O AND LUMP=l THEN GROUP=2;
IF MAST=l AND LUMP=l THEN GROUP=3;
IF MAST=O AND LUMP=O THEN GROUP=O;
DXCLUSTER=CATX(' " OF DX1-DX15);
RUN;
DATA INPATBC2;
SET INPATBC20LD;
IF GROUP NOT IN ('0'
RUN;

'3');

From this code, 8333 cases of mastectomy and 892 cases of lumpectomy were obtained.
Some had missing values on some variables. It was decided to exclude cases with
missing age or race using the following code:

Code 7.2: Elimination of cases with missing age or race
DATA SURGERY;
SET INPATBC2;
IF RACE GE 3 THEN RACEGP=3; ELSE RACEGP=RACE;
IF AGE LT 40 THEN AGEGP=l;
ELSE IF 40 LT AGE LE 60 THEN AGEGP=2;
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ELSE AGEGP=3;
IF AGE NE . AND RACE NE .,

RUN;

With the use of this code, the size of the mastectomy group was reduced to 673 cases.
The sizes were very different and to address this issue, a random sample of the
mastectomy group of the size of the lumpectomy group was chosen. The code below
shows the process.
Code 7.3: Selection of a random sample from the mastectomy group with the size of the
lumpectomy group.
/*get the equal sizes*/
DATA LUMPECTOMY;
SET SURGERY;
IF GROUP=2;
RUN;

DATA MASTECTOMY;
SET SURGERY;
IF GROUP=l;
RUN;
PROC SURVEYSELECT DATA=MASTECTOMY N=673
METHOD=SRS SEED=1234 OUT=SAMPLEMAST;
RUN;
DATA ANALYSISDATA;
SET SAMPLEMAST LUMPECTOMY;
RUN;

The resulting set was used for analysis. It contained 673 cases of mastectomy and 673
cases oflumpectomy. Next, the variable preparation is discussed.
7.3.2. Outcome variables
The main outcome variables were in-hospital length of stay (LOS) at the time of the
procedure and hospital total charges (TOTCHG). In-hospital death (DIED) was also
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analyzed. All these variables are recorded in the data. LOS and TOTCHG are continuous
and DIED is categorical.
7.3.3. Input variables
Demographics: Demographics factored in the analysis were the patient's age, gender and
race which are present in the data.
Charlson index: the Charlson index is a measure of the burden of comorbidities [70].
Deyo's modification of the Charlson index for administrative data was used [71]. Deyo
developed an algorithm to compute the charlson index in data where diagnoses are
recorded with ICD-9-codes. Table 7.2 provides the translation of the charlson
comorbidity index components [70] into ICD-9-CM codes used by Deyo et al. [71]
Table 7.2: Translation of charlson comorbidity index component into ICD-9-CM codes
from Deyo' s paper [71]
Diagnostic category

ICD-9-CM codes

Assigned
weight

Myocardial infarction

410-410.9,412

1

Congestive heart failure

428-428.9

1

Peripheral vascular disease

430-438

1

Cerebrovascular disease

430-438

1

Dementia

290-290.9

1

Chronic pulmonary disease

490-496, 500-505, 506.4

1

Rheumatologic disease

710.0, 710.1, 710.4, 714.0-714.2,
714.81, 725

1

Peptic ulcer disease

531-534.9, 531.4-531.7, 532.4532.7,533.4-533.7,534.4-534.7

1
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Diagnostic category

ICD-9-CM codes

Assigned
weight

Mild liver disease

571.2,571.5,571.6,571.4-571.49

1

Diabetes

250-250.3, 250.7

1

Diabetes with chronic
complications

250.4-250.6

1

Hemiplegia or paraplegia

344.1,342-342.9

2

Renal disease

582-582.9, 583-583.9, 585, 586,
588-588.9

2

Any malignancy, including
leukemia and lymphoma

140-172.9,174-195.8,200-208.9

2

Moderate or severe liver disease

572.2-572.8, 456.0-456.21

3

Metastatic solid tumor

196-199.1

6

AIDS

042-044.9

6

The following code was used to compute the Charlson index using Deyo' s adaptation to
the ICD -9-CM code:
Code 7.4: Code to compute the Charlson index using Deyo's adaptation
DATA ANALYSISDATA;
LENGTH ICD9CODE $5.;
LENGTH INDEX 3;
IF N =1 THEN DO;
DECLARE HASH H(DATASET:"BEA.DEYO_CHARLSON_INDEX",
ORDERED: "NO") ;
H.DEFINEKEY ("ICD9CODE");
H.DEFINEDATA ("INDEX", "ICD9CODE");
H.DEFINEDONE();
CALL MISSING(ICD9CODE, INDEX);
END;

SET ANALYSISDATA;
ARRAY DXX {14} $ DX2-DX15;
CHARLSON=O;
DO I=l TO 14;
IF H.FIND(KEY: DXX[I])=O THEN CHARLSON=CHARLSON+INDEX;
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END;
OUTPUT;
RUN;

DATA ANALYSISDATA;
SET ANALYSISDATA;
ARRAY PRR {1S} $ PRI-PR15;
DO 1=1 TO 15;
IF PRR[I]='3848' THEN CHARLSON=CHARLSON+1;
END;
OUTPUT;
RUN;
DATA ANALYSISDATA;
SET ANALYSISDATA;
IF CHARLSON GE 3 THEN CHARLSONl=3; ELSE CHARLSONl=CHARLSON;
RUN;

7.4. Statistical methods
Categorical variables were tabulated using the frequencies and continuous variables were
visualized using kernel density estimation. Comparison of the two surgical procedures
with respect to in-hospital length of stay and hospital charges in the short term analysis
was studied with ANOVA models on log-transformed variables. These variables were
log-transformed to approach the normal distribution assumed by the ANOV A models.
The risk of in-hospital death was analyzed with univariate logistic regression. The SAS
codes used are presented below.
Code 7.5: Frequency
PROC FREQ DATA=ANALYSISDATA;
TABLES CHARLSONl*GROUP AGEGP*GROUP RACEGP*GROUP DIED*GROUP;
RUN;

Code 7.6: Kernel Density Estimation
/*overall distributions*/
ODS GRAPHICS ON;
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PRoe KDE DATA=ANALYSISDATA;

UNIVAR LOS/GRIDL=O GRIDU=20 OUT=ALLLOS;
UNIVAR TOTCHG/GRIDL=O GRIDU=100000 OUT=ALLTOTCHG;
RUN;

ODS GRAPHICS OFF;
/*distributions per group*/
PROe SORT DATA=ANALYSISDATA;

BY GROUP;
ODS GRAPHICS ON;
PROe KDE DATA=ANALYSISDATA;
UNIVAR LOS/GRIDL=O GRIDU=20 OUT=LOS;
UNIVAR TOTCHG/GRIDL=O GRIDU=100000 OUT=TOTCHG;
BY GROUP;
RUN;
ODS GRAPHICS OFF;

Code 7.7: ANOVA model
/*log transformation of the variables*/
DATA ANALYSISDATA;

SET ANALYSISDATA;
LOS1=LOG(LOS);
TOTCHG1=LOG(TOTCHG) ;
RUN;

/*ANOVA* /
PROe GLM DATA=ANALYSISDATA;

CLASS GROUP AGEGP RACEGP;
MODEL LOS1=GROUP AGEGP RACEGP CHARLSON1;
MEANS GROUP;
CONTRAST 'GP2 vs. GP1' GROUP 1 -1 0;
CONTRAST 'GP3 vs. GP1' GROUP 1 0 -1;
CONTRAST 'GP3 vs. GP2' GROUP 0 1 -1;
RUN;
PRoe GLM DATA=ANALYSISDATA;

CLASS GROUP AGEGP RACEGP;
MODEL TOTCHG1=GROUP AGEGP RACEGP CHARLSON1;
MEANS GROUP;
CONTRAST 'GP2 VS. GP1' GROUP 1 -1 0;
CONTRAST 'GP3 VS. GP1' GROUP 1 0 -1;
CONTRAST 'GP3 VS. GP2' GROUP 0 1 -1;
RUN;

Code 7.8: Logistic Regression
PRoe LOGISTIC DATA=ANALYSISDATA DESCENDING;

CLASS GROUP /REF=FIRST;
MODEL DIED=GROUP
ODDSRATIO GROUP;
RUN;
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7.5. Results
7.5.1. Data description

NIS 2005 contains discharge information on 7,968,569 patients among whom 4,692,644
(58.89%) are women. Of these women, 15,437 were diagnosed with breast cancer, and
9403 (60.91 %) among the breast cancer discharges were associated with a surgical
procedure for breast cancer treatment. From this group, 178 observations were associated
with procedures that involved both mastectomy and lumpectomy; they were excluded
from the analysis, yielding an analysis set of 9225 hospital discharges. Only 11 (0.12%)
deaths were recorded from all of these procedures.
After elimination of cases with missing age and race, there were 673 observations with
lumpectomy and 6327 with mastectomy. To overcome potential problems that may result
from the differences in sample sizes, a random sample of 673 discharges with
mastectomy was selected to use in the comparison.
The average age was 63 (see Table 7.3) and all the records were of patients 40 years and
older. The white population made up 77.19% and the black population represented
11.00% of all the records. More discharges were of patients with a Charlson index of 0
(42.35%); however, a considerable proportion had a Charlson index of3 or more
(41.31 %).
Table 7.3: NIS 2005 Data description for the short term analysis
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Variable
Age [mean(std)]
Age [n (%)]
<40
40-60
>60
Race [n (%)]
White
Black
Other
Charlson [n(%)]
0
1
2
~3

Died

all sample (n=1346)
63 (14)

Mastectomy (n=673)
62 (14)

Lumpectomy (n=673)
64 (14)

0(0.00)
518 (38.48)
828 (61.52)

0(0.00)
269 (39.97)
404 (60.03)

0(0.00)
249 (37.00)
424 (63.00)

1039 (77 .19)
148 (11.00)
159 (11.81)

522 (77.56)
68 (10.10)
83 (12.33)

517 (76.82)
80 (11.89)
76 (11.29)

570 (42.35)
124 (9.21)
96 (41.31)
556 (41.31)
6 (0.45)

312 (46.36)
63 (9.36)
28 (4.16)
270 (40.12)
2 (0.30)

258 (38.34)
61 (9.06)
68 (10.10)
286 (42.50)
4 (0.59)

7.5.2. Outcomes variable description
The main outcome variables for the short-term analysis were in-hospital death, length of
stay and total charges.
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Figure 7.1: In-hospital death distribution
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The in-hospital death following a surgical procedure for breast cancer treatment was in
general very low. Percentages were higher in the lumpectomy group.
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Figure 7.2: Kernel density estimation for the in-hospital length of stay for all observations
The average length of stay during hospitalization was less than 5 days for most of the
observations.
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Figure 7.3: Kernel density estimation for the hospital total charges for all the observations
Most of the discharges were associated with hospital charges that are less than $20,000.
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Figure 7.4: Comparative in-hospital length of stay distributions in the two groups
More discharges in the mastectomy group were associated with a shorter length of stay in
comparison to the lumpectomy group. A high probability of a longer stay was observed
in the lumpectomy group.
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Figure 7.5: Comparative hospital total charges distributions in the two groups
The total charges were found to be comparable in the two groups. However, lumpectomy
had a slightly higher probability of lower charge.

7.5.3. Inferential statistics: Group effect comparisons
In this part ofthe study, differences observed in the descriptive statistics above, were
tested for their statistical significance using ANOVA models and Chi-square tests. Tests
were performed at a 0.05 significance level. The Table 7.4 below contains a summary of
the statistical results.
Table 7.4: Short-term two group comparison

Outcome variable

Mastectomy (n=673)
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p-value

Outcome variable

Mastectomy (0=673)

Length of stay [mean (std)]
2.42 (3.28)
Total charges [mean (std)]
20796 (16950)
In-hospital death [OR (95% CI)]
Ref
OR: odds ratio, CI: confidence mterval

Lumpectomy
(0=6731
2.74 (5.87)
21159 (33364)
0.5 (0.09,2.73)

p-value
<0.0001
0.02
0.42

Comparison of the in-hospital length ofstay: patients who had a lumpectomy had a
longer stay in comparison to those who had a mastectomy. This difference was found to
be statistically significant with a p-value less than 0.0001 (see Table 7.4). Comparison of
the hospital total charges: the average total charges were above $20,000 in both groups.
The lowest charges were observed in the mastectomy group. It was found that the type of
procedure had a significant effect on the hospital charges (see Table 7.4); lumpectomy
and mastectomy had significantly different total hospital charges (p-value=0.02).
Comparison of the in-hospital death proportions: The probability of in-hospital death
was very low in all three groups. The risk of in-hospital death was about 50% lower in
the lumpectomy group than in the mastectomy group, but this reduced risk was not
statistically significant (OR = 0.5, CI: 0.09 to 2.73, p-value: 0.42, see Table 7.4).

7.6. Summary
In this chapter, statistical methods were used to analyze both health and clinical outcomes
after surgery. Two procedure groups were compared: lumpectomy and mastectomy. In
terms of outcomes it was found that patients in the lumpectomy group had a significantly
longer stay and more hospital charges.
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CHAPTER 8
USE OF DATA MINING, STATISTICAL METHODS AND COST
EFFECTIVENESS TECHNIQUES TO COMPARE SHORT TERM POSTOPERATIVE FOLLOW-UP OUTCOMES FOR LUMPECTOMY AND
MASTECTOMY
8.1. Objective
In this chapter, classical statistical models are used to compare lumpectomy to
mastectomy in terms of clinical outcomes (healthcare resources use and cost). In addition,
data mining methods were used to enhance statistical methods in the analysis of the
longitudinal data. First, clusters of diagnoses are used as a factor in statistical comparison
models. Then, data mining predictive models are contrasted to find and build a simple 90day post-operative hospital re-admission. Finally cost effectiveness techniques are used
to evaluate the short-term costs.

8.2. Data -MarketScan Database [13]
Additional data used are from the Reuter's MarketScan database records of 2000 and
2001. The MarketScan data was described in section 1.3.4.
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8.3. Data pre-processing
8.3.1. Patient selection
First, cases of breast cancer were extracted from the MarketScan records of2000 using
ICD-9-CM diagnosis codes described in Table 7.1. Next, observations with a procedure
code of mastectomy or lumpectomy were retained. Procedures were queried using ICD-9CM procedure codes (see table 7.1) as well as the Current Procedural Terminology, 4th
edition (CPT -4) codes [72] (Table 8.1).
Table 8.1: CPT -4 codes for mastectomy and lumpectomy

Procedure
Mastectomy

CPT-4 codes
19303
19304
19305
19307

Description
Simple, complete mastectomy
Subcutaneous mastectomy
Radical mastectomy
Modified radical mastectomy

Lumpectomy

19301

Partial mastectomy
(lumpectomy)

For this purpose of patient selection, the following SAS codes were used.
Code 8.1: Selection of cases of breast cancer and of mastectomy and lumpectomy
/*isolate breast cancer cases*/
DATA DATA;
SET BEA.CCAEI001 BEA.CCAEI012;
DX1=TRIM(DX1); DX2=TRIM(DX2); DX3=TRIM(DX3); DX4=TRIM(DX4);
DX5=TRIM(DX5); DX6=TRIM(DX6); DX7=TRIM(DX7); DX8=TRIM(DX8);
DX9=TRIM(DX9); DX10=TRIM(DX10); DX11=TRIM(DX11);
DX12=TRIM (DX12); DX13=TRIM.( OX 13 ); DX14=TRIM (DX14) ;
DX15=TRIM(DX15);
ARRAY DXX {15} $ DX1-DX15;
BC=O;
DO 1=1 TO 15;
IF DXX[I] IN ('1740' '1741' '1742' '1743' '1744'
'1745'
, 1746 ' '1 7 4 8' '1 7 4 9 ') THEN BC=l;
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END;
IF DSTATUS IN ('20' '21' '22' '23'
'29') THEN DIED=l; ELSE DIED=O;

'24'

'25'

'26'

'27'

'28'

RUN;
DATA BREASTCANCER;
SET DATA;
IF BC=l;
RUN;

/*procedure groups*/
DATA BREASTCANCER;
SET BREASTCANCER;
PROC1=TRIM(PROC1); PROC2=TRIM(PROC2); PROC3=TRIM(PROC3);
PROC4=TRIM(PROC4); PROC5=TRIM(PROC5); PROC6=TRIM(PROC6);
PROC7=TRIM(PROC7); PROC8=TRIM(PROC8); PROC9=TRIM(PROC9);
PROC10=TRIM(PROC10); PROC11=TRIM(PROC11);
PROC12=TRIM(PROC12); PROC13=TRIM(PROC13);
PROC14=TRIM(PROC14); PROC15=TRIM(PROC15);
ARRAY PR {15} $ PROC1-PROC15;
MAST=O;
LUMP=O;
DO 1=1 TO 15;
IF PR[I] IN ('8541' '8542' '8543' '8544' '8544' '8546'
'8547' '8548' '19303' '19304' '19305' '19307') THEN MAST=l;
IF PR[I] IN ('8521' '19301') THEN LUMP=l;
END;
IF
IF
IF
IF

MAST=l
MAST=O
MAST=l
MAST=O

AND
AND
AND
AND

LUMP=O
LUMP=l
LUMP=l
LUMP=O

THEN
THEN
THEN
THEN

GROUP=l;
GROUP=2;
GROUP=3;
GROUP=O;

RUN;
DATA BCSURGERY;
SET BREASTCANCER;
IF GROUP NE 0;
RUN;

8.3.2. Selection of post-operative data

The selection algorithm described in the section above queried all the hospitalizations in
which a lumpectomy or a mastectomy was performed. For each patient retained, the first
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occurrence was considered the initial procedure hospitalization and the first observation
of the follow up.
Using the ENROLID, all records of2000 and 2001 were then extracted from the inpatient
admission, inpatient service, outpatient service, outpatient pharmaceutical claims and
enrollment tables. Below, the codes used for extraction are presented.
Code 8.2: Separation of pre- from-post-operative inpatient records
DATA INPATIENT;
SET INPATIENT;
BY ENROLID;
RETAIN SURGERY;
IF FIRST.ENROLID THEN SURGERY=O;
IF MAST=l OR LUMP=l THEN SURGERY+l;
RUN;

/*post-surgery data*/
DATA POSTOP;
SET INPATIENT;
IF SURGERY NE 0;
RUN;
/*surgery hospitalization*/
DATA OPDAY;
SET POSTOP;
BY ENROLID;
IF FIRST.ENROLID AND GROUP=O THEN DELETE;
IF FIRST.ENROLID;
RUN;

Code 8.3: Outpatient and medication sets
/*inpatient data*/
DATA OUTPATIENT;
SET CCAEOOOA CCAEOOOB CCAEOOOC CCAEOOOD CCAEOOOE CCAEOOOF
CCAEOOIA CCAEOOIB CCAEOOIC CCAEOOID CCAEOOID CCAEOOIF
CCAEOOIG CCAEOOIH;
FORMAT DATE MMDDYYIO.;
DATE=SVCDATE;
RUN;
/*medication data*/
DATA MEDICATION;
SET CCAEDOOA CCAEDOOB CCAEDOOC CCAEDOOD
CCAEDOIA CCAEDOIB CCAEDOIC CCAEDOID CCAEDOIE CCAEDOIF;
FORMAT DATE Iv:IMDDYYIO.;
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DATE=SVCDATE;

RUN;

Code 8.4: Post-surgery outpatient records
/*data with date of operation date*/
DATA OPDATE;
SET OPDAY (KEEP=ENROLID GROUP ADMDATE);
FORMAT DATE MMDDYYIO.;
DATE=ADMDATE;
RUN;
/*outpatient data*/
PROC SORT DATA=OPDAY;
BY ENROLID;
PROC SORT DATA=BEA.OUTPATIENT;
BY ENROLID;
DATA OUTPATBCSURGERY;
MERGE OPDATE (IN=INA) OUTPATIENT (KEEP=ENROLID DATE SVCDATE
PAY) ;
BY ENROLID;
IF INA;
DIFF = DATDIF (ADMDATE,DATE, 'ACT/ACT');
RUN;

PROC SORT DATA=OUTPATBCSURGERY;
BY ENROLID DATE;
RUN;
DATA OUTPATBCSURGERY;
SET OUTPATBCSURGERY;
BY ENROLID;
RETAIN OP;
IF FIRST.ENROLID THEN DO;
OP=O;
END;
IF DIFF GE 0 THEN OP=l;
RUN;
DATA OUTPATPOSTOP;
SET OUTPATBCSURGERY;
IF OP NE 0;
RUN;
DATA OUTPATPOSTOP;
SET OUTPATBCSURGERY;
BY ENROLID;
IF FIRST.ENROLID THEN NVIS=O;
NVIS+l;
RUN;
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Code 8.5: Post-surgery medication records
/*medication data*/
PROC SORT DATA=OPDAY;
BY ENROLID;
PROC SORT DATA=MEDICATION;
BY ENROLID;
DATA MEDBCSURGERY;
MERGE OPDATE (IN=INA) MEDICATION (KEEP=ENROLID DATE SVCDATE
PAY) ;
BY ENROLID;
IF INA;
DIFF = DATDIF(ADMDATE,DATE, 'ACT/ACT');
RUN;

PROC SORT DATA=MEDBCSURGERY;
BY ENROLID DATE;
RUN;
DATA MEDBCSURGERY;
SET MEDBCSURGERY;
BY ENROLID;
RETAIN OP;
IF FIRST.ENROLID THEN DO;
OP=O;
END;
IF DIFF GE 0 THEN OP=l;
RUN;
DATA MEDPOSTOP;
SET MEDBCSURGERY;
IF OP NE 0;
RUN;
DATA MEDPOSTOP;
SET MEDPOSTOP;
BY ENROLID;
IF FIRST.ENROLID THEN NMED=O;
NMED+l;
RUN;

Code 8.5: Computation of post-operative follow-up time
/*with 2000 enrollment records*/
DATA ENROLOO;
SET CCAETOOA(KEEP=ENROLID DTEND) CCAETOOB (KEEP=ENROLID
DTEND) ;
BY ENROLID;
IF LAST.ENROLID;
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RUN;
DATA FOO;

MERGE OPDAY ENROLOO;
BY ENROLID;
FYOO=YRDIF(ADMDATE,DTEND, 'ACT/ACT');
FDOO=DATDIF(ADMDATE,DTEND, 'ACT/ACT');
RUN;

/*with 2006 enrollment records*/
DATA ENROL01;

SET CCAETOIA (KEEP=ENROLID DTEND) CCAETOIB(KEEP=ENROLID
DTEND) BEA.CCAETOIC(KEEP=ENROLID DTEND);
BY ENROLID;
IF LAST.ENROLID;
RUN;
DATA F01;

MERGE OPDAY ENROL01;
BY ENROLID;
FYOl
YRDIF (ADMDATE,DTEND, 'ACT/ACT');
FDOl = DATDIF (ADMDATE,DTEND, 'ACT/ACT');
FORMAT ENDDATE MMDDYYIO.;
ENDDATE
'31DEC2001'D;
FYOIEND
FDOIEND

YRDIF(ADMDATE,ENDDATE, 'ACT/ACT');
DATDIF(ADMDATE,ENDDATE, 'ACT/ACT');

RUN;

/*post-surgery enrollment time*/
DATA POSTOPFTIME;

MERGE OPDAY(KEEP=ENROLID IN=INA) FOO(DROP=DTEND)
F01(DROP=DTEND) ;
BY ENROLID;
IF INA;
FYTIME=MAX(FYOO,FY01);
FDTIME=MAX(FDOO,FD01);
IF FYTIME LT 0 THEN FYTIME=FYOIEND;
IF FDTIME LT 0 THEN FDTIME=FDOIEND;
RUN;

8.3.3. Outcome variables
Healthcare resources use: The healthcare resources considered were the post-operative

length of stay, hospital re-admissions, outpatient services and prescribed medications
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(new and refills). These clinical outcomes were compared between patients who
underwent the lumpectomy and those who underwent the mastectomy initially.
Healthcare resource cost: The costs per encounter for all healthcare resource use were

compared.
Post-operative hospital re-admission: the proportions of patient re-admitted at least once

were compared in both surgical groups.
Re-operation: Re-operation rates were evaluated for patients in both groups of the breast

cancer surgical treatment.
8.3.4. Input variables
Age: the age at time of initial surgical procedure
Charlson index: the Charlson index of the patient at time of the initial procedure. Here

also, Deyo's adaptation of the Charlson index to ICD-9-CM codes was used (refer to
Table 7.2 and Code 7.4).
Disease cluster: the diagnoses of the initial surgery for all the patients were grouped into

clusters. Each patient was assigned to a disease cluster that symbolized the medical
condition burden. Disease clusters were obtained using SAS Enterprise Miner 6.2. Text
Mining and Cluster analysis were performed in the data mining interface of SAS, SAS
Enterprise Miner (EM) 6.2 on the diagnoses. First, all the diagnoses for each patient were
concatenated in one variable and transformed into a string (Code 8.6). Then, this string of
diagnoses was set to be considered as a text document in EM. The Text Miner node in
EM (Figure 8.1) was used to discover number patterns and cluster them using the
137

Expectation Maximization cluster algorithm. The maximum number of cluster to be
formed was set to five.
Code 8.6: Use of the catx function in SAS to concatenate all the diagnoses into one string
DATA SASUSER. CLUSTERS ;
SET OPDAY;
DX=CATX(' I , OF DX1 -DX 1 5) ;
KEEP ENROLID DX;
RUN;

Figure 8.1: Diagram flow of the Text Miner node in SAS Enterprise Miner

Region: the region in which the initial procedure took place was considered as an input
for analysis. In the MarketScan data, five categories are given to the region variable: (1)
Northeast, (2) North Central, (3) South, (4) West and (5) Unknown.

8.4. Use of statistical methods and cluster analysis to analyze clinical outcomes
8.4.1. Summary of statistical methods
Descriptive statistics and data visualization were performed using codes similar to Codes
7.5 and 7.6. Comparison of the two surgical procedures with respect to in-hospital length
of stay and hospital charges for the initial procedure was studied with ANOV A models
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on log-transformed variables. Longitudinal data (post-operative length of stay and
hospital charges per hospitalization) were compared with Repeated measure ANOV A on
log-transformed variables. The risk of re-operation and hospital re-admissions was
analyzed with univariate logistic regression. The time to re-operation and time to rehospitalization were compared using the log-rank test. The number of re-operation and
the number ofre-hospitalizations were compared using the Kruskal-Wallis test. All the
statistical analyses were performed in SAS [72] using SAS codes [73] in the interface
SAS Enterprise Guide (EG) 4.3. To perform ANOVA and univariate logistic regression,
codes similar to Codes 7.7 and 7.8 were used. Below, SAS codes for the Kruskal-Wallis
test and the Repeated Measure ANOVA codes are presented.
Code 8.7: the Kruskal-Wallis Test
PROC NPAR1WAY WILCOXON DATA=ANALYSISDATA1;
CLASS GROUP;
VAR NVIS;
RUN;

Code 8.8: Repeated Measure ANOV A
DATA OUTPATPOSTOP1;
MERGE ANALYSISDATA1(KEEP=ENROLID GROUP IN=INA)
OUTPATPOSTOP;
BY ENROLID;
RUN;
/*log-transformation of the variables*/
DATA OUTPATPOSTOP1;
SET OUTPATPOSTOP1;
PAY1=LOG (PAY) ;
RUN;
/*ANOVA* /
PROC GLM DATA=OUTPATPOSTOP1;
CLASS GROUP ENROLID NVIS;
MODEL PAY1=GROUP ENROLID(GROUP) NVIS GROUP*NVIS/SS3;
RANDOM ENROLID(GROUP);
TEST H=GROUP E=ENROLID(GROUP);
MEANS GROUP;
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RUN;
/*medication charges*/
DATA MEDPOSTOP1;
MERGE ANALYSISDATA1(KEEP=ENROLID GROUP) MEDPOSTOP;
BY ENROLID;
RUN;
/*log-transformation of the variables*/
DATA MEDPOSTOP1;
SET MEDPOSTOP1;
PAY1=LOG (PAY) ;
RUN;
/*ANOVA* /
PROC GLM DATA=MEDPOSTOP1;
CLASS GROUP ENROLID NMED;
MODEL PAY1=GROUP ENROLID(GROUP) NMED GROUP*NMED/SS3;
RANDOM ENROLID(GROUP);
TEST H=GROUP E=ENROLID(GROUP);
MEANS GROUP;
RUN;

8.4.2. Results
8.4.2.1. Data description
The inpatient data sets of the years 2000 and 2001 contained 494,106 records for a total
of 137,890 patients. The females in this dataset were 236,001 (63.12%) of all patients
among which 3919 (1.66% of all females) were diagnosed with breast cancer. Among
these women with breast cancer, 1284 (89.29%) were treated with mastectomy, 154
(10.70%) were treated by lumpectomy. The rest of the patients, 2481 (63.31 %) did not
receive either a mastectomy or a lumpectomy and they were dropped from the analysis.
Thus, the surgery set contained 1438 patients among which the majority of 89.29%
underwent a mastectomy and 10.70% underwent a lumpectomy (see Table 8.2).
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Table 8.2: Summary of the database of analysis

Database size
Females in the database
Females with breast cancer
Breast cancer patients treated by
surgery
Mastectomy alone
Lumpectomy alone

Size and percentage
137,890
236,001 (63.12% of the total sample)
3919 (1.66% of all females)
1438(36.69% of all patients with breast cancer)
1284 (89.29% of the breast cancer surgery sample)
154 (10.70% of the breast cancer surgery sample)

In order to have comparable group sample sizes, a random sample of size 154 was
selected from the mastectomy group and used in the study. Thus, the study set had a total
of 308 patients. After extracting all the records of 2000 and 2001 for the 308 patients in
the analysis, the total number of inpatient records after the initial procedure was 4090.
The post-operative outpatient services were 782,259 all together and the post-operative
medication claims were a total of 95, 181.
8.4.2.2. Cluster analysis
Cluster analysis was performed to obtain a grouping for the diagnosis at the time of the
initial procedure. Patients presented many different conditions and in the database, up to
15 diagnoses are recorded per visit. Clustering the diagnoses provided a way to define
them in a small number of groups. Four diagnosis clusters were obtained. Cluster 1
contained diagnoses related to breast cancer with metastasis in other sites, cluster 2
grouped patients with breast cancer with affected lymph nodes, cluster 3 contained
patients who had breast cancer localized only in the breast and cluster 4 contained
patients who were diagnosed with breast cancer and had a personal history of breast
cancer (see Table 8.3). The clustering process elaborated in section 8.3.4 was used.
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Table 8.3: Description of the diagnosis clusters
Diagnosis
cluster
ICD 9 codes and description
174.8: breast cancer in the outer specified sites
611.9: unspecified breast disorder
1
198.89: secondary malignant in other sites
233.0: breast carcinoma in-situ
174.6: breast cancer in Axillary tail
174.4: breast cancer in the upper-outer quandrant
196.3: secondary and unspecified malignant
neoplasm of lumph nodes of axilla and upper limp
2
198.89: secondary malignant in other sites
174.9: breast cancer, unspecified breast site
174.8: breast cancer in the outer specified sites
174.2: breast cancer in the upper-inner quadrant
239.3: neoplasm of unspecified nature in the breast
3
174.1: breast cancer in central portion
229.0: benign neoplasm ofthe lymph nodes
611.72: lump or mass in breast
4
611.8: other specified disorders of breast
174.0: breast cancer in the nipple and areola
401.9: unspecified Essential hypertension
174.3: malignant neoplasm of female breast in the
lower inner quadrant
VlO.3: personal history of breast cancer

Cluster name
Breast cancer with
metastasis in the other
sites

Breast cancer with
affected lymph nodes

Breast cancer in the
breast only

Breast cancer with a
personal history of
breast cancer

8.4.2.3. Descriptive statistics: distribution of the input variables
The sample data comprised a cohort of 308 between the ages of 27 to 67 years old with
an average value of 52 (standard deviation 8, see Table 8.4). More than half ofthe
patients had a Charlson index of 2 (40.26%) and less than 1% had a Charlson index of 1.
Many patients were in diagnosis cluster 3 (36.21 %) and among the rest, the majority were
in diagnosis cluster 4 (27.59%). Most operations took place in the north central (39.94%)
and the area with the least number of initial breast cancer surgical operations was the
northeast with 13.64%. The post-operative continuous enrollment follow-up time was on
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average 249 days (standard deviation 178) varying from 0 to 728 with a median of218
(interquartile range 116 - 337).
Table 8.4: Description of the analysis data

Variable

Age [mean (standard deviation)]
Age n (%)
<40
40-60
>60
Charlson index n (%)
0
1
2
>=3
Post-operative follow-up days [mean (standard
deviation)]
Disease cluster n (%)
Breast cancer with metastasis
Breast cancer with affect lymph nodes
Breast cancer in the breast only
Breast cancer with personal history of breast cancer
Region of initial procedure n (%)
Northeast
North central
South
West

All
patients
(n=308)
52 (8)

Mastectom
y (n=154)

Lumpectom
y (n=154)

53 (8)

52 (8)

22 (7.14)
228 (74.03)
58 (18.83)

11 (7.14)
109 (70.78)
34 (22.08)

11 (7.14)
119 (77.27)
24 (15.58)

71 (23.05)
3 (0.97)
124 (40.26)
110 (35.71)
249 (178)

32 (20.78)
1 (0.65)
65 (42.21)
56 (36.36)
253 (173)

39 (25.32)
42 (1.30)
59 (38.31)
54 (35.06)
245 (183)

12 (20.69)
9 (15.52)
21 (36.21)
16 (27.59)

5 (16.67)
4 (13.33)
8 (26.67)
13 (43.33)

7 (25.00)
5 (17.86)
13 (46.43)
3 (10.71)

42 (13.64)
123 (39.94)
78 (25.32)
64 (20.78)

21 (13.64)
60 (38.96)
53 (34.42)
20 (12.99)

21 (13.64)
63 (40.91)
25 (16.23)
44 (28.57)

8.4.2.4. Descriptive statistics: distribution of the outcome variable of interest
Breast cancer treatments, especially surgery, trigger hospitalizations and frequent
outpatient services. Even though each treatment sequence has its own characteristics and
each patient has a different and specific reaction, similar treatments will have similar
patterns in terms of healthcare resource usage. In the current study, statistical analysis
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tests and models were used to compare lumpectomy to mastectomy in length of stay per
post-operative hospitalization, charges per post-operative hospitalization, charges per
post-operative outpatient service and charges per post-operative medication. The analysis
was performed on a longitudinal data set where each patient could have more than one
record. During this period of post-operative follow-up time, only 12 individuals were reoperated, four in the mastectomy group and eight in the lumpectomy group.
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Figure 8.2: Number of post-operative hospital admissions
Throughout the two years 2000 and 2001 , a majority of the patients (84.09%) were not
re-hospitalized. About 12.34% were re-hospitalized only once; among the rest who were
re-hospitalized, only six patients had more than three hospital-stays (see Figure 8.2). A
higher percentage in the lumpectomy group was re-hospitalized at least once in
comparison to the mastectomy group.
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Figure 8.3: Number of post-operative outpatient services
During the 249 mean follow-up days (standard deviation 178, Table 8.4), most of the
patients in the data analysis had over 60 outpatient services. In this category, the
percentages were higher in the mastectomy group.
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Figure 8.4: Number of post-operative prescribed medications
In the follow-up time (249 days on average), more patients had over 20 prescribed
medications. The percentages were higher in the mastectomy group.
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Figure 8.5: Length of stay per post-operative hospitalization
This graph shows that the probability of a shorter hospital stay was higher in the
mastectomy group while the probability of longer stay was higher in the mastectomy
group. The distributions cross around three days.
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Figure 8.6: Charges per post-operative hospital stay
The distributions of the total hospital charges for each post-operative hospital admission
were skewed to the right for both procedures. The probability of lower charges was
higher for the lumpectomy group and the probability of higher charges was higher for the
mastectomy group.
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Figure 8.7: Charges per post-operative outpatient service
The distributions of outpatient services crossed around $200 for mastectomy and
lumpectomy. Lumpectomy had a lower probability of charges under $200 and a higher
probability of charges over $200.
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Figure 8.8: Charges per post-operative prescribed medication
The group of patients who underwent mastectomy had higher probability for higher
medication costs over $100. The probability of costs below $100 was higher in the
lumpectomy group.

8.4.2.5. Inferential statistics results: Comparison of the effect of the surgical
procedure groups
The hypothesis was that in terms of clinical resource usage, lumpectomy will be
comparable to mastectomy and in terms of clinical charges; mastectomy would have the
least charges. In terms of risk of re-hospitalization, it was expected that patients who had
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mastectomy will have a higher risk of post-operative hospital admission. The descriptive
statistics above suggested differences in outcome variables of interest; however, it was
necessary to test these differences for statistical significance.
To compare the in-hospital stay and charges per post-operative hospitalization, the
charges per post-operative outpatient service, the cost per post-operative prescribed
medication, the Repeated Measure ANOVA models discussed in section 8.4 were used.
To evaluate the significance ofthe difference between the number of hospitalizations, the
number of outpatient services and the number of prescribed medications, Mann Whitney
tests (Wilcoxon Rank-Sum tests) were used, and to compare the difference of the rates of

re-hospitalization, Logistic Regression models were used. All of the statistical tests were
two-sided and the significance level was set to 0.05. For continuous variables, means and
standard deviations were calculated to describe the central tendency. For categorical
variables, counts and percentages were presented. Since the continuous variables were
highly skewed to the right, logarithmic transformations were performed and the
transformed variables in the form of new-variable = log (old-variable) were used for
analysis. The transformation was used in an attempt to normalize these variables and
comply to the assumption of the ANOVA models.
8.4.2.5.1. Comparison oflumpectomy and mastectomy with respect to healthcare
resources use
Clinical resource use was considered to be the hospital resource utilization, the outpatient
service utilization and the prescribed drug use. The analysis used the log-transformed
variables.
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Comparison of in-hospital stay during the index hospitalization (Fable 8.5): During the
initial procedure hospitalization, patients who underwent the mastectomy stayed an
average two days (standard deviation two days) while patients in the lumpectomy group
stay an average one day (standard deviation one day). This difference of about one day
was found to be statistically significant (p-value < 0.0001).
Comparison of in-hospital stay per post-operative admission (Fable 8.5): The average
length of stay per all-type hospitalization was found to be three days (standard deviation:
three days) for a patient in the mastectomy group and two days (standard deviation: two
days) for a patient in the lumpectomy group. For breast cancer related hospitalizations,
the length of stay was on average about two days for both groups (standard deviation:
three days for mastectomy and two days for lumpectomy. The comparison ofthe two
groups showed that the group did not have a significant effect on the length stay for alltype post-operative hospitalization (p-value: 0.33) and for post-operative breast cancer
related hospitalization (p-value: 0.57).
Comparison of the number ofpost-operative hospitalizations (Fable 8.5): Patients in both
procedure groups had on average less than one post-operative hospitalization (all-type as
well as breast cancer related). Statistical analysis of the effect of procedure type on postoperative hospitalizations resulted in non-significant results (p-value: 0.09 for all type
admissions and 0.23 for breast cancer related admissions).
Comparison o/the number ofpost-operative outpatient services (Fable 8.5): The
mastectomy group came out with the highest number of all-type outpatient services with
an average of 166 services per patient (standard deviation: 132) in comparison to 140
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services per patient (standard deviation: 141) in the lumpectomy group. The number of
breast cancer related outpatient services was also larger for the mastectomy group
(average: 92, standard deviation: 109 versus average: 78, standard deviation 103).
However, these differences were not statistically significant (p-value: 0.05 for all-type
and 0.15 for breast cancer related).
Comparison o/the number o/post-operative prescribed medications (Fable 8.5): Patients

in the mastectomy group had more prescribed medications than in the lumpectomy group
(25, standard deviation 28 versus 23, standard deviation 25), but this difference was not
statistically significant (p-value: 0.43).
8.4.2.5.2. Comparison lumpectomy and mastectomy with respect to healthcare
resources use charges
Comparison o/the hospital charges/or the initial procedure hospitalization (Fable 8.5):

On average, the hospitalization of the initial procedure cost $9191 (standard deviation
$5410) for a mastectomy and $6911 (standard deviation $3856) for a lumpectomy.
Statistical analyses revealed that the type of procedure had an effect on the hospital
charge for the index hospitalization (p-value <0.0001).
Comparison o/the hospital charges per post-operative admission (Fable 8.5): The

average hospital charges per all-type hospitalization per patient were highest in the
Mastectomy group ($9187, standard deviation $5872 in comparison to $7404, standard
deviation $5765). For breast cancer related post-operative hospitalization, this difference
was also observed. For the Mastectomy group, the average was $9481 (standard deviation
$7044) and for Lumpectomy $7194 (standard deviation: $5553). The effect of the
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surgical procedure group on the hospitalization charges was found to be not significant
(p-value: 0.06 for all-type re-admissions and 0;67 for breast cancer related readmissions ).
Comparison o/the outpatient charges per post-operative service (Table 8.5): Patients in

the lumpectomy group had the highest charges per all-type post-operative outpatient
service with an average of$196 (standard deviation $914) as opposed to $89 (standard
deviation $458). However, this difference was not statistically significant (p-value: 0.19).
For breast-cancer related post-operative outpatient services, patients in the lumpectomy
group still had the highest charges with an average of$230 (standard deviation: 974) as
opposed to $170 (standard deviation: 589). This difference was found to be statistically
significant (p-value: 0.0006).
Comparison o/the medication charges per post-operative prescription (Table 8.5): The

effect of the surgery group on the average medication charges was not significant (pvalue: 0.14) even though the charges were on average higher in the lumpectomy group
($94, standard deviation $259 versus $62, standard deviation $183).
8.4.2.5.3. Comparison lumpectomy and mastectomy with respect to hospital readmission

During the follow-up time, 19 patients (12.34%) who had Mastectomy and 30 patients
who had Lumpectomy (19.48%) were re-hospitalized at least once for any reason. This
re-hospitalization rate difference of about 7% was not statistically significant (p-value:
0.09, Table 8.5). In general, patients who had the mastectomy were re-hospitalized much
sooner (208 days, standard error 6 days) than those who underwent the lumpectomy (282
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days, standard error 7 days) but this time difference of more than 80 days was not
statistically significant (p-value: 0.07, Table 8.5).
During this post-operative follow-up time, four patients (2.60%) in the Mastectomy
group and eight patients (5.19%) in the Lumpectomy group were re-hospitalized with
breast cancer as the primary cause (diagnosis). This difference was not statistically
significant (p-value: 0.24, Table 8.5).

8.4.2.5.4. Comparison lumpectomy and mastectomy with respect to re-operation
In the study data, four patients from the Mastectomy group (2.60%) and eight patients
from the Lumpectomy group (5.19) were re-operated. The difference in re-operation rate
was found to be not significant (p-value: 0.24, Table 8.5). In general, patients in the
mastectomy group were re-operated non-significantly sooner than patients in the
lumpectomy group (60 days versus 240 days on average, p-value: 0.12).
Table 8.5: Comparison of healthcare resources use and charges
Outcome variable
Healthcare resources use [mean (SD)]
All-type
Initial procedure length of stay
Length of stay per post-operative stay
(days)
Number of hospitalizations
Number of outpatient.services
Number of prescribed medications
Breast cancer related
Length of stay per post-operative stay
(days)
Number of hospitalizations
Number of outpatient services
Healthcare resources charges ($)[ mean
(SD)]

Mastectomy
(n=154)

Lumpectomy
(n=154)

p-value

2 (2)
3 (3)

1 (1)
2 (2)

<0.0001
0.33

0.19 (0.62)
166 (132)
25 (28)

0.26 (0.62)
140 (141)
23 (25)

0.09
0.05
0.43

2 (3)

2 (2)

0.57

0.02 (0.16)
92 (109)

0.07 (0.34)
78 (103)

0.23
0.15
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Outcome variable

Mastectomy
(n=154)

Lumpectomy
(n=154)

p-value

All-type
Initial procedure charges
9191 (5410)
6911 (3856)
<0.0001
Hospital charges per post-operative stay
9187 (5872)
7404 (5765)
0.06
Outpatient charges
89 (458)
196 (914)
0.19
Medication charges
62 (183)
94 (259)
0.14
Breast cancer related
Hospital charges per post-operative stay
9481 (7044)
7194 (5553)
0.67
170 (589)
Outpatient charges
230 (974)
0.0006
Re-hospitalization
N(%)
19 (12.34)
30 (19.48)
0.09
OR (95% CI)
REF
1.72(0.92,3.21) 0.09
Days to re-admission [mean (SE)]
208 (6)
282 (7)
0.07
Re-operation
All-type
N(%)
4 (2.60)
8 (5.19)
0.24
OR (95% CI)
2.05(0.6,6.97)
REF
0.06
Days to re-operation [mean (SE)]
60 (0.6)
240 (2)
0.12
Breast cancer related
N(%)
4 (2.60)
8 (5.19)
0.24
OR (95% CI)
REF
2.05 (0.6, 6.97) 0.25
..
AbbrevIatlOns: SD: standard deviatlOn, OR: odds ratio, CI: confidence interval, SE:
standard error

8.5. Use of predictive modeling to analyze hospital re-admission
8.5.1. Objective
A secondary aim to the current analysis was to predict the risk of 90-day hospitalization
after undergoing a mastectomy or a lumpectomy. A hospitalization shortly after surgery
can be a signal of surgery complications. Patients were followed until they were no
longer enrolled with their insurance or until the end of the study period, which is
December 31 st, 2001. The objective was, more specifically, to provide a simple predictive
model.
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8.5.2. Summary of methods
EM was used to compare different predictive modeling techniques on the 90-day postoperative hospital admission. The input variables were the age divided into three groups
(less than 40 years old, 40 to 60 years old, over 60 years old), disease cluster, type of
procedure (lumpectomy or mastectomy) and the Charlson index at the time of the initial
procedure in three groups (0 or 1,2, and at least 3). Age was categorized following the
recommendation of the American Cancer Society that all women should have an annual
mammogram starting at age 40. The cut-point of age 60 was included to analyze if there
exist differences in outcomes for women who are past the age range of menopause. The
Charlson index was categorized to evaluate the outcomes of patients with comorbidities
(Charlson index 2:: 1) to those with no burden of comorbidities (Charlson index = 0). EM
was used to fit and compare three predictive model methods, the logistic regression, the
neural network and the decision tree. Goodness of fit was evaluated using the
misclassification rate, the average squared error and the area under the receiver operating
characteristic curve (the ROC index). The misclassification rate quantifies in term of
percentage the number of elements that were misclassified by the predictive model. A
small misclassification rate is desired. The average squared error assesses the
performance of the model by mean squared difference between the actual and the
predicted value [59]. The smaller the average squared error, the better the fit. The ROC
curve plots the sensitivity (true prediction rate) against I-specificity (false prediction rate)
for consecutive cut-offs points for the probability of the target [74]. The area under the
ROC curve or c-statistic is a common measure of model discrimination. A c-statistic of
0.5 is similar to the probability of tossing a coin and is considered to be a poor fit with
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equal group sizes. Any c-statistic greater than 0.5 indicates better fit; however, it is
desirable to have a value of at least 0.7 [74]. A value of 1 signifies a perfect fit. A flow
chart of the comparative performance of predictive models is presented in Figure 8.2.
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Figure 8.9: Flow chart of predictive model comparison
8.5.3. Results
8.5.3.1. Data description
Due to the small size of the data available, the data were not divided into a training set, a
validation set and a testing set; it was used as a whole for model construction and model
evaluation. The input variables used were the surgical procedure, the disease cluster, the
Charlson index and the age group.
8.5.3.2. Model selection
Among the three models, Logistic Regression discriminated the best with an ROC index
of 0.58. The Neural Network and the Decision Tree did not have a good discrimination
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(c-statistic: 0.5). The misclassification rate was 12% for the logistic regression and 13%
for both the Neural Network and the Decision Tree. The average squared error values
were close in the three models (0.107 for logistic regression and 0.113 for both Neural
Networks and Decision Tree, Table 8.6). The best predictive model was found to be the
logistic regression.
Table 8.6: predictive model comparison
Model
Logistic
Regression
Neural Networks
Decision Tree

Misclassification
rate
0.12

Average Squared
Error
0.107

Roc
index
0.58

0.13
0.13

0.113
0.113

0.5
0.49

Choice

*

8.5.3.3. Predictive model with the logistic regression
First, a bivariate analysis was performed to evaluate which of the input variables had an
effect on the 90-day post-operative hospital re-admission. Then, the effects of the
variables with a significant association were analyzed in a multivariate logistic
regressIOn.
Table 8.7: Association with post-operative re-hospitalization
Input variable
Surgical procedure
Charlson index
Age group
Disease cluster

p-value
0.009
0.7
0.41
0.9
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Only the surgical procedure had a significant association with 90-day post-operative
hospital admission (Table 8.7). The risk of90-day post-operative hospital admission was
about three times higher for a patient who had a lumpectomy in comparison to a patient
who had a mastectomy (unadjusted odds ratio: 2.031, 95 % confidence interval: 1.0164.06, adjusted odds ratio: 124.669,95% confidence interval: 1.059-124.669, Table 8.8).
Unadjusted models were constructed using only the procedure group as input. Adjusted
results were obtained from the analysis of models which included the Charlson index, age
group and disease cluster in addition to procedure type.
Table 8.8: Odds ratio
Surgical procedure
p-value
Mastectomy lumpectomy
2.031 (1.016,4.06)
Unadjusted OR (95% CI) REF
0.0449
Adjusted* OR (95% CI) REF
11.49 (1.059, 124.669) 0.0447
*Adjusted for disease cluster, Charlson index and age group
Risk measure

8.5.3.4. Construction of a simple predictive model
In the analysis data set, 128 patients who had the mastectomy (47.76%) and 26 patients
who had the lumpectomy (65%) were re-hospitalized within 90-days after surgery. The
unadjusted risk of 90-day post-operative re-hospitalization was about twice higher for a
patient in the lumpectomy group compared to a patient in the mastectomy group. The risk
of re-hospitalization as a function of the procedure only can be expressed as
RE-HOSPITALIZA nON RISK = 48% MASTECTOMY + 65% LUMPECTOMY
where mastectomy and lumpectomy are dichotomous variables, taking the value 1 if a
patient undergoes the procedure.
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Using this simple equation, the following risks were obtained
Table 8.9: Risk of90-day hospital re-admission as a function of the procedure type

90-day post-operative hospital admission risk
Procedure
Mastectomy 48%
Lumpectomy 65%

8.6. Post-operative short-term Cost Effectiveness Analysis
8.6.1. Objective
A cost effectiveness analysis using the claims data was another secondary objective of
the current study. The aim was to evaluate the comparative cost impact when
lumpectomy is chosen instead of mastectomy.

8.6.2. Summary of methods
A special case of stochastic model, Markov Chain was used here. The definition of a
stochastic process and a Markov Chain were provided in section 6.4. In previous sections
of the current chapter, it was found that the 90-day post-operative hospital re-admission
rate was 48% for mastectomy and 65% for lumpectomy. From these values, the
probability of a post-operative hospital re-admission per day can be estimated to be
0.48/90 = 0.005 for the mastectomy procedure and 0.65/90 = 0.007 for the lumpectomy
procedure. Using the data of the procedure hospitalization, it was found that the
maximum length of stay was 20 days for mastectomy and 6 days for lumpectomy. Thus,
the probability of being discharged per day when in the hospital can be estimated by 1120

= 0.05 for mastectomy and 1/6 = 0.17 per day for lumpectomy. In Table 8.5, the average
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charges for the initial procedure of $9191 (average $5410) for Mastectomy and $6911
(standard deviation $3856) for lumpectomy were found. Using these estimates computed
from the data, the state transition matrices M (M) and M (L) can be written as
M(M)=

p (not hospitalizedlnot hospitalized)
[ P (hospitalizedlnot hospitalized)
[0.995
0.05

P (not hospitalized IhosPitaliZed)]
P (hospitalized Ihospitalized)

0.005]
0.95 for Mastectomy

M(L)=

p (not hospitalizedlnot hospitalized)
[ P (hospitalizedlnot hospitalized)
0.993

= [ 0.17

P (not hospitalized IhosPitalized)]
P (hospitalized Ihospitalized)

0.007]
0.83 for Lumpectomy

Here, entries represent probabilities for moving from one state to the next in any given
post-operative day. At day

°

(the index hospitalization), all patients are hospitalized.

Thus, the initial state matrix is Ao = [P (not hospitalization)

[0

P (hospitalized)]

1] for both procedures. Day n after surgery, the state matrix can be obtained by

Measure of Effectiveness can be estimated as follows:
E (M) = PM (not hospitalized) * 154 and E (L) = PL (not hospitalized) * 154 and the
incremental effectiveness of lumpectomy compared to mastectomy is
E (L) - E (M) = 154* (P L (not hospitalized) - PM (not hospitalized))
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where E (M) is the effectiveness of mastectomy and E (L) is the effectiveness of
lumpectomy.
Measures of cost can be estimated as by the average charges for the procedure
hospitalization. Hence, the incremental cost effectiveness ratio at day n (ICERn) can be
computed as follows:
ICER = C (L)-C (M) =
n

E (L)-C (M)

6911-9191
154* (PL (not hospitalized) - PM (not hospitalized))

where C (M) represents the cost associated with mastectomy and C (L) represents the
cost associated with lumpectomy.

8.6.3. Results
In Table 8.1 0, different values ofthe ICER are presented for different values of n. To
illustrate how computations are performed, ICER30 is presented here. At day 30, the state
matrices are

A30 (M) = Ao

* [M (M)] 30 = [0

1] [0.995
0.05

0.257] for Mastectomy

and

A30 (L) = Ao

* [M (L)] 30 = [0

1] [0.993
0.17
Lumpectomy.

With these estimates, the corresponding incremental cost effectiveness ratio of
lumpectomy in comparison to mastectomy is
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leER =
30

6911-9191
154* (0.958 - 0.742)

= -67.30 ~ -67

-,

which means that lumpectomy saved about $67 per patient who had it instead of
mastectomy each day after hospitalization at day 30.
Table 8.10: Incremental cost effectiveness ratio values for different days after the initial
surgery

n

An (M) =
[PM (Ii) PM (h)]

An (L) =
[PM (Ii) PM (h)]

1
2
3
4
5
10
15
20
30
40
50
60
70
80
90
100

[0.17 0.83]
[0.005 0.95]
[0.31 0.69]
[0.09 0.903]
[0.142 0.858]
[0.425 0.575]
[0.184 0.816]
[0.52 0.48]
[0.224 0.776]
[0.598 0.402]
[0.393 0.607]
[0.823 0.177]
[0.52 0.48]
[0.909 0.091]
[0.616 0.384]
[0.9445 0.055]
[0.742 0.257]
[0.958 0.042]
[0.96 0.04]
[0.814 0.185]
[0.96 0.04]
[0.855 0.145]
[0.879 0.121]
[0.96 0.04]
[0.96 0.04]
[0.892 0.108]
0.101]
[0.899
[0.96 0.04]
[0.903 0.096]
[0.96 0.04]
[0.96 0.04]
[0.906 0.094]
Abbreviations: h = hospitalized, h = not hospitalized

leERn

-123
-67
-50
-43
-38
-33
-37
-43
-67
-99
-137
-178
-212
-237
-253
-267

Short
interpretation
Savings of $123
Savings of $67
Savings of $50
Savings of $43
Savings of $38
Savings of$33
Savings of $37
Savings of $43
Savings of $67
Savings of $99
Savings of $137
Savings of$178
Savings of $212
Savings of $237
Savings of $253
Savings of $267

Table 8.11 shows that lumpectomy is associated with cost savings in comparison to
mastectomy after surgery in terms of hospital use.

8.7. Summary
In this chapter, with the use of statistical analysis, it was found that patients in the
mastectomy group had a longer stay and more charges during the initial procedure in
comparison to patients in the lumpectomy group. However, in terms of post-operative
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healthcare resource use, the outcomes were statistically comparable. The use of cluster
analysis revealed that the patients could be classified into four clusters that represent the
extent of the breast cancer condition. Predictive modeling was used to construct a simple
model of post-operative hospital admission. It was found that the risk of 90-day postoperative hospital admission was 65% with lumpectomy while it was 48% with
mastectomy. The use of cost effectiveness methods showed that lumpectomy was
associated with cost savings each day after surgery in terms of hospital usage. At day 1
after surgery, it was found that the savings amount was $127. At day 100 after surgery,
the savings were $267. The lowest savings were observed around day 10 for an amount
of about $33.
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CHAPTER 9
USE OF DATA MINING AND COST EFFECTIVENESS ANALYSIS TO
COMPARE LUMPECTOMY TO MASTECTOMY USING ONLINE
COMMENTS OF SATISFACTION AS A MEASURE OF QUALITY OF LIFE
9.1. Objective
In this chapter, the aim was to perform a cost effectiveness analysis of lumpectomy in
comparison to mastectomy. The outcome was patient satisfaction as a measure of quality
of life. An assumption was made that satisfaction with surgery will improve satisfaction
with personal conditions and thus improving the quality of life. Costs were estimated
from the Nationwide Inpatient Sample (NIS) data. Thus, the hospital perspective was
used. Only direct (gross) costs of the hospitalization in which the procedure is performed
were considered. Since time was not a factor in the two alternatives, a deterministic
model was used. The objective was to use SAS functions and SAS Text Miner tools to
measure an estimate of the probabilities of satisfaction with mastectomy or lumpectomy
from comments that patients post on online discussion boards. These probabilities were
then used in a cost effectiveness model to evaluate the cost of satisfying a patient with the
surgery performed.

9.2. Decision tree
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The two alternatives were mastectomy and lumpectomy. In the decision tree, the
discharge status was included as an event since that may influence patient satisfaction.
The outcome was the fact that either the patient was satisfied or not. Figure 9.1 contains
the decision tree with the two alternatives, the events and the outcomes.

discharge routine
(DR)

discharge home
health care (DR)

satisfied (S)

satisfied (S)

lYIastectomy

other discharge alive
(DA)

satisfied (S)

died
Llunpectomy versus
Mastectomy
discharge routine
(DR)

discharge home
health care (DR)

satisfied (S)

satisfied (S)

lunpectomy
satisfied (S)

#

died
0.5

Figure 9.1: Decision tree for the cost-effectiveness model
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9.3. Data -Online comments
In the current analysis, web posts from www.breastcancer.org were studied. The website
www.breastcancer.org contains general information on breast cancer: symptoms,
diagnoses, treatments, post-treatment advice, etc. One of the things the website offers to
its viewers is a set of discussion boards. The discussion boards contain many subjects
related to the breast cancer journey. Each subject contains many forums and in each
forum, there are many topics. Here, the forum of 'surgery-before, during and after' in the
subject of 'test, treatments and side effects' was chosen. Within this forum, the interest
was on topics that explored the comparison or the choice oflumpectomy or mastectomy.
A topic can be created by an individual creating an account and posting a concern, a
question, or a quest of advice. By responding to this posting, participants or viewers post
their comments. The comments analyzed were about what patients responding with
information of what type of choice they made, why they made this choice, whether they
are satisfied and what kind of advice they can give to the person asking the question.

9.4. Pre-processing
9.4.1. Transformation of comments into a table
Here, each posting constituted a document. Because of this nature ofthe data, the macro
%TMFIL TER was not used since it stores each web page as a document and in this case,

there were many documents (comments) in one web page. Instead, the topics were
screened to evaluate which ones talked about the comparison of lumpectomy to
mastectomy. The following topics were found:
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Lumpectomy or mastectomy
Future follow-up -lumpectomy vs. MX*
Lumpectomy vs. mastectomy ( 7 times)
What were the reasons that you had a mx versus a lumpectomy
Lumpectomy vs. skin-sparing mastectomy for cosmetic purposes
How to decide between lumpectomy and mastectomy
Mastectomy vs. lumpectomy
Need to decide: lumpectomy vs. mastectomy
Lumpectomy or mastectomy
Lumpectomy: re-excision or mastectomy
Mastectomy vs. lumpectomy decision
Mastectomy or lumpectomy
For those who "could" have lumpectomy ... why choose Mast*
Mastectomy or Lumpectomy
Lumpectomy or Mastectomy
Mastectomy vs. Lumpectomy MRI
*mx, mast = mastectomy
The content of the pages of these topics was copied, pasted and formatted in Microsoft
Word and then Excel to a table. The data contained a total of337 web posts discussing
the choice between mastectomy and lumpectomy.

9.4.2. Use of SAS to format the table in appropriate analysis format
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The final table obtained in Excel contained multiple rows per document (comment). The
next step was to use SAS functions to form a table in which a row represented the whole
comment of an individual. Next, the SAS codes used are presented
Code 9.1: Creation of the common identification number (lD) for all the rows of a same
comment
DATA COMMENTS1;
SET COMMENTS;
IF NAME NE I
RUN;

I

THEN 10+1;

Code 9.2: Transpose the data per person to obtain one row and many columns
PROC TRANSPOSE OATA=COMMENTSl OUT=COMMENTS2;
VAR POST;
BY 10;
RUN;

Code 9.3: Concatenate all the columns into one to obtain the whole comment in one cell
per person
DATA COMMENTS3;
SET COMMENTS2;
LENGTH POSTS $ 32767;
POSTS=CATX(' ' f OF COLI-COL12);
RUN;

Table 9.1: Random sample of the pre-processed data
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9.4.3. Exploring the resulting data to obtain analysis variable values
The comments analyzed in chapter 10 were used for the purpose of this chapter as well.
After the data were preprocessed and in the final data each row presented a comment, the
data were entered into Enterprise Miner. The sample node (Figure 9.2) was used to select
a random sample of20 comments (5.93%) that were read completely to evaluate how
patients expressed their satisfaction and how they announced what procedure they
underwent.

Figure 9.2: Flow diagram for comment sampling
Two variables needed to be created from the comments: (1) the type of procedure the
person underwent and (2) whether this person was satisfied. One way to do this would be
to read all the comments and to note the values ofthese variables. However, this method
is not efficient, as it will require a lot of time. For a few comments, it is can be done but
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as the number of comments increase, it becomes difficult. Here, only 10 comments were
completely read and evaluated. It was noted that patients used different expressions but
some similarities were present: (1) the verbal part of the expression was similar to 'had',
'chose', 'opted for', 'ended up going with', 'decided on'; (2) the procedure choice was
announced with or without the article 'a' as 'mastectomy', 'mx', 'bilateral mastectomy',
'bmx', 'blmx', 'lumpectomy', 'lump'; (3) satisfaction with the surgery was recognized by
the presence of words such as 'happy', 'satisfied', 'OK', 'fine'. All these words and
expressions were used in a SAS index function to create the procedure type and the
satisfaction in the code below.

Code 9.1: SAS code to create procedure type and satisfaction variables
DATA DATA;
SET SASUSER.DATA;
IF (INDEX(POSTS, 'had mastectomy'»O
OR INDEX (POSTS, 'chose mastectomy'»O
OR INDEX (POSTS, 'prefered mastectomy'»O
OR INDEX (POSTS, 'opted for mastectomy'»O
OR INDEX(POSTS, 'ended up going with mastectomy'»O
OR INDEX (POSTS, 'decided on mastectomy'»O) THEN
GROUP=l;
*GROUP=l represents the mastectomy procedure;
*repeat the code above replacing 'mastectomy' by 'mx',
'bilateral mastectomy', 'bmx', 'blms';
*repeat the whole resulting code adding the article
'a'
in front of the procedure;
IF (INDEX(POSTS, 'had lumpectomy'»O
OR INDEX(POSTS, 'chose lumpectomy'»O
OR INDEX (POSTS, 'prefered lumpectomy'»O
OR INDEX (POSTS, 'opted for lumpectomy'»O
OR INDEX (POSTS, 'ended up going with lumpectomy'»O
OR INDEX (POSTS, 'decided on lumpectomy'»O) THEN
GROUP=2;
*GROUP=l represents the mastectomy procedure;
*repeat the code above replacing 'lumpectomy' by
'lump' ;
*repeat the whole resulting code adding the article
'a'
in front of the procedure;
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IF (INDEX(POSTS, 'happy'»O OR INDEX(POSTS, 'satisfied'»O
OR INDEX (POSTS, 'OK'»O OR INDEX (POSTS, 'ok'»O
OR INDEX (POSTS, 'fine'»O)
THEN SATISFIED=l; ELSE SATISFIED=O;

RUN;

Code 9.1 covered a total of 84 comments (25%) which is more than four times the
comments read completely. The results are tabulated below.
Table 9.2: Satisfaction probability estimates by procedure

Satisfied Mastectomy [N (%)] Lumpectomy [N (%)]
No
19 (63.33)
26 (48.15)
Yes
11 (36.67)
28 (51.85)

Clearly the percentage of satisfied individuals is higher in the lumpectomy group than in
the mastectomy group. A chi-square test revealed however, that this difference is not
statistically significant (p-value = 0.18).

9.5. Data - NIS
The NIS, which is an in-hospital discharge database was used to compute an estimate of
the probability of the discharge status. The discharge status in NIS is recorded in a
variable called DISPUNIFORM, which has the following categories [13]: (1) routine; (2)
transfer to short term hospital; (5) other transfers, including skilled nursing facility,
intermediate care, and another type of facility, (6) home health care, (7) against medical
advice, (20) died in hospital, (99) discharge alive, destination unknown. The following
code was used to create the categories corresponding to the events in the decision tree:
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Code 9.2: SAS code to create the categories of the event 'discharge status' in the decision
tree.
DATA ANALYSISDATA;
SET SASUSER.ANALYSISDATA;
IF DISPUNIFORM=l THEN DISCHARGE=l;
ELSE IF DISPUNIFORM=6 THEN DISCHARGE=2;
ELSE IF DISPUNIFORM=20 THEN DISCHARGE=4;
ELSE DISCHARGE=3;
RUN;

The results are tabulated below.
Table 9.3: Probability estimates of the event 'discharge status'

Discharge status
Mastectomy rn (%)1
Discharge routine
505 (75.04)
Discharge home health care
136 (20.21)
Other discharge alive
30 (4.46)
Died
2 (0.30)

Lumpectomy rn (%)]
531 (78.90)
103 (15.30)
35 (5.20)
4 (0.59)

The NIS was also used to compute the cost of each alternative as the total hospital
charges. To compute the charges, the SAS code PROC MEANS procedure was used.
Code 9.3: code used to compute the total costs per procedure.
PROC MEANS DATA=ANALYSISDATA SUM;
VAR TOTCHG;
BY GROUP;
RUN;

9.6. Using probability values to fill out the decision tree
The probability estimate obtained from the analysis of comments and from the NIS data
were used to fill out the decision tree (Figure 9.2).
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0.0059

Figure 9.3: The decision tree filled with obtained probability estimates
9.7. Measure of Effectiveness
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Effectiveness was measured as the number of satisfied individuals in each procedure
type. To compute effectiveness, the probability estimates obtained in the tree (Figure 9.3)
were used.

9.7.1. Effectiveness in the Mastectomy group
Let P represent the probability measure, S represent satisfaction, M the mastectomy
group, DR the discharge routine, DH the discharge to home health care, DA the other
discharge alive to define the probability of satisfaction given that the mastectomy
procedure is computed below.
P (SIM) = P (SIDRIM) * P (DRIM) + P (SIDHIM) * P (DHIM) + P (SIDAIM) * P (DAIM)

= (0.3667)*(0.7504) + (0.3667)*(0.2021) + (0.3667)*(0.046) = 0.36615
The mastectomy group from the NIS data contained 673 individuals; thus, the expected
number of satisfied patients in this group was
(673) * (0.36615) = 246

9.7.2. Effectiveness in the Lumpectomy group
Using the same definition as in the paragraph above and letting L represent Lumpectomy,
the probability of satisfaction given that the lumpectomy procedure is computed below.
P (SIL) = P (SIDRIL) * P (DRIL) + P (SIDHIL) * P (DHIL) + P (SIDAIL) * P (DAIL)
= (0.5185)*(0.7890) + (0.5185)*(0.1530) + (0.5185)*(0.0520) = 0.515389

176

The lumpectomy group from the NIS data contained 673 individuals as well. In fact, a
random sample of the mastectomy group was selected to match the lumpectomy group
sample size of 673 (refer to chapter 7 for details). Thus the expected number of satisfied
patients in this group was
(673)

* (0.515389) = 347

The incremental effectiveness of lumpectomy with respect to mastectomy was found to
be 347 - 246 = 101 satisfied individuals.

9.S. Measure of cost

The cost was measured computed from the NIS data and it was shown that the total
charges for all the patients in the mastectomy group was $13,704,584 and in the
lumpectomy group $13,647,285. Thus, the incremental cost oflumpectomy with respect
to mastectomy was $13,647,285 - $13,704,584 = -$52,299

9.9. Incremental Cost Effectiveness Ratio (ICER)

The incremental cost effectiveness ration is the relative cost by the relative effectiveness.
Here, it was -$52,299 / 101 = -$517.812 . This value represents the incremental cost per
satisfied patient if the lumpectomy is used instead of a mastectomy. Hence, in this case,
lumpectomy saves $517 for each satisfied individual in comparison to mastectomy.
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9.10. Summary

Data mining sample node did a good job of sampling a small set that was representative
of the population (comments). With a sample of 20 comments, it was possible to screen
84 comments for what type of procedure they underwent and whether they were satisfied.
Although, 84 comments are still a small subset ofthe 337 comments, it was four times
the size of the comments read. There is room for improvement on this method; it can be
explored on how to use text mining to screen the sampled comments. This would help
increase the size of the sample and thus covering a larger number of comments. Patient
satisfaction is very important in measuring treatment success. This chapter provides a
simple method that permits the use of open source discussion board comments to factor
patients' input into analysis and especially in cost effectiveness analysis.
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CHAPTER 10
USE OF TEXT MINING TO ANALYZE PATIENT OPINION WITH
LUMPECTOMY OR MASTECTOMY IN THE FORM OF ONLINE COMMENT
POSTING
10.1. Objective
The objective of the current section was to use online discussion boards' comments to
analyze patients' satisfaction after mastectomy or lumpectomy. In today's society, the
analysis of patient input goes beyond a simple participation in a survey study or filling a
post-treatment survey. A survey study, though effective and still a valuable means of
analysis ofthe patient's opinion, requires all the hustle that comes with a research studyadequate preparation, and inconvenience of a small sample size due to lack of volunteers.
Very few individuals actually fill out the post-treatment satisfaction forms that are either
given or sent to them. With the expansion of the internet to the actual extent, most people
tum to it to express their feeling about many things including healthcare. Their comments
can be about experience, satisfaction or frustration, advice, etc. Today, there are forums
of about everything. Here, the forums of lumpectomy versus mastectomy are analyzed.
Patient input is very important in analyzing treatment effectiveness. The use of web posts
in discussion boards' forums offers a quick and easy way to factor patient opinion into
effectiveness analysis.
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10.2. SAS Text Miner in SAS Enterprise Miner
SAS Text Miner is an option offered by SAS Enterprise Miner to analyze text documents.
In addition to being able to transform documents submitted to it into knowledge, it has
the capability to crawl the web with the use of %TMFIL TER macro. This macro finds the
documents related to an initial website and subsequent links [59] and saves them in a
directory on the local computer. These documents can then be analyzed by SAS Text
Miner techniques and tools.

10.3. Data - Online comments
The comments pre-processed and analyzed in chapter 9 were used for the purpose ofthis
chapter as well. Here, the data obtained after the preprocessing of section 9.4.2 were
used.

10.4. Analysis with SAS Text Miner
The pre-processed data were entered into SAS Enterprise Miner and were analyzed with
the Text Miner node (see Figure 10.1 for the process flow).

-

,.

Figure 10.1: Process flow for Text Mining analysis
Most settings of the Text Miner node were left at default (Figure 10.2). The parsing was
done using a synonym list provided with the SAS Enterprise Miner software package and
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Text Miner was set to create clusters automatically with a total number of no more than
four clusters and no more than five descriptive terms per cluster.

Figure 10.2: Enterprise Miner Text Miner node settings for the analysis
10.5. Results - Clusters and concept links
A total of three clusters were created out of280 documents (83.09% of the total sample
size). Most comments (36% of the 280 documents) were about things to take into
considerations before making the choice (second opinion, breast cancer, local recurrence
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possibility). The second big cluster (29%) contained comments about the fact that the
best decision is personal. The smallest cluster (23%) contained web posts about
responders who decided to have a breast reconstruction after the surgery.
Table 10.1: Clusters of the comments (Total number of documents = 280)

Cluster
number
1
2
3

Descriptive terms
Second opinion, breast cancer,
local recurrence, good luck
Personal decision, survival rate,
invisible threads, best choice
Whole reconstruction, straight
away making

N
(%)
115
(36)
91
(29)
74
(23)

Cluster name
Give advice on what to
consider to make a choice
Made a personal decision
Had breast reconstruction
right after surgery

The clusters obtained reflect the main thought while making the decision. Text Miner has
a tool, concept links, that helps to evaluate the strength of association between terms.
Next the concept links of the terms related to mastectomy, advice and decision are
analyzed.

Figure 10.3: Concept links ofthe term ' bilateral mastectomy'
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The term ' bilateral mastectomy' had a strong association with the terms 'node' and
' longer surgery'.

Figure 10.4: Concept links of the term ' single mastectomy'
The term ' single mastectomy' was strongly associated with ' breast cancer diagnosis',
'node positive', ' implant reconstruction' and ' annual screenings'.

Figure 10.5: Concept links of the term ' good advice '
The term ' good advice' was strongly associated with all the terms it was linked to.
However, the strongest association was with the term ' actual event' .
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Figure 10.6: Concept links of the term ' good decision'
The term ' good decision' was also strongly associated with all the terms it was linked to.
Just like the term ' good advice', the strongest association was with the term ' actual
event'.

Figure 10.7: Concept links of the term ' form

r~gret '

The term ' form regret' was strongly associated with all the terms it was linked to. These
terms include: ' personal issues', ' absolute worst' , and ' genetic predisposition' .

10.6. Summary
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In this section, Text Miner was found to be an important tool that can be used to analyze
online comments posted. It helps reduce many posts into a handful of groups gathered by
the similarity of their content. Also, it helps in analyzing the links and the strengths of
associations of the terms used in comments. Here, the analysis of web posts on the choice
between mastectomy and lumpectomy showed that more commenters wrote about things
taken into consideration to make a choice. The second largest group contained patients
who advocated that the best decision is personal. The use of concept links to analyze the
association of different terms showed that the term 'bilateral mastectomy' was strongly
linked to the terms 'node' and 'longer surgery'.
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CHAPTER 11
USE OF DECISION ANALYSIS METHODS TO EVALUATE THE LONG-TERM
-10 YEARS- COMPARATIVE EFFECTIVENESS FOR LUMPECTOMY AND
MASTECTOMY
11.1. Objective
The purpose of this chapter is to complement the statistical analysis with decision science
to provide more details on the comparison of outcomes for mastectomy and lumpectomy.
Here, the literature review is used to estimate effectiveness for the long term. The studies
used are here [2-6] also presented in the literature review in chapter 3. With the use of
statistical analysis, these studies concluded that lumpectomy was equivalent to
.Mastectomy in terms of long term overall survival as well as disease free survival.
Decision analysis is based on conditional probability and its theory is reviewed in chapter
6. The effectiveness is expressed as no tumor recurrence and survival in 10-years after
surgery.

11.2. The decision trees
Decision analysis was performed in terms of comparative effectiveness of the
lumpectomy in contrast to mastectomy. Comparative effectiveness can be defined as a
comparison of strategies in terms of their health and clinical outcomes. The effectiveness
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for the current study was measured as deaths averted or local-regional recurrence averted
by the use of mastectomy in comparison to lumpectomy. The trees in Figures 11.1 and
11.2 were used to evaluate the alternatives.

lO-year recurrence
cancer recurrence
Mastectomy
No lO-year
recurrence

Breast cancer
surgical treatment

no cancer recurrence
lO-year recurrence
cancer recurrence
Lumpectomy
No lO-year
recurrence
no cancer recurrence

Figure 11.1: Decision tree to evaluate lumpectomy in comparison to mastectomy in terms
of tumor recurrence averted.

lO-year survival

life
Mastectomy
No lO-year survival

Breast cancer
surgical treatment

death
lO-year survival

life
Lmnpectomy
No lO-year survival

death

Figure 11.2: Decision tree to evaluate lumpectomy in comparison to mastectomy in terms
of death averted.
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11.3. Literature search strategy, selection and data extraction
11.3.1. Literature search strategy and selection
The MEDLINE (Medical Literature Analysis and Retrieval System Online) database was
searched with the use of PUBMED. MEDLINE is a National library database of life and
biomedical science research bibliographies [15]. It covers numerous medical fields
including medicine, nursing, dentistry, veterinary medicine, the healthcare system and the
pre-clinical sciences. PUBMED is a free database that accesses MEDLINE.
Of interest were studies that focused on the comparison of breast conserving surgery and
mastectomy published in English between 2000 and 2010. The searching phrase was
'lumpectomy versus mastectomy in USA'. The process returned a total of 240 results.
After reviewing the titles, 56 abstracts were retrieved and analyzed. Next, the abstracts
were reviewed and seven articles were fully retrieved and used for the literature review
and related work.
The outcome of interest for the current analysis was 10-year mortality and 10-year
recurrence. Eligible for the data abstraction were articles that reported the number of
individuals who died and the number of recurrences. Other selection criteria included
study design, study population, sample size and main outcome of interest. Studies that
were not clinical trials and studies that did not report percentages for mortality or
recurrence were excluded. Finally, five articles were considered to be relevant for the
current analysis.
11.3.2. Data extraction
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For these studies, the following data were extracted: the total sample size and the size of
each arm, the follow-up time, the recurrence and the mortality percentages. These data
were used to estimate effectiveness in the analysis. Table 11.1 provides details on these
articles and on the data extracted.
Table 11.1: Studies used in the Comparative Effectiveness Analysis

Study
reference
and size
[6] (n=237)

Follow-up
time
About 20
years
About 20
years

Group
Mastectomy
BCS
[2] (n=1851)
Total mastectomy
Lumpectomy
Lumpectomy and irradiation
Radical mastectomy
[3] 6 (n=701) About 20
years
BCS
10 years
Mastectomy
[4] (n=868)
BCS
Mastectomy
[5] (n=237)
Median 121
months (about Lumpectomy and Radiation
10 years)
*BCS: Breast conservation surgery

Localregional
Group recurrence
(%)
size
116
33
121
37
589
37.2
634
42.4
628
34.1
348
8
352
30
428
12
448
20
116
10
121
5

Death
(%)
42
48
Not
available
Not
available
34
35
25
23

In study [2], the local-regional recurrence results were presented in terms of individuals
who developed a recurrent tumor. Corresponding percentages were computed and
presented here.
Only two groups were considered for the current study, the mastectomy and lumpectomy.
Some articles used in the current project, designed their studies with three groups. For
these studies, groups that involved the same main procedure were merged and results
were estimated by pooled values.

189

The follow-up time was chosen to be 10 years. Hence, all the 20-year results were
adjusted. The 1O-year percentages were estimated by half of the 20-year percentages.
Table 11.2 contains the values from pooled, adjusted results for studies [6], [2] and [3].
Table 11.2: Adjusted data for studies [6], [2] and [3]
Study
reference

Group

[6]

Mastectomy

[2]
[3]

Bes

Total mastectomy
Lumpectomy
Radical mastectomy

Bes

Local-regional
recurrence
(%)
16.5
18.5
18.6
19.13
4
15

Death (%)
21
24
Not available
Not available

11.3.3. Computation of probability estimates
From the data presented in Tables 11.1 and 11.2, a pooled population of 3894 patients in
total was obtained, among which, 1598 (41.04%) underwent mastectomy (see Table
11.3).
Table 11.3: Estimated group sizes of the pooled data for comparative effectiveness

Total
Mastectomy
Lumpectomy

Size
3894
1598
2300

Percentage
100
41.04
59.06

Expected mortality and local and regional recurrences associated with each surgery
treatment were considered for the current analysis and they were computed using data
values summarized below from Tables 11.1 and 11.2.
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Table 11.4: Summary of probability estimates from the literature

Study reference

Mastectomy
Size Recurrence Mortality

Lumpectomy
Size Recurrence Mortality

[6]
[2]
[3]
[4]
[5]

116
589
348
428
116

121
1262
352
448
121

0.165
0.186
0.4
0.12
0.10

0.21
NA
NA
0.34
0.25

0.18
0.19
0.15
0.20
0.5

0.24
NA
NA
0.35
0.23

11.4. Results
11.4.1. Effectiveness in terms of lO-year local/regional recurrence: Expected
local/regional recurrences
The expected probability of local/regional recurrence of breast cancer was calculated
from the data in Table 11.4.

Mastectomy: (116*0.165 + 589*0.186 + 349*0.4 + 428*0.12 + 116*0.10) / (116 + 589 +
349 + 428 + 116) = 0.1287
Lumpectomy: (121 *0.18 + 1262*0.19 + 352*0.15 + 448*0.20 + 121 *0.5) / (121 + 1262
+ 352 + 448 + 121) = 0.2026
The difference in expected probability of local and regional recurrence of breast cancer in
10 years after surgery treatment between lumpectomy and mastectomy is 0.2026 - 0.1287
= 0.0739. That is in 10 years, 739 women out of 10,000 would be expected to not have
recurrent breast cancer by undergoing mastectomy instead oflumpectomy.

11.4.2. Effectiveness in-terms of lO-year mortality: Expected deaths
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The expected probabilities of death from breast cancer in the mastectomy and
lumpectomy groups are computed below. Only data extracted from studies [6], [4] and
[5] were used.
Mastectomy: (116*0.21 + 428*0.34 + 116*0.25) / (116 + 428 + 116) = 0.3013
Lumpectomy: (121 *0.24 + 448*0.35 + 121 *0.23) / (121 + 448 + 121) = 0.3097
The difference in expected probability of death from breast cancer in the 10 years after
surgical treatment between lumpectomy and mastectomy is 0.3097 - 0.3013 = 0.0084.
Thus, an expected number of 84 deaths are prevented in 10 years per 10,000 breast
cancer patients who undergo mastectomy.

11.5. Summary

In summary, decision science complements statistical analysis here, in providing the
number of deaths and recurrences averted by the alternative procedure. In a population of
10,000 women undergoing surgery for breast cancer, 10 years down the road,
mastectomy was found to prevent 739 recurrences and 84 deaths. While statistical
analysis provides significance or no significance, the use of decision science was found to
give more specific details to the decision maker.
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CHAPTER 12
DISCUSSION AND CONCLUSION
12.1. Overview

In the current study, statistical methods complemented with data mining, decision
analysis and cost effectiveness analysis methods were used to compare lumpectomy to
mastectomy in administrative data, literature review data and online comment postings.
The comparison was made to determine whether lumpectomy outcomes statistically
differ from mastectomy outcomes, to evaluate if a simple predictive model could be
constructed to predict post-operative hospital admission within 90 days after surgery
using type of procedure as input and to evaluate patient satisfaction with the procedure.
Traditional statistical analyses methods were used to test the differences between groups
of procedures. Data mining methods were utilized to create and evaluate the performance
of a predictive model. Decision analysis techniques were used to evaluate the
effectiveness of lumpectomy in comparison to the effectiveness of mastectomy on a 10
year period. Cost effectiveness methods were used to evaluate the incremental cost per
satisfied patient oflumpectomy in comparison to mastectomy. As a result, primary and
secondary analyses were performed using the NIS data, the Thomson Reuter's Market
Scan data, data from the medical literature and data from online po stings in breast cancer
forums.
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12.2. Description of findings
The NIS data was used to compare health and clinical outcomes during the
hospitalization for the surgery, the MarketScan longitudinal data was used to compare
clinical and healthcare utilization outcomes after the surgery for a period of 249 days
average, the literature was used to assess the differences in health outcomes 10 years after
the surgical treatment and the online comments were used to explore patient satisfaction
after surgery.
With the use of statistical methods, it was found that at the procedure hospitalization,
patients who had lumpectomy had a significantly longer stay (p-value < 0.0001), higher
hospital charges (p-value: 0.02) but similar in-hospital death (p-value: 0.42). The analysis
of longitudinal data, with statistical methods, showed that post-operative healthcare
utilizations were similar in both surgery groups. The use of a predictive model, chosen by
data mining to be the best, revealed that patients who undergo lumpectomy are twice
more likely to have at least one hospital admission in 90 days after surgery (p-value:
0.0449). Lumpectomy, or in general breast conservation surgery, has been extensively
compared to mastectomy in clinical trials in terms of disease free survival and overall
survival [2-7, 34-37]. Their conclusions have been concordant; lumpectomy was found to
be comparable to mastectomy in terms of these outcomes. Methods used for data analysis
were statistical models, in particular survival analysis models. The current analysis did
not compare lumpectomy to mastectomy in terms of long term survival. Thus, a contrast
of these studies to the current one cannot be performed in these terms. Instead, a long
term comparison was made in terms of deaths in recurrence averted using decision
analysis methodologies. It was found that in 10 years, an estimate of 84 would be
194

prevented death and 739 would be prevented to have recurrence by the use of
mastectomy on 10,000 breast cancer women in contrast to lumpectomy. No studies are
available that compared lumpectomy to mastectomy in terms of immediate and short term
follow-up health outcomes after surgery using real world data. Numerous studies
compared mastectomy and breast conservation surgery in terms of cost. Barlow et al. [41]
found that breast conservation surgery had higher short-term (:5 1 year) costs but lower
long-term (~ 5 years) after diagnosis. Polsky et al. [42] found that after surgery,
providing a choice is economically attractive in comparison to restricting the choice to a
single therapy. In the current study, it was found that short after surgery (average 8
months), mastectomy was associated with higher post-operative hospital charges,
outpatient services and medications. The difference of these results with earlier published
reports may be explained by the small sample size of the current study and a relatively
short follow-up time. In addition, the capitation status was unknown for all the patients in
the cohort.
The analysis of online comments from breastcancer.org discussion board forums revealed
that a high number of posts (36%) were from patients who were advising on what to
consider making a choice (second opinion, local recurrence). In terms of patient's choice,
Kirby [39] found that many patients, given the choice between breast conserving surgery
and mastectomy, choose mastectomy because they feel much safer and/or want to
decrease the risk of further surgery. In the current study, it was found that patients
express that the choice is personal and that local recurrence is one factor for making a
decision.
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An analysis of the patient satisfaction reveals that only 36.67% of the patients who
indicate that they underwent mastectomy were satisfied while up to 51.85% of the
patients who indicate that they underwent lumpectomy were satisfied. A cost
effectiveness analysis showed that lumpectomy saved $517 per satisfied patient in
comparison to mastectomy.

12.3. Implications
12.3.1. Implications in data analysis

In the medical and public health literature, statistical methods are the ones mostly used
for research. They perform well in clinical trial data but are limited when it comes to
large administrative databases. Yet, a look in recent published reports shows that the use
of administrative data to answer some key research questions is increasing. Methods used
in the current study will provide statisticians in the medical and public health field as a
way to augment data mining to statistical methods. Also, the algorithm used to evaluate
patient satisfaction and find the type of procedure in posted comments will help
researchers with limited funds conduct studies on patient opinion.
12.3.2. Implications in breast cancer surgical treatment

Every woman is at risk of breast cancer and the risk of developing breast cancer increases
with age [10]. Medical science is evolving and today, more than ever before, women
have many options of treatment sequence. Surgery remains, however, the core line of
treatment action. Breast conserving surgery and specifically lumpectomy have been
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proven to have the same effect as mastectomy in long-term disease free and overall
survival. Nevertheless, its comparative effectiveness in health outcomes and healthcare
resources use in the period following surgery is still to be discussed. The current study
will help patients and their families as well as healthcare providers and those financially
responsible in their choice decision making and their preparation to enter the treatment
phase.

12.4. Limitation
12.4.1. Limitation related to the methods and the analysis

Although the predictive modeling comparison isolated a best model in terms of
performance, the chosen model was still weak with only a c-statistic of 0.58 when a
desirable value is at least 0.7. This model needs to be improved. Inclusion of cancer
characteristics may help improve the performance.
The method used to extract the type of procedure and whether satisfied covered only 25%
of the comments. This low percentage can partially be explained by the fact that some
patients did not specifically say what procedure they had. Nevertheless, these methods
need to be improved to rely completely on the software and less on the user reading
comments.
12.4.2. Limitation related to the data and the variables

The analysis used administrative data in which patients were selected using ICD-9-CM
codes and CPT -4 codes. An assumption that these were accurate and correctly entered
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was made. For the follow-up analysis, the study population comprised individuals and
their dependents with employer sponsored insurance. This portion of the population is
more likely to be younger and relatively healthier. Hence, the results should be cautiously
interpreted in terms of generalizability to the entire US population. In addition, these data
lack information on some demographics variables such as race. Also, these data do not
have information on breast cancer characteristics such as staging and class which have
been found to influence the choice of surgical procedure and may influence the clinical
resource usage as well as charges. Another limitation encountered associated to the data
is its nature. The patients are not randomly assigned to procedures; which introduces
selection bias to the analysis. Propensity score matching or other matching techniques
that attempt to mimic the randomization processes could be used to address this problem
if the dataset available is initially large enough.
The analysis mainly considers all-cause hospital usage, all-cause clinical usage and longterm all-cause mortality. A more sophisticated analysis may wish to adjust the cause of
the hospital usage, the cause of the clinical usage and the cause of death and to compare
the treatments with respect to these causes. It was not known which capitation status the
patient's insurance plans were. Hence, the cost analysis may be affected by the fact that
some patients have capitated insurance plans while others did not.

12.5. Contribution of the current study to research
12.5.1. Contribution to comparative effectiveness analysis
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In the field of comparative effectiveness, the current study innovates the current
techniques by giving methodologies to supplement statistical models with data mining,
decision analysis and cost effectiveness analysis methods to obtain a complete picture of
the comparison containing short and long term outcomes when administrative data are
used.

12.5.2. Contribution to breast cancer surgical treatment
The current analysis provides a complement to the results already available in the area of
comparison oflumpectomy to mastectomy. It is already established that lumpectomy is
equivalent to mastectomy for breast cancer surgical treatment in terms of long term
overall survival and disease-free survival. The current study complements these results by
providing the following comparison:
(1) Hospital usage during the surgery
(2) Healthcare resource use (hospital admissions, outpatient services, prescribed
medications) and charges for up to eight months after surgery
(3) Post-operative hospital re-admission in 90 days
(4) Patient satisfaction
(5) Deaths and recurrences prevented in 10 years
(6) Cost effectiveness each day after surgery in the payer's perspective

12.6. Areas of future research
12.6.1. Further research in methodologies

199

Further research regarding use of data mining in comparing lumpectomy to mastectomy
includes construction of a predictive model for repeat operation. For this purpose, data
providing a long follow-up are needed and if cancer characteristics are not available,
cluster analysis can be used to group patients in different breast cancer categories. An
improvement of the algorithm to analyze online comments should be done. Text mining
should be explored and methods developed to obtain detailed information such as type of
procedure and/or satisfaction, without the user having to read any comment.

12.6.2. Further research in health outcomes
Further research regarding the comparison of the breast cancer surgical treatments will
warrant a deeper analysis of these procedures. To accomplish this, a larger sample and a
longer follow-up time should be considered and the procedure groups should be
compared adjusting for important breast cancer characteristics, including but not limited
to staging. Moreover, propensity score matching should be used to obtain comparative
groups in order to achieve a conclusion with limited bias and confounding. The repeat
operation should be analyzed to evaluate the group with a greater risk of undergoing a
subsequent surgery. Also, a better and more accurate post-operative hospital admission
predictive model should be constructed using patient demographics, breast cancer
characteristics, hospital characteristics, pre-operative disease cluster and comorbidity
condition. A decision analysis and a cost effectiveness analysis should be performed from
the analysis data. Further research also includes the analysis of access to breast cancer
surgical treatment, looking especially at age disparities since new data show that some
patients are denied surgery because they may be too old [75].
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12.7. Summary of the current study
12.7.1. Summary of methods
The use of administrative data for medical and public health research is increasing and
due to its low cost, it is taking the place once held by clinical trials. These data are now
very large and more than ever, it is necessary to develop methods to analyze them
adequately. The main objective of this study was to provide methodologies and statistical
models, supplemented by data mining, decision analysis and cost effectiveness methods
to analyze these data.
Statistical models are still of great importance when the data are processed, cleaned and
transformed right. They do come short though, when the assumptions cannot be satisfied,
the randomness required cannot be assumed or achieved through some mimic processes
and when the data are just too large and statistical tests are more likely to be significant
no matter what.
Data mining looks promising in this research field. It can help accomplish much more
than statistical analyses since it does not make any assumptions. It has exploratory
capabilities; it can generate hypotheses and test them at the same time. The interest of
using data mining in medical and public health research is growing.
Decision analysis and Cost Effectiveness methods have been used in medical and
healthcare research before. However, this is the first time effectiveness is measured using
patient opinion expressed through discussion boards.
12.7.2. Summary of results

201

Lumpectomy and mastectomy are the two main options available as a first line for breast
cancer treatment episode, especially in the case of early stage diagnosis. It is of great
importance for the patients that an optimal choice be made to maximize their short term
and long term outcomes. The purpose of this study was to compare lumpectomy to
mastectomy in peri and post-operative health and clinical outcomes as well as healthcare
resources use. The ultimate goal was to complement published reports that have
evaluated the long-term outcomes, but do not consider short-term outcomes. Mastectomy
is the removal of the whole infected breast while lumpectomy is a minimally invasive
procedure during which only the tumor and surrounding healthy tissues are removed from
the infected breast. Lumpectomy was introduced and recommended for early stages as an
alternative to mastectomy given that it was shown to achieve the same survival
effectiveness. Thus, the one objective of the current study was to analyze whether this
effectiveness translates into real world cases in short term outcomes; in other words,
whether lumpectomy was as beneficial as mastectomy shortly after surgery as well. This
goal was realized by evaluating the differences in these procedures and testing these
differences for statistical significance. In addition, a long-term comparative effectiveness
was performed to evaluate the deaths and tumor recurrences. Overall, this study found
that lumpectomy was associated with longer in-hospital stay, higher hospital charges,
higher in-hospital death rates and a higher risk of 90-day post-operative hospitalization. It
was also found that, in a period of 10 years after surgery, mastectomy would prevent
deaths and recurrences if used instead oflumpectomy. In terms of cost, lumpectomy
saved money per satisfied patient and more patients who underwent lumpectomy were
satisfied compared to those who underwent mastectomy.
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12.S. Conclusion

The current study encountered limitation in model development: a weak predictive
model, a small sample extracted from the comments online. Other limitations were due to
the use of administrative and insurance data, the lack of cancer characteristics, an overall
small size, a short follow-up period and lack of information on capitation status of the
insurance plans. These limitations imply that the methods should be applied and the
results should be interpreted with caution. Despite these limitations, this analysis
provides useful methodologies for administrative and web data and important information
on the existing debate of the comparison of lumpectomy and mastectomy in health
outcomes. A more in depth analysis considering a larger sample size, a longer postoperative follow-up time and adjusted procedure groups would lead to better methods and
to a better understanding of the surgery type effect on immediate and follow-up postoperative outcomes.
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